Source: Data as uploaded by States-UTs on HMIS portal, status as of 20 July 2018.
\\n\\n
IntechOpen Book Series will also publish a program of research-driven Thematic Edited Volumes that focus on specific areas and allow for a more in-depth overview of a particular subject.
\\n\\nIntechOpen Book Series will be launching regularly to offer our authors and editors exciting opportunities to publish their research Open Access. We will begin by relaunching some of our existing Book Series in this innovative book format, and will expand in 2022 into rapidly growing research fields that are driving and advancing society.
\\n\\nLaunching 2021
\\n\\nArtificial Intelligence, ISSN 2633-1403
\\n\\nVeterinary Medicine and Science, ISSN 2632-0517
\\n\\nBiochemistry, ISSN 2632-0983
\\n\\nBiomedical Engineering, ISSN 2631-5343
\\n\\nInfectious Diseases, ISSN 2631-6188
\\n\\nPhysiology (Coming Soon)
\\n\\nDentistry (Coming Soon)
\\n\\nWe invite you to explore our IntechOpen Book Series, find the right publishing program for you and reach your desired audience in record time.
\\n\\nNote: Edited in October 2021
\\n"}]',published:!0,mainMedia:{caption:"",originalUrl:"/media/original/132"}},components:[{type:"htmlEditorComponent",content:'With the desire to make book publishing more relevant for the digital age and offer innovative Open Access publishing options, we are thrilled to announce the launch of our new publishing format: IntechOpen Book Series.
\n\nDesigned to cover fast-moving research fields in rapidly expanding areas, our Book Series feature a Topic structure allowing us to present the most relevant sub-disciplines. Book Series are headed by Series Editors, and a team of Topic Editors supported by international Editorial Board members. Topics are always open for submissions, with an Annual Volume published each calendar year.
\n\nAfter a robust peer-review process, accepted works are published quickly, thanks to Online First, ensuring research is made available to the scientific community without delay.
\n\nOur innovative Book Series format brings you:
\n\nIntechOpen Book Series will also publish a program of research-driven Thematic Edited Volumes that focus on specific areas and allow for a more in-depth overview of a particular subject.
\n\nIntechOpen Book Series will be launching regularly to offer our authors and editors exciting opportunities to publish their research Open Access. We will begin by relaunching some of our existing Book Series in this innovative book format, and will expand in 2022 into rapidly growing research fields that are driving and advancing society.
\n\nLaunching 2021
\n\nArtificial Intelligence, ISSN 2633-1403
\n\nVeterinary Medicine and Science, ISSN 2632-0517
\n\nBiochemistry, ISSN 2632-0983
\n\nBiomedical Engineering, ISSN 2631-5343
\n\nInfectious Diseases, ISSN 2631-6188
\n\nPhysiology (Coming Soon)
\n\nDentistry (Coming Soon)
\n\nWe invite you to explore our IntechOpen Book Series, find the right publishing program for you and reach your desired audience in record time.
\n\nNote: Edited in October 2021
\n'}],latestNews:[{slug:"intechopen-supports-asapbio-s-new-initiative-publish-your-reviews-20220729",title:"IntechOpen Supports ASAPbio’s New Initiative Publish Your Reviews"},{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"}]},book:{item:{type:"book",id:"3860",leadTitle:null,fullTitle:"Capsaicin - Sensitive Neural Afferentation and the Gastrointestinal Tract: from Bench to Bedside",title:"Capsaicin - Sensitive Neural Afferentation and the Gastrointestinal Tract",subtitle:"from Bench to Bedside",reviewType:"peer-reviewed",abstract:"The capsaicin, a component of paprika, has been used in the culinary practice of every day nutritional practice. This agent is known to cause a variety of actions in the body through activating capsaicin-sensitive afferent neurons. A recently launched book entitled, Capsaicin-Sensitive Neural Afferentation and the Gastrointestinal Tract: from Bench to Bedside, is attractive for several reasons. First, Prof. Mozsik, a chief editor of this book, is known internationally as an expert in capsaicin pharmacology. Since he has worked for many years as a head of internal medicine, taking care of patients with various GI diseases, he is able to make a correct interpretation of various findings obtained in basic researches to clinical events. Second, although there are many articles about capsaicin, they mostly deal with basic research and finding but do not include much about clinical finding. Third, this book encompassed review articles written by internationally accepted scientists leading the field of capsaicin research, who highlighted the current state of knowledge on pharmacology, physiology and clinical phathophysiology of capsaicin-sensitive afferent neurons, and discussed directions for future research. Overall, this book is for people who are interested in the capsaicin action in body.",isbn:null,printIsbn:"978-953-51-1631-8",pdfIsbn:"978-953-51-7219-2",doi:"10.5772/57289",price:139,priceEur:155,priceUsd:179,slug:"capsaicin-sensitive-neural-afferentation-and-the-gastrointestinal-tract-from-bench-to-bedside",numberOfPages:380,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"62e71e4f81c52b92224c231016a34231",bookSignature:"Gyula Mozsik, Omar M. E. Abdel- Salam and Koji Takeuchi",publishedDate:"July 16th 2014",coverURL:"https://cdn.intechopen.com/books/images_new/3860.jpg",numberOfDownloads:19689,numberOfWosCitations:6,numberOfCrossrefCitations:2,numberOfCrossrefCitationsByBook:1,numberOfDimensionsCitations:11,numberOfDimensionsCitationsByBook:2,hasAltmetrics:0,numberOfTotalCitations:19,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"November 18th 2013",dateEndSecondStepPublish:"November 25th 2013",dateEndThirdStepPublish:"February 21st 2014",dateEndFourthStepPublish:"March 23rd 2014",dateEndFifthStepPublish:"April 22nd 2014",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"58390",title:"Dr.",name:"Gyula",middleName:null,surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik",profilePictureURL:"https://mts.intechopen.com/storage/users/58390/images/system/58390.png",biography:"Gyula Mózsik MD, Ph.D., ScD (med), is an emeritus professor of Medicine at the First Department of Medicine, Univesity of Pécs, Hungary. He was head of this department from 1993 to 2003. His specializations are medicine, gastroenterology, clinical pharmacology, clinical nutrition, and dietetics. His research fields are biochemical pharmacological examinations in the human gastrointestinal (GI) mucosa, mechanisms of retinoids, drugs, capsaicin-sensitive afferent nerves, and innovative pharmacological, pharmaceutical, and nutritional (dietary) research in humans. He has published about 360 peer-reviewed papers, 197 book chapters, 692 abstracts, 19 monographs, and has edited 37 books. He has given about 1120 regular and review lectures. He has organized thirty-eight national and international congresses and symposia. He is the founder of the International Conference on Ulcer Research (ICUR); International Union of Pharmacology, Gastrointestinal Section (IUPHAR-GI); Brain-Gut Society symposiums, and gastrointestinal cytoprotective symposiums. He received the Andre Robert Award from IUPHAR-GI in 2014. Fifteen of his students have been appointed as full professors in Egypt, Cuba, and Hungary.",institutionString:"University of Pécs",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"24",totalChapterViews:"0",totalEditedBooks:"11",institution:{name:"University of Pecs",institutionURL:null,country:{name:"Hungary"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"170511",title:"Dr.",name:"Koji",middleName:null,surname:"Takeuchi",slug:"koji-takeuchi",fullName:"Koji Takeuchi",profilePictureURL:"https://mts.intechopen.com/storage/users/170511/images/5419_n.jpg",biography:"Koji Takeuchi, PhD received his Ph.D. degree from the University of Tokyo, Tokyo, Japan. He is a Professor Emeritus & Guest Professor of the Kyoto Pharmaceutical University as well as a Guest Professor of Doshisha Women’s College of Liberal Arts. His research interest covers numerous areas of GI pharmacology and physiology, and his most notable contribution is to understanding of mucosal defense, focusing on the regulation of acid/bicarbonate secretion, the role of capsaicin-sensitive afferent neurons, and the influences of non-steroidal anti-inflammatory drugs and prostaglandins; their mode of action, cyclo-oxygenase isozymes, receptors that drive physiological responses, and their role in mucosal injury, protection and healing. He published more than 400 papers in the peer-reviewed journals and about 20 book chapters.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorTwo:{id:"252344",title:"Dr.",name:"Omar",middleName:"M.E.",surname:"Abdel- Salam",slug:"omar-abdel-salam",fullName:"Omar Abdel- Salam",profilePictureURL:"https://mts.intechopen.com/storage/users/252344/images/system/252344.jpg",biography:'Dr. Omar M.E.Abdel-Salam, MD, PhD has received PhD in Medical Sciences in the Hungarian Academy of Sciences in Budapest in 1997 after studying at the University of Pécs, Hungary, during the period of 1992-1997. He is currently working as an Professor of Pharmacology in the Department of Toxicology and Narcotics, Medical Division, National Research Centre, Cairo. As a head of the Department of Toxicology and Narcotics, his research goals are in the fields of cannabis and other addictive drugs. His other research interests include: gastric acid secretion and its regulation; gastric mucosal injury; role of sensory nerves in gastric mucosal protection; hepatic protection; bile secretion; inflammation, analgesia, modulation by different agents; the role of antidepressants and the serotonin reuptake inhibitors in inflammation and nociception; neurodegeneration and neuroprotection. Based on this research and training, he has received several awards and honors, such as: The Prize of The Hungarian Academy of Sciences and The Academic Press for the best book in medicine for the year 1998 together with Professor Mózsik Gy, and Professor Szolcsányi J.; Certificate of Excellency in Scientific Publication from the National Research Centre, Cairo in 2009, 2011, 2012, 2013 and is serving one of the active members of the Egyptian Society of Toxicological Sciences. He is a member of the Editorial Board of: Inflammopharmacology, World Journal of Gastrointestinal Pharmacology and Therapeutics, Orphan Drugs: Research and Reviews, American Journal of Medicine and Medical Sciences, Journal of the Egyptian Society of Toxicology, The World Journal of Gastroenterology. He has authored or co-authored 180 research articles, 7 book chapters, 1 book: “Capsaicin-Sensitive Afferent Nerves in Gastric Mucosal Damage and Protection”. Mózsik Gy, Abdel-Salam O.M.E., Szolcsányi J (eds).AkadémiaiKiadó, Budapest, 1997. He is a co-editor of the book “Twenty Five Years of Peptic Ulcer Research in Hungary. From basic sciences to clinical practice (1971-1995)”.Author: GyulaMózsik; Lajos Nagy; AKirály. Publisher: Budapest: Akadémiai Kiadó, Budapest, 1997 and Capsaicin - Sensitive Neural Afferentation and the Gastrointestinal Tract: from Bench to Bedside", book edited by Gyula Mozsik, Omar M. E. Abdel- Salam and Koji Takeuchi, ISBN 978-953-51-1631-8, Published: July 16, 2014. InTech. He is the editor of the book “Capsaicin as a Therapeutic Molecule” Series: Progress in Drug Research, Vol. 68, Springer Basel.',institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1021",title:"Hepatology",slug:"gastroenterology-hepatology"}],chapters:[{id:"46956",title:"Discovery and Mechanism of Gastroprotective Action of Capsaicin",doi:"10.5772/58684",slug:"discovery-and-mechanism-of-gastroprotective-action-of-capsaicin",totalDownloads:2291,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"János Szolcsányi",downloadPdfUrl:"/chapter/pdf-download/46956",previewPdfUrl:"/chapter/pdf-preview/46956",authors:[{id:"159292",title:"Dr.",name:"Janos",surname:"Szolcsanyi",slug:"janos-szolcsanyi",fullName:"Janos Szolcsanyi"}],corrections:null},{id:"47154",title:"Pharmacobotanical analysis and regulatory qualification of Capsicum fruits and Capsicum extracts. A survey.",doi:"10.5772/58812",slug:"pharmacobotanical-analysis-and-regulatory-qualification-of-capsicum-fruits-and-capsicum-extracts-a-s",totalDownloads:3142,totalCrossrefCites:1,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"Monika Kuzma, Tibor Past, Gyula Mozsik and Pal Perjesi",downloadPdfUrl:"/chapter/pdf-download/47154",previewPdfUrl:"/chapter/pdf-preview/47154",authors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"},{id:"170467",title:"Prof.",name:"Pal",surname:"Perjesi",slug:"pal-perjesi",fullName:"Pal Perjesi"},{id:"170585",title:"Dr.",name:"Monika",surname:"Kuzma",slug:"monika-kuzma",fullName:"Monika Kuzma"},{id:"170586",title:"Dr.",name:"Tibor",surname:"Past",slug:"tibor-past",fullName:"Tibor Past"}],corrections:null},{id:"46867",title:"Allyl Isothiocyanate, a Pungent Ingredient of Wasabi and Mustard Oil, Impairs Gastric Paracellular Barrier in Primary Cultures from the Rat Stomach via TRPA1-Independent Pathway",doi:"10.5772/58603",slug:"allyl-isothiocyanate-a-pungent-ingredient-of-wasabi-and-mustard-oil-impairs-gastric-paracellular-bar",totalDownloads:1738,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Kimihito Tashima, Misako Kabashima, Kenjiro Matsumoto, Shingo\nYano, Susan J. Hagen and Syunji Horie",downloadPdfUrl:"/chapter/pdf-download/46867",previewPdfUrl:"/chapter/pdf-preview/46867",authors:[{id:"170624",title:"Prof.",name:"Kimihito",surname:"Tashima",slug:"kimihito-tashima",fullName:"Kimihito Tashima"}],corrections:null},{id:"46939",title:"Cooperative Effects of Neuronal Nitric Oxide Synthase and Endothelial Nitric Oxide Synthase on Gastric Hyperemic Response to Intragastric Capsaicin",doi:"10.5772/58557",slug:"cooperative-effects-of-neuronal-nitric-oxide-synthase-and-endothelial-nitric-oxide-synthase-on-gastr",totalDownloads:1472,totalCrossrefCites:0,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"Syunji Horie, Masaki Raimura, Kenjiro Matsumoto, Takao Namiki,\nKatsutoshi Terasawa, John V. Priestley and Kimihito Tashima",downloadPdfUrl:"/chapter/pdf-download/46939",previewPdfUrl:"/chapter/pdf-preview/46939",authors:[{id:"170624",title:"Prof.",name:"Kimihito",surname:"Tashima",slug:"kimihito-tashima",fullName:"Kimihito Tashima"},{id:"67783",title:"Prof.",name:"Takao",surname:"Namiki",slug:"takao-namiki",fullName:"Takao Namiki"},{id:"170625",title:"Prof.",name:"Syunji",surname:"Horie",slug:"syunji-horie",fullName:"Syunji Horie"},{id:"170626",title:"Dr.",name:"Kenjiro",surname:"Matsumoto",slug:"kenjiro-matsumoto",fullName:"Kenjiro Matsumoto"},{id:"170716",title:"Dr.",name:"Masaki",surname:"Raimura",slug:"masaki-raimura",fullName:"Masaki Raimura"},{id:"170717",title:"Prof.",name:"Katsutoshi",surname:"Terasawa",slug:"katsutoshi-terasawa",fullName:"Katsutoshi Terasawa"},{id:"170927",title:"Prof.",name:"John V.",surname:"Priestley",slug:"john-v.-priestley",fullName:"John V. Priestley"}],corrections:null},{id:"46606",title:"Modulation of Capsaicin-Induced Gastric Protection by Endogenous Prostaglandins through EP2/IP Receptors",doi:"10.5772/58337",slug:"modulation-of-capsaicin-induced-gastric-protection-by-endogenous-prostaglandins-through-ep2-ip-recep",totalDownloads:1478,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Koji Takeuchi",downloadPdfUrl:"/chapter/pdf-download/46606",previewPdfUrl:"/chapter/pdf-preview/46606",authors:[{id:"170511",title:"Dr.",name:"Koji",surname:"Takeuchi",slug:"koji-takeuchi",fullName:"Koji Takeuchi"}],corrections:null},{id:"46633",title:"Mechanism of Capsaicin-Stimulated Gastric HCO3- Secretion – Comparison with Mucosal Acidification",doi:"10.5772/58336",slug:"mechanism-of-capsaicin-stimulated-gastric-hco3-secretion-comparison-with-mucosal-acidification",totalDownloads:1449,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Koji Takeuchi and Eitaro Aihara",downloadPdfUrl:"/chapter/pdf-download/46633",previewPdfUrl:"/chapter/pdf-preview/46633",authors:[{id:"170511",title:"Dr.",name:"Koji",surname:"Takeuchi",slug:"koji-takeuchi",fullName:"Koji Takeuchi"},{id:"170721",title:"Dr.",name:"Eitaro",surname:"Aihara",slug:"eitaro-aihara",fullName:"Eitaro Aihara"}],corrections:null},{id:"47145",title:"The Role of Capsaicin-Sensitive Afferent Nerves in Gastric Mucosal Protection Initiated Centrally or Peripherally under Experimental Conditions",doi:"10.5772/58573",slug:"the-role-of-capsaicin-sensitive-afferent-nerves-in-gastric-mucosal-protection-initiated-centrally-or",totalDownloads:1372,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Klara Gyires",downloadPdfUrl:"/chapter/pdf-download/47145",previewPdfUrl:"/chapter/pdf-preview/47145",authors:[{id:"170740",title:"Dr.",name:"Klara",surname:"Gyires",slug:"klara-gyires",fullName:"Klara Gyires"}],corrections:null},{id:"47147",title:"Stable Gastric PentadecapeptideBPC 157, Somatosensory Neurons and Their Protection and Therapeutic Extensions — A Survey",doi:"10.5772/58681",slug:"stable-gastric-pentadecapeptidebpc-157-somatosensory-neurons-and-their-protection-and-therapeutic-ex",totalDownloads:1978,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Predrag Sikiric",downloadPdfUrl:"/chapter/pdf-download/47147",previewPdfUrl:"/chapter/pdf-preview/47147",authors:[{id:"170554",title:"Dr.",name:"Predrag",surname:"Sikiric",slug:"predrag-sikiric",fullName:"Predrag Sikiric"}],corrections:null},{id:"46876",title:"Lafutidine Protects the NSAID-Induced Small Intestinal Lesions Mediated by Capsaicin-Sensitive Afferent Neurons",doi:"10.5772/58604",slug:"lafutidine-protects-the-nsaid-induced-small-intestinal-lesions-mediated-by-capsaicin-sensitive-affer",totalDownloads:1290,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Kikuko Amagase and Koji Takeuchi",downloadPdfUrl:"/chapter/pdf-download/46876",previewPdfUrl:"/chapter/pdf-preview/46876",authors:[{id:"170718",title:"Dr.",name:"Kikuko",surname:"Amagase",slug:"kikuko-amagase",fullName:"Kikuko Amagase"}],corrections:null},{id:"46801",title:"Capsaicin-Sensitive Afferent Nerves and the Human Gastrointestinal Tract",doi:"10.5772/58360",slug:"capsaicin-sensitive-afferent-nerves-and-the-human-gastrointestinal-tract",totalDownloads:1733,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Gyula Mózsik, András Dömötör, József Czimmer, Imre L. Szabó and\nJános Szolcsányi",downloadPdfUrl:"/chapter/pdf-download/46801",previewPdfUrl:"/chapter/pdf-preview/46801",authors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],corrections:null},{id:"46799",title:"Capsaicin is a New Gastrointestinal Mucosal Protecting Drug Candidate in Humans — Pharmaceutical Development and Production Based on Clinical Pharmacology",doi:"10.5772/58359",slug:"capsaicin-is-a-new-gastrointestinal-mucosal-protecting-drug-candidate-in-humans-pharmaceutical-devel",totalDownloads:1747,totalCrossrefCites:1,totalDimensionsCites:3,hasAltmetrics:1,abstract:null,signatures:"Gyula Mózsik, Tibor Past, Tamás Habon, Zsuzsanna Keszthelyi, Pál\nPerjési, Mónika Kuzma, Barbara Sándor, János Szolcsányi, M.E.\nAbdel-Salam Omar and Mária Szalai",downloadPdfUrl:"/chapter/pdf-download/46799",previewPdfUrl:"/chapter/pdf-preview/46799",authors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"3317",title:"Current Topics in Gastritis",subtitle:"2012",isOpenForSubmission:!1,hash:"f771281e35f030a6438b269e736f910d",slug:"current-topics-in-gastritis-2012",bookSignature:"Gyula Mozsik",coverURL:"https://cdn.intechopen.com/books/images_new/3317.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5881",title:"Gastric Cancer",subtitle:null,isOpenForSubmission:!1,hash:"228701f521d44d2fff6d81063740d974",slug:"gastric-cancer",bookSignature:"Gyula Mózsik and Oszkár Karádi",coverURL:"https://cdn.intechopen.com/books/images_new/5881.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4817",title:"Membrane-bound Atp-dependent Energy Systems and the Gastrointestinal Mucosal Damage and Protection",subtitle:null,isOpenForSubmission:!1,hash:"33b0ab37b6c96db36130daafb1cd9701",slug:"membrane-bound-atp-dependent-energy-systems-and-the-gastrointestinal-mucosal-damage-and-protection",bookSignature:"Gyula Mozsik and Imre Szabo",coverURL:"https://cdn.intechopen.com/books/images_new/4817.jpg",editedByType:"Authored by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"3",chapterContentType:"chapter",authoredCaption:"Authored by"}},{type:"book",id:"7943",title:"Nutrition in Health and Disease",subtitle:"Our Challenges Now and Forthcoming Time",isOpenForSubmission:!1,hash:"bf9135b4940c5e9bf0f7de103e543946",slug:"nutrition-in-health-and-disease-our-challenges-now-and-forthcoming-time",bookSignature:"Gyula Mózsik and Mária Figler",coverURL:"https://cdn.intechopen.com/books/images_new/7943.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6810",title:"Capsaicin and its Human Therapeutic Development",subtitle:null,isOpenForSubmission:!1,hash:"9b0d5832824ac89f96d0557555448206",slug:"capsaicin-and-its-human-therapeutic-development",bookSignature:"Gyula Mozsik",coverURL:"https://cdn.intechopen.com/books/images_new/6810.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7103",title:"Constipation",subtitle:null,isOpenForSubmission:!1,hash:"0f5c714417d2c8a2e536ff6f78302cea",slug:"constipation",bookSignature:"Gyula Mózsik",coverURL:"https://cdn.intechopen.com/books/images_new/7103.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5162",title:"The Gut Microbiome",subtitle:"Implications for Human Disease",isOpenForSubmission:!1,hash:"f21c4722be61a42e7e6ed30cb898b9ad",slug:"the-gut-microbiome-implications-for-human-disease",bookSignature:"Gyula Mozsik",coverURL:"https://cdn.intechopen.com/books/images_new/5162.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9850",title:"Norovirus",subtitle:null,isOpenForSubmission:!1,hash:"0a573915d5892542cecdef25db03d0f3",slug:"norovirus",bookSignature:"Gyula Mózsik",coverURL:"https://cdn.intechopen.com/books/images_new/9850.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8935",title:"Mineral Deficiencies",subtitle:"Electrolyte Disturbances, Genes, Diet and Disease Interface",isOpenForSubmission:!1,hash:"8bc7bd085801296d26c5ea58a7154de3",slug:"mineral-deficiencies-electrolyte-disturbances-genes-diet-and-disease-interface",bookSignature:"Gyula Mózsik and Gonzalo Díaz-Soto",coverURL:"https://cdn.intechopen.com/books/images_new/8935.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6924",title:"Adenosine Triphosphate in Health and Disease",subtitle:null,isOpenForSubmission:!1,hash:"04106c232a3c68fec07ba7cf00d2522d",slug:"adenosine-triphosphate-in-health-and-disease",bookSignature:"Gyula Mozsik",coverURL:"https://cdn.intechopen.com/books/images_new/6924.jpg",editedByType:"Edited by",editors:[{id:"58390",title:"Dr.",name:"Gyula",surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"79356",slug:"corrigendum-to-risk-assessment-and-health-safety-and-environmental-management-of-carbon-nanomaterial",title:"Corrigendum to: Risk Assessment and Health, Safety, and Environmental Management of Carbon Nanomaterials",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/80612.pdf",downloadPdfUrl:"/chapter/pdf-download/80612",previewPdfUrl:"/chapter/pdf-preview/80612",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/80612",risUrl:"/chapter/ris/80612",chapter:{id:"66689",slug:"risk-assessment-and-health-safety-and-environmental-management-of-carbon-nanomaterials",signatures:"Guilherme Lenz e Silva, Camila Viana, Danieli Domingues and Fernanda Vieira",dateSubmitted:null,dateReviewed:"February 26th 2019",datePrePublished:"April 11th 2019",datePublished:"February 19th 2020",book:{id:"8137",title:"Nanomaterials",subtitle:"Toxicity, Human Health and Environment",fullTitle:"Nanomaterials - Toxicity, Human Health and Environment",slug:"nanomaterials-toxicity-human-health-and-environment",publishedDate:"February 19th 2020",bookSignature:"Simona Clichici, Adriana Filip and Gustavo M. do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/8137.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"64160",title:"Prof.",name:"Simona",middleName:null,surname:"Clichici",slug:"simona-clichici",fullName:"Simona Clichici"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"251730",title:"Dr.",name:"Guilherme",middleName:"Fredeico Bernardo",surname:"Lenz E Silva",fullName:"Guilherme Lenz E Silva",slug:"guilherme-lenz-e-silva",email:"guilhermelenz@usp.br",position:null,institution:null},{id:"286148",title:"Dr.",name:"Camila",middleName:null,surname:"Viana",fullName:"Camila Viana",slug:"camila-viana",email:"camilaoviana@gmail.com",position:null,institution:{name:"Centro de Desenvolvimento da Tecnologia Nuclear",institutionURL:null,country:{name:"Brazil"}}},{id:"286149",title:"Dr.",name:"Fernanda",middleName:null,surname:"Vieira",fullName:"Fernanda Vieira",slug:"fernanda-vieira",email:"fevieira2001@gmail.com",position:null,institution:{name:"Centro de Desenvolvimento da Tecnologia Nuclear",institutionURL:null,country:{name:"Brazil"}}},{id:"286151",title:"M.Sc.",name:"Danieli",middleName:"Silva",surname:"Domingues",fullName:"Danieli Domingues",slug:"danieli-domingues",email:"danielisilva@ymail.com",position:null,institution:{name:"Centro de Desenvolvimento da Tecnologia Nuclear",institutionURL:null,country:{name:"Brazil"}}}]}},chapter:{id:"66689",slug:"risk-assessment-and-health-safety-and-environmental-management-of-carbon-nanomaterials",signatures:"Guilherme Lenz e Silva, Camila Viana, Danieli Domingues and Fernanda Vieira",dateSubmitted:null,dateReviewed:"February 26th 2019",datePrePublished:"April 11th 2019",datePublished:"February 19th 2020",book:{id:"8137",title:"Nanomaterials",subtitle:"Toxicity, Human Health and Environment",fullTitle:"Nanomaterials - Toxicity, Human Health and Environment",slug:"nanomaterials-toxicity-human-health-and-environment",publishedDate:"February 19th 2020",bookSignature:"Simona Clichici, Adriana Filip and Gustavo M. do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/8137.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"64160",title:"Prof.",name:"Simona",middleName:null,surname:"Clichici",slug:"simona-clichici",fullName:"Simona Clichici"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"251730",title:"Dr.",name:"Guilherme",middleName:"Fredeico Bernardo",surname:"Lenz E Silva",fullName:"Guilherme Lenz E Silva",slug:"guilherme-lenz-e-silva",email:"guilhermelenz@usp.br",position:null,institution:null},{id:"286148",title:"Dr.",name:"Camila",middleName:null,surname:"Viana",fullName:"Camila Viana",slug:"camila-viana",email:"camilaoviana@gmail.com",position:null,institution:{name:"Centro de Desenvolvimento da Tecnologia Nuclear",institutionURL:null,country:{name:"Brazil"}}},{id:"286149",title:"Dr.",name:"Fernanda",middleName:null,surname:"Vieira",fullName:"Fernanda Vieira",slug:"fernanda-vieira",email:"fevieira2001@gmail.com",position:null,institution:{name:"Centro de Desenvolvimento da Tecnologia Nuclear",institutionURL:null,country:{name:"Brazil"}}},{id:"286151",title:"M.Sc.",name:"Danieli",middleName:"Silva",surname:"Domingues",fullName:"Danieli Domingues",slug:"danieli-domingues",email:"danielisilva@ymail.com",position:null,institution:{name:"Centro de Desenvolvimento da Tecnologia Nuclear",institutionURL:null,country:{name:"Brazil"}}}]},book:{id:"8137",title:"Nanomaterials",subtitle:"Toxicity, Human Health and Environment",fullTitle:"Nanomaterials - Toxicity, Human Health and Environment",slug:"nanomaterials-toxicity-human-health-and-environment",publishedDate:"February 19th 2020",bookSignature:"Simona Clichici, Adriana Filip and Gustavo M. do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/8137.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"64160",title:"Prof.",name:"Simona",middleName:null,surname:"Clichici",slug:"simona-clichici",fullName:"Simona Clichici"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11867",leadTitle:null,title:"Echocardiography",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tAlthough the diagnosis and overall survival of patients with various cardiac diseases have improved in the last years, there still remains a significant proportion of patients with unfavorable prognoses. The evaluation of these patients necessitates effective imaging techniques in both diagnosis and long-term follow-up. Even though Cardiac Magnetic Resonance imaging is currently the imaging modality of choice for tissue characterization, advanced echocardiography represents a modern alternative. Speckle tracking echocardiography can be used to assess myocardial deformation at both segmental and global levels. Since distinct myocardial pathologies affect deformation differently, information about the underlying tissue can be offered by strain imaging. Echocardiography advances also show promising results in the improvement of diagnostic accuracy, management, and follow-up and a major advantage of echocardiography over other imaging modalities is the ability to use it in real-time, in the cardiac catheterization laboratory, allowing for the performance of imaging immediately before, during, and after interventional procedures. Furthermore, the prevalence of adult congenital heart disease continues to grow due to advances in surgical and diagnostic techniques. Echocardiography has proven to be a useful tool in the diagnosis and follow-up of these patients, both after percutaneous and surgical procedures, and its utility has expanded significantly due to the development of better technology. In addition, stress echocardiography could be useful in the evaluation of several cardiac diseases and should be preferred over other imaging modalities due to the lower cost, wider availability, and radiation-free nature.
\r\n\tThis book intends to provide the reader with a comprehensive overview of the current state-of-the-art novel imaging techniques by focusing on the most important evidence-based developments in this area.
Dementia is a multifaceted disorder that impairs cognitive functions such as memory, language, and executive functions necessary to plan, organize, and prioritize tasks required for goal-directed behaviours. Ninety percent of persons with dementia present with dementia of the Alzheimer’s type, vascular dementia, diffuse Lewy body dementia, or frontotemporal dementia [1]. All of these conditions affect the neurological functioning of the brain with different pathologies resulting in different clinical presentations [1]. In most, if not all cases, individuals with dementia experience difficulties interacting with their physical and social environments. The current chapter supports the use of virtual reality to explore the nature of these interactions.
The most common cause of dementia is Alzheimer’s disease, which leads to a physiological impairment in the functioning of neurons in the cerebral cortex [2], primarily in the hippocampus. The first stage of this type of dementia is marked by the individuals’ inability to retain new information reliably and their difficulty in using cueing to enhance the retention of information. Typically, in the second stage, communication, behavioural and personality changes become more pronounced affecting daily life. In the last stage of Alzheimer’s disease, most affected individuals lose their functional abilities to perform goal-oriented tasks which may include eating, grooming, and other self-care activities [3].
Vascular dementia is usually caused by a series of small strokes, resulting in an inadequate blood supply to the brain governing memory and thinking [2]. In addition to memory problems, individuals with vascular dementia may experience early gait disturbance, frequent falls, personality changes, depression, and issues related to emotional control [1].
Both diffuse Lewy body dementia and frontotemporal dementia present similar signs and symptoms manifested in both Alzheimer’s disease and vascular dementia. The areas of the brain that are most affected in diffuse Lewy body dementia are very similar to those affected by Alzheimer’s disease [4] but in frontotemporal dementia, the neuronal degeneration affects primarily the frontal and temporal lobes [5]. Diffuse Lewy body dementia has several hallmark features not common with Alzheimer’s disease such as visual and/or auditory hallucinations, delusions, and fluctuation of cognition impairments, whereas frontotemporal dementia is marked by early behavioural changes such as aggressiveness [1] and more language-based deficits such as primary progressive aphasia [5].
Regardless of the form of dementia, many persons with dementia spend less time than their age-matched peers engaging in daily social activities. They are more likely to experience confusion and difficulties recognizing familiar environments or people at some point in the progression of the disease [2]. Even in the early stages, a simple fear of forgetting someone’s name or getting lost in a new environment may impede persons with dementia from participating in social activities, as does their difficulty in communicating [1, 6]. Communication is critical to daily-life functioning as it provides a means to express one’s needs or wishes [7]. Coupled with impaired memory, communication problems lead persons with dementia to have difficulties staying on topic [6, 8]. Conversational partners thus abandon their efforts for communication out of frustration, further isolating the persons with dementia.
In addition to memory and communication problems, persons with dementia have difficulty maintaining attention. When attending to a task, they may struggle to deactivate irrelevant stimuli in order to successfully perform cognitive tasks [9]. The result is that various important daily activities which require multi-tasking or undivided attention become challenging or impossible [9]. For instance, dementia might make it hard to socialize with several people at any given time [6].
All of these symptoms predispose individuals with dementia to social isolation and a progressive loss of autonomy. As such, they need to rely on individuals in their immediate environment to make sense of the world. The heavy reliance on others can ultimately be detrimental to their sense of self and well-being as they may be no longer able to exercise their own life choices.
According to the Disability Creation Process model of functioning, a problem in life participation can be created when functional limitations (e.g. communication problems) interact with environmental factors (e.g. negative attitudes) that are non-facilitating [10]. Three interacting domains are used to describe the lived experience of individuals with functional limitations in creating successful engagement in life activities. The first domain, personal factors, includes organic systems and capabilities, which, together, entail all components of the human body that interrelate with the individuals’ potential to perform mental or physical tasks; it also includes other variables such as age, sex and socio-cultural identity [10]. In the case of dementia, this domain would include the pathophysiological changes to the brain as well as their consequences on processes such as perception, memory and language. The second domain, environmental factors, encompasses the resources – which could be either facilitators or obstacles – within the individuals’ living dimensions [10]. In dementia, for instance, this might include the physical design of long term care facilities, the attitude of the general public, or the access to health coverage. These factors influence the lived experiences as they can make life easier or harder as one transitions through the journey of dementia. Finally, the last domain, social (life) participation, refers to the result of the interaction of the first two domains as they impact the lived experiences valued by the individuals and their respective socio-cultural context [10]. This domain encompasses important life areas such as work, interpersonal relationships, community involvement and so on. Overall, this model of functioning gives a framework from which to identify the role of environmental factors in creating positive or negative lived experiences. For example, a simple goal-oriented task such as get-a-book-sit-and-read may be challenging for persons with dementia due to impaired executive functions. That is, they may simply not think of initiating the task of reading the book or may have difficulty planning the steps for executing the activity. An environmental cue such as a chair located near a bookcase might help persons with dementia improve their planning, organizing, and prioritization (i.e. executive functions) – to get a book, sit, and read. The impairment (i.e. dementia) in this example does not change, but the environment facilitates the realization of the activity. Fundamentally, the Disability Creation Process model offers a framework from which to understand the relationships amongst all the domains and help identify areas which might improve the lived experience through the modification of either or all of the domains.
If we are to improve the lived experiences of persons with dementia, attention must be allocated to altering the environment while other investigations continue to strive for a cure. Unfortunately, current pharmacotherapies for dementia act on the symptoms or succeed in slowing its progression but fall short of addressing the underlying pathology of dementia [11-13]. While environmental interventions have been the key to improved quality of life in dementia until a cure is found, it is important to not create overly facilitating environments. Environments that under-challenge persons with dementia may further deteriorate persons with dementia’s quality of life by under-using their existing abilities. Lawton and Nehemow [14] describe this as ‘environmental press’. In order to ensure an ideal zone of maximum comfort, the demands of the environment (weak to strong) should be balanced with the individual’s level of competence (low to high). Situations where there is a strong environmental press on an individual with lower levels of competence will result in negative affect and maladaptive behaviour. Likewise, environments that are weak and demand little of the individual who has higher levels of competence will also result in negative and maladaptive behaviours. In the case of the get-a-book-sit-and-read task, placing a chair right beside the bookcase in addition to hiring an attendant who will get the book may prevent persons with dementia from using any residual planning processes, thereby fostering a sense of helplessness and loss of personhood.
The balance between the demands of the environment and the capabilities of the individual is difficult to maintain and study in a systematic fashion. One of the biggest limitations is the trade-off between experimental control and realism [15]. In other words, the more experimental control researchers have over an experience, the less ecologically valid it will be. The use of immersive virtual environment technology or virtual reality may be the answer to this shortcoming.
Immersive virtual environments allow researchers to create very realistic environments while maintaining a high level of experimental control [16]. Immersive virtual environments technology has been used in therapy for phobias [17, 18], stress [19-21], anxiety [22, 23], exercising [24], and memory problems [25, 26], yet it has hardly been used in the area of dementia. Several reasons might explain the dearth of publications on this topic. On the one hand, scientists might assume that persons with dementia cannot use the necessary paraphernalia to engage with virtual environments. On the other hand, there may be a concern that the cognitive difficulties associated with dementia prevent participants from attaining the level of presence necessary to engage with these environments.
As the numbers of individuals with dementia rise, there is an ever increasing interest in the use of technology to improve safety and quality of life. Smart Home Technology and environmental control systems are prime examples of emerging new technologies that have shown some success in facilitating the environment for individuals with disabilities, as well as improving their safety. Smart Home Technology is found in homes that are programmed to facilitate independent living. These homes include, for example, lights that turn on when the inhabitant gets out of bed and systems that remind indivudals with cognitive problems to turn off the stove. These are only a few examples of the large amount of technologies integrated within these homes to assist with everyday living [27]. While these types of technologies are seen as promising in assessing function, Brandt and colleagues, using a systematic review of the literature, found no solid evidence of their use in the area of dementia [27]. Only one group of authors in their selected studies included participants with cognitive difficulties (i.e. participants with traumatic brain injury) while most examined the performance of these technologies with participants with primarily physical limitations. Even in these populations with physical limitations, the evidence was inconclusive.
Bharucha and colleagues [28] searched the literature for strong evidence supporting the use of environmental assistive technologies for individuals with dementia. These systems use a large range of different sensors and artificial intelligence to assist the person with dementia as well as help ensure their safety. CareWatch consists of door opening and bed occupancy sensors that will alert the caregiver if the person with dementia exits the home at night. COACH is a system that can be used to guide people with dementia in hand washing. It provides verbal prompts and monitors to remind the person to wash their hands and assist them through the process [28]. These technologies allow for greater independence, security and overall quality of life for both the person with dementia and the caregiver, but strong evidence is still lacking. Bharucha and colleagues [28] found a dearth of studies focussed on dementia as a target population. When it came to individuals with cognitive problems, the search yielded studies whose participants were primarily young with nondegenerative conditions such as traumatic brain injuries. Again, the results were inconclusive as to the impact of these technologies. The authors call for more high quality investigations on the use of these technologies with dementia and for a need for more cost effectiveness data on these systems. In light of the cost of some of these systems, perhaps it would be worthwhile investing in experimental trial protocols that use technologies such as virtual reality. Rather than build these environments, virtual reality might help test their applicability in a virtual world prior to going to market.
On a more therapeutic note, technologies such as robot therapy and ‘video respite’ have shown some preliminary promise. One such example is the use of a seal robot named Paro which was designed for use with the elderly [29]. As an accompaniment and social stimulator to individuals with dementia living in long-term care facilities, its integrated sensors allow it to interact in various ways when it is touched. While the authors claim its widespread use, along with other robotic animals, the evidence for reducing levels of depression and improving quality of life in people with dementia needs more support. While the participants seemed to interact well with the ‘virtual’ animal, the evidence for diminishing stress and improving interactions is scarce for the population of individuals with dementia.
Similarly, ‘Video Respite’ has shown only preliminary success in regards to people with dementia [30]. Video respite is a videotape application that simulates the visit between an actor in the video and the person with dementia. For instance, people with dementia are seated in front of a television screen while an actor ‘reminisces’ with them about life in an earlier time. It is used mainly to provide respite for the caregiver as the person with dementia is occupied by the video. People with dementia watching the videos were subjectively found to be calmer and their disruptive behaviours were reduced.
The introduction of various types of technological media for use with people with dementia appears to be increasing. However, the evidence to support their use in helping people with dementia and their caregivers is scarce. Several interesting hypotheses can be generated however from these data. First of all, could media such as virtual reality be helpful in testing the preliminary effectiveness of these technologies prior to their development? With the advent of augmented reality, a person with dementia could potentially be immersed in a virtual apartment with simulated technological ‘aids’ to functioning. The impact of each environmental aid could be evaluated individually as well as in combination with other aids. Second, the preliminary evidence with robot therapy suggests that individuals with dementia may be able to obtain some level of presence with a ‘non-real’ animal. Is this indicative that they are able to obtain presence in other forms of media such as immersive virtual reality?
There is still insufficient evidence for concluding that immersive virtual environment technology can or cannot be used with persons with dementia. Flynn et al. [31] incorporated a user-centred-approach and found that it is feasible to immerse persons with dementia in a virtual environment via immersive virtual environment technology. The authors reported that persons with dementia felt a sense of control and enjoyed the interaction in virtual environments, as well as demonstrated little difficulty in manoeuvring a joystick [31]. There was also no significant deterioration in terms of simulator sickness and well-being [31].
Cushman, Stein, and Duffy (32) examined the feasibility of using immersive virtual environment technology to detect navigational deficits in people with Alzheimer’s disease. Users had to navigate their ways through both a real hospital lobby and a virtual hospital lobby. By using eight navigation subtests, the authors found that the use of virtual environments was an effective method to assess navigational skills, and that quantifying a virtual-world navigational performance is easier and less time-consuming than quantifying a real-world navigational performance. In another study [33], Shaick, Martyr, Blackman, and Robbinson used virtual reality to observe how a physical outdoor environment could affect way finding. Persons with dementia were immersed within an outdoor virtual environment and were asked to go for a walk. Many facilitators and barriers which might affect orientation were incorporated such as larger street signs, street signs with pictures of uncommon objects, street signs with names only or unattractive street layouts. The authors found that if the street felt unappealing for the persons with dementia, it became a barrier to the overall success of the walk. In 2009, the same environments were used to examine spatial navigation in healthy older adults as opposed to older adults with dementia [34]. The users were asked to navigate a virtual neighbourhood and subsequently asked to recognize certain city buildings and objects. Young adults were quicker and more accurate than both older adults and individuals with Alzheimer\'s disease, while individuals with Alzheimer’s disease had more difficulty with the recognition task than normally-ageing participants. In summary, these studies provide some evidence that, at least in the earlier stages, persons with dementia can use the paraphernalia and be successfully immersed in virtual environments. While these studies have shown some success with the use of virtual reality for assessing navigation, the question remains as to whether persons with dementia can obtain presence for all types of functional problems.
Early descriptions of presence define it as believing oneself to be in an environment while being physically located in another [35]. While presence is a necessary precursor for successful use of virtual environments, Riva, Waterworth, Waterworth and Mantovani [36] remind us that obtaining presence is not a media-dependent phenomenon. That is, the ability and belief that one can act upon one’s environment and at the same time be influenced by this environment exists regardless of the medium of transmission [36]. In addition, attaining presence requires constant processing between human sensory and cognitive skills [37]; hence the concern that it might not be feasible with persons with dementia. Since there is very little literature pertaining to the use of virtual reality with persons with dementia, a better understanding of the phenomenon of presence will help with our understanding of how people with dementia might interact with their environments.
Riva et al. [36] suggest that presence is what links our volitional motivation to act upon our environment and our cognitive adjustment to changes in our environments. These interactions however can be explained as they evolve over several layers [38]. According to these authors, the first layer, proto presence, involves an unconscious sense of the self in space which is constructed using proprioceptive information. At this level the individual obtains a sense of how his body moves in the environment, and the challenge in virtual reality is to create technology that is sensitive to this proprioceptive feedback. The small literature reported above on the assessment of navigation suggests that individuals with early dementia are able to attain this layer of presence. Until the technology is able to capture propioceptive information more systematically, we may not be in a position to explore this level of presence in greater detail in the virtual environment [38]. Nevertheless, preliminary studies are promising that persons with dementia are indeed capable of obtaining proto presence.
In the second layer, core presence, the individual is able to determine what is real and what is not real based on the processing of perceptual information [38]. The perceptual information thus captured forms an integrated percept that is continually adjusted in real time according to current changes in the environment. The emphasis is on the here and now and the individual who obtains presence is influenced by these changes. The vast literature on environmental modifications to alter the expression of disruptive behaviours in dementia [35, 36] suggests that the actions of people with dementia can somewhat be mediated by a systematic control of the environment. For instance, persons with advanced dementia have been shown to improve real life navigation by the addition of visual environmental cues [41]. According to Riva et al. [36] the saliency of the stimuli is very important at this level since it is the perceptual information which creates this layer of presence. Once again the studies on navigation would suggest that persons with dementia are sensitive to the saliency of the stimuli as Schaik et al. [33] were able to create obstacles and facilitators by modifying the road signs. Persons with dementia were influenced by the visual nature of the information they received in the immersive virtual environment.
In the third layer of presence, extended presence, Riva et al. [38] argue that the individual uses cognitive processes to understand the meaningfulness of the environment. These processes require the individual to process the information received through levels one and two and compare it to information in memory to attach meaning and relevance. Based on what we know about the cardinal signs of dementia, persons with dementia should have considerable difficulties with this level of presence. According to Riva et al. [36], the individual in an immersive virtual environment will make hypotheses about what will happen in the environment as he makes sense of what he sees. It is plausible to assume that individuals with dementia may not be able to make these hypotheses or may make erroneous ones. If this is true, presence could only be achieved as high as the core level where information is processed online in the here and now.
Bouchard et al. [42] observed that activation of the parahippocampal cortex is correlated with a greater sense of extended presence [38]. This area of the brain is important in giving contextual meaning to scenes and locations [42]. According to these authors, the lateral surface of the occipital lobe, fusiform gyrus, and adjacent insula cortex are involved in providing virtual reality users with awareness in detecting the discrepancy between the virtual environment and the physical world; one might refer to this as core presence [38]. Since Alzheimer’s disease can impair the functioning of either or all the brain regions stated above [43-46], one might argue that persons with dementia might not have the cognitive ability to analyze information within context and understand the meaningfulness of the environment. Hence, in dementia one might hypothesize that the processed information about the environment does not generate the same intention as was meant. It might be possible that individuals with dementia may find meaning in what they see but may be attaching the perceived information to wrong meanings in memory because they cannot access their memories as efficiently and effectively as individuals without dementia. It seems that the virtual environment might be ideal to test out this theory.
Current judgement theory indicates that our decision-making is governed by a two-system view in which the intuitive mode is monitored and corrected, if necessary, by the controlled mode [47]. The operation for the intuitive mode is automatic, and it is responsible for generating impressions [47]. In contrast, the operation for the controlled mode is more effortful as it is involved in deliberate reasoning [43]. In the event whereby the controlled mode is malfunctioning, as is often the case with persons with dementia, it is likely the intuitive mode would dominate. Persons with dementia might continue to believe in the impression they generated, regardless of whether it is right or wrong, given that the intuitive mode is not overridden by the controlled mode. In addition, the lack of a controlled mode reduces the ability for persons with dementia to experience doubt, a cognitive ability that allows the subject to deal with incompatible thoughts on the same subject [47]. This suggests that persons with dementia may be able to imagine, interact, and develop an emotional link towards the subjects within the virtual environment without a dilemma arising around whether it is real or not. Overall, this reasoning might suggest that persons with dementia may experience a greater sense of Riva et al.’s [38] core presence but a lesser extent – or erroneous – sense of Riva et al.’s [38] extended presence.
Immersive virtual environment technology gives researchers the opportunity to study how persons with dementia interact with their environment and which elements are most facilitating or creating the least distress while capitalizing on residual cognitive resources. Virtual reality technologies offer the potential to capture the impact of physical environments, as well as social interactions by deconstructing these environments. Further research into this area will help develop a better understanding of how persons with dementia can act to influence their environments and how changes in the environment can affect them. The objective may not be to learn a new skill but rather to understand how to better design physical spaces or modify social environments for better quality of life.
One of the advantages of virtual reality is the potential to control and modify these environments when it cannot be easily, or completely, changed outside of the virtual world. For example, human interaction and social presence would be particularly useful to examine in persons with dementia using virtual reality. More detailed knowledge about how others influence interactions with persons with dementia would help offer advice for caregivers on how to interact with this population. For instance, one might manipulate the verbal and non-verbal aspects of communication of virtual humans as they interact with the user [16, 48]. As Garcia et al. [48] pointed out, if we want to study the impact of tone of voice on persons with dementia during social interaction, we could create experimental conditions where a virtual human modifies tone of voice while maintaining neutral facial expressions. This type of experimentation is impossible outside of the virtual environment since human conversational partners cannot voluntarily isolate these parameters. Knowing more about the impact of these changes in the environment may lead to remarkable changes in clinical approaches and improve quality of life. Immersive virtual environment technologies offers a promising avenue for testing these hypotheses as well as helping us to better understand the processes involved in presence.
It is unlikely for persons with dementia to acquire new skills as they tend to experience rapid deteriorations in their brain mappings throughout the journey of dementia. Such progression, however, might be slowed down by medications and brain-stimulating activities based on the theory of neuroplasticity – the ability of brains and nervous systems to reconstruct new cellular synapses as a result of the interaction with enriched environments [49, 50]. Nonetheless, the perception of such environments may be different for individuals, and it would be financially impossible to construct a customized enriched environment for every individual. Virtual Reality has the potential to fulfil this requirement at a lower cost.
In addition, virtual reality would allow researchers to systematically study the various desired brain-stimulating activities as a function of the rate of neuroplasticity experienced in persons with different types of dementia. It is known that dementia of different types may experience deterioration in different regions of the brains; thus, it is very important to explore the possibility of conducting such ‘targeted’ brain-stimulating activities in light of deteriorating regions of the damaged brain.
It is surprising to see how little immersive virtual environment technology has been used with individuals with dementia, one of the largest growing clinical populations. The Disability Creation Process model of functioning suggests that each individual may experience the impact of diseases differently. It highlights the role of environmental factors in creating situations where social participation may be limited. Immersive virtual environment technology may prove to be useful in testing the role played by physical and social environments by immersing persons with dementia in virtual environments and observing the results following the process of virtual-environment-remodelling [33]. Immersive virtual environment technology can help us understand more about how persons with dementia interact with their environments – whether physically with the objects or socially with other people in their surroundings. Should the remodelling improve the lives of persons with dementia, such modification may be implemented outside the world of virtual environments.
Until a cure is found, our most promising interventions will rely on environmental modifications. Should we confirm that persons with dementia are unable to obtain extended presence, as argued in this paper, but can function at the level of core presence, this may prove to be a satisfactory level for improving quality of life. Persons with dementia typically function in the here and now and immersive virtual environment technologies might prove to be useful in creating pleasant virtual worlds where they may find it easier to interact while maximizing residual cognitive processes. These worlds may offer much needed respite to both formal and informal caregivers while allowing pleasant, meaningful activities in the here and now for persons with dementia. The literature is clear that success in lived experiences is dependent on both the personal and environmental factors. Immersive virtual environment technology can shed an important light on one of these domains.
The COVID-19 pandemic has brought attention to the necessity of emergency preparedness and response (EP&R) in India\'s education, training, capacity building, and infrastructure development. During the pandemic, healthcare workers, particularly pharmacy professionals (PPs) in India, continued to deliver medication, supplies, and services. In India, the public-private healthcare system is complex and of variable quality. Gaps in pharmacy practice education and training, as well as a lack of understanding about pharmacists\' roles, cause complications for patients. This lack of difference complicates job requirements and successful placement of healthcare professionals in patient care, EP&R task forces, and policy representation. During this unprecedented pandemic situation, we have also observed malpractice and bogus distribution in the healthcare and pharmaceutical arena in terms of personal protective kits, medications, injectable, life-saving oxygen, and other products. The following are a few of the incidents. The central division police in Bangalore (India’s Global BPO & IT Hub) filed a complaint of bed-blocking at a private hospital and arrested three people, one of whom is an Arogya Mitra (primary contact for beneficiaries at every empaneled hospital care provider), for allegedly extorting Rs. 1.20 lakh from the son of a COVID-19 patient who later died. In the last few weeks, at least 178 COVID-19 patients in India have died due to a lack of oxygen. Another 70 deaths have been linked by patients’ families to a lack of oxygen, though this has been refuted by authorities. “Death of COVID patients due to non-supply of oxygen not less than genocide,” the Allahabad High Court ruled in response to reports spreading on social media regarding the death of COVID-19 patients in Lucknow and Meerut due to a shortage of oxygen [1]. Five persons were arrested after the Delhi police raided an industrial manufacturing site in Uttarakhand\'s Kotdwar, where duplicate Remdesivir injections were being made. This reflects the reality of Good Pharmacy Practice in this country, as well as the ethical norms that apply to it. It is critical to re-evaluate and re-establish pharmacy practice standards in healthcare settings throughout the country, in accordance with World Health Organization (WHO) and International Pharmaceutical Federation (FIP) principles. As a result, healthcare workers have a great deal of reliance and responsibility, especially in current pandemic circumstances. The pharmacy zone is adaptive, growing, and becoming more diverse, providing a comprehensive range of job and management opportunities [2]. PPs are human service professionals tasked with keeping people safe by distributing drugs according to prescriptions. In India, there are about 1,000,000 (1 million) enrolled PPs working in diverse capacities and contributing to the country\'s well-being, making it the world\'s third-largest medical service with active gathering. In its real definition, pharmacy practice, which encompasses clinical, community, and hospital pharmacy, is referred to as overall healthcare. PPs form a crucial link between physicians, nurses, and patients in the social community group through the adaptation and application of GPP in healthcare settings, with the ultimate emphasis on patient well-being and protection. In order to instill quality and elevate the standard in this chaotic scenario, the country must take stringent steps. Good pharmacy practice (GPP) is defined by the International Pharmaceutical Federation and the World Health Organization as practices that fulfill the individual requirements of patients or people who use pharmacy services by providing adequate evidence-based care. Pharmaceutical assistance is defined in developed countries as a pharmaceutical practice model that includes attitudes, ethical values, behaviors, skills, appointments, and co-responsibility to prevent diseases, promote, and recover health in an integrated manner as part of the healthcare process, highlighting, among other requirements, the institution\'s full adoption of the GPP. In the context of the Indian healthcare system and adopting a "new normal" due to the unprecedented event of COVID-19, there is a need for a GPP program designed by the Indian Government or its stakeholders, as well as raising the standard and importance of GPP for healthcare professionals in the current scenario.
India is a developing country in southern Asia with 29 states and seven union territories, 22 nationally recognized languages, and a population of 1.38 billion. India is a rural country with an agriculture-based economy, with rural areas accounting for over 75% of the population. In recent decades, India\'s average income has risen dramatically, resulting in growing urbanization, improved middle-class access to a better lifestyle, and increasing awareness of health insurance. Male and female literacy rates have climbed to 82% and 65%, respectively. According to reports, the average life expectancy is 69.9 years [3]. According to World Bank research from 2020, about 400 million Indians live on less than $1.25 a day, and 44% of children are hungry. Even though the government has taken attempts to reduce baby and maternal death rates, they remain high. Ancient Hindus acknowledged pharmacy as a complementary healing profession, and they specialized in vegetable treatments. Vedic and Brahmanic medicine were the two periods of Hindu medicine. The Vedic period or Vedic age (c. 1500–c. 500 BCE), and was a rudimentary period. During the Vedic period, sin was thought to be a major source of disease. Between 800 BC and 1000 AD, the Brahmanic period was a high-quality time for Hindu medical education. The works of Charaka, Susruta, and Vagbhat, which are based on ancient Vedic themes, are the three great masterpieces of Brahmanic medicine [4]. The origins of pharmacy in India can be traced back to Ayurveda, which dates to 5000 BC. Lord Brahma initially taught Ayurveda, or "life science," which was further transmitted by Charaka and Sushruta [5]. The Charaka Samhita, early work on Ayurveda, focuses on vegetable goods as well as some animal and earth goods. The classification of medications in this book is based on how they affect different bodily parts [4]. In 900 AD, Tamilnadu established a hospital to treat piles, jaundice, bleeding, and tuberculosis [5]. Tantrism was a prominent philosophical and religious movement that emerged in India after the downfall of Buddhism; it brought the art and science of the production of metallic compounds, particularly mercury and sulfur, to the fore [4]. In 1811, Scotch M. Bathgate built the first chemist shop in Calcutta, which is regarded as the birthplace of pharmacy practice in India. In December 1860, Madras Medical School began pharmacy instruction, enrolling students with only middle school education; the pharmacy degree was 2 years long. Madras Medical College (MMC), Chennai, established the diploma course in pharmacy in 1874. The Bengal Chemists and Druggists Association was founded in 1926 after the Calcutta Chemists and Druggists Association was founded in 1920. The first issue of the official
Many issues face India\'s healthcare system, including the need to lower mortality rates, enhance physical infrastructure, provide health insurance, and train healthcare experts and workers. A rise in communicable diseases, lifestyle diseases, and noncommunicable diseases has been recorded. Diseases such as poliomyelitis, leprosy, and newborn tetanus will be eradicated; nevertheless, certain previously controlled infectious diseases, such as dengue fever, viral hepatitis, tuberculosis, malaria, and pneumonia, have resurfaced or developed medication resistance.
Even though Indians are now more affluent as a result of the rise of the middle class, their eating habits have shifted dramatically to unhealthy, high-sugar, high-fat diets, leading to an increase in lifestyle diseases such as hypertension, cancer, and diabetes. Furthermore, India\'s healthcare institutions and services would be burdened by the expanding older population.
Due to a dearth of hospital beds and skilled medical personnel such as doctors, nurses, and pharmacists, the people do not have access to their medical needs. In comparison to urban areas, healthcare services are much scarcer in rural communities. Females have an adversely skewed proportion in the healthcare workforce when compared to males. In the 11th five-year plan, total healthcare expenditure (comprising state funds, private funds, and external flows) accounted for 4.1% of GDP (GDP). The 12th five-year plan (2012–2017) intends to raise public health spending from 1.1% of GDP to 2–3% of GDP [6].
The state is responsible for the healthcare system. This system is currently managed by both public and private (for profit and nonprofit) groups. Policymaking, planning, guiding, aiding, reviewing, and coordinating the activities of various provincial health authorities are all responsibilities of the federal government, as is providing financing to implement national healthcare initiatives [7]. Allopathic hospitals, hospital beds, Indian System of Medicine and Homeopathy hospitals, subcenters, Pharmacy Health Care (PHC), Community Health Center (CHC), blood banks, Eye Bank, psychiatric hospitals, and cancer hospitals are all part of India\'s healthcare infrastructure [7]. The Department of Ayurveda, Yoga, and Naturopathy, as well as Unani, Siddha, and Homeopathy, provide medical and healthcare services (AYUSH). The ownership of the public sector is split between the federal and state governments, municipalities, and panchayats (local governments). Dispensaries, primary health centers, subcenters, and health posts are among the facilities. Teaching hospitals, secondary-level hospitals, first-level referral hospitals (community health centers/rural hospitals), dispensaries, primary health centers, subcenters, and health posts are among the facilities. Public facilities for specific occupational groups are also included, including organized labor (Employees State Insurance Scheme), defense, government employees (Central Government Health Scheme), railways, post and telegraph, and mining, to name a few. The private sector (profit/nonprofit) is the most prevalent, with services ranging from >1000 beds to two beds. Health-related facilities are available through the federal government healthcare program in 25 cities, with 246 allopathic dispensaries [7]. Private healthcare providers are currently treating 78% of outpatients and 60% of inpatients in India. Private healthcare providers range from world-class hospitals that promote medical tourism by providing world-class treatments to international clients and Indians who can afford it to private doctors who have minimal medical expertise or formal training on the other end of the spectrum. Furthermore, the private sector controls 80% of doctors, 26% of nurses, and 49% of hospital beds, demonstrating its power.
In contrast to India, the number of hospitals in other nations is not given. However, according to World Bank statistics, available at https://data.worldbank.org/indicator/SH.MED.BEDS.ZS India\'s accessible beds per 1000 population is lower than that of a lot of other countries. As a state of concern, public health and hospitals are largely responsible for the upkeep, providing health treatment to individuals, and maintaining hospital information. However, the following details are provided below:
Number of Primary Health Centers (PHCs), Community Health Centers (CHCs), Sub-District/Divisional Hospitals (SDHs), District Hospitals (DHs), and beds in India, by State/UT, as uploaded by the States/UTs on the Ministry\'s Health Management Information System (HMIS) portal.
Number of government hospitals and beds in rural and urban areas in India, broken down by state/UT, as published in National Health Portal 2018.
The Ministry of AYUSH provides information on the number of AYUSH hospitals and beds in each state/UT.
Total and state-by-state number of hospitals and beds maintained by the Ministry of Defense.
Number of railway hospitals and beds, as reported in the National Health Portal 2018 publication.
Number of State Insurance Corporation employees, hospitals, and beds, per state/UT, and total, as published in the National Health Portal 2018.
State/UT | No. of public facilities | No. of beds available in public facilities | ||||
---|---|---|---|---|---|---|
PHC | CHC | SDH | DH | Total | ||
Andaman & Nicobar Islands | 27 | 4 | 3 | 34 | 1246 | |
Andhra Pradesh | 1417 | 198 | 31 | 20 | 1666 | 60,799 |
Arunachal Pradesh | 122 | 62 | 15 | 199 | 2320 | |
Assam | 1007 | 166 | 14 | 33 | 1220 | 19,115 |
Bihar | 2007 | 63 | 33 | 43 | 2146 | 17,796 |
Chandigarh | 40 | 2 | 1 | 4 | 47 | 3756 |
Chhattisgarh | 813 | 166 | 12 | 32 | 1023 | 14,354 |
Dadra & Nagar Haveli | 9 | 2 | 1 | 1 | 13 | 568 |
Daman & Diu | 4 | 2 | 2 | 8 | 298 | |
Delhi | 534 | 25 | 9 | 47 | 615 | 20,572 |
Goa | 31 | 4 | 2 | 3 | 40 | 2666 |
Gujarat | 1770 | 385 | 44 | 37 | 2236 | 41,129 |
Haryana | 500 | 131 | 24 | 28 | 683 | 13,841 |
Himachal Pradesh | 516 | 79 | 61 | 15 | 671 | 8706 |
Jammu & Kashmir | 702 | 87 | 29 | 818 | 11,342 | |
Jharkhand | 343 | 179 | 13 | 23 | 558 | 7404 |
Karnataka | 2547 | 207 | 147 | 42 | 2943 | 56,333 |
Kerala | 933 | 229 | 82 | 53 | 1297 | 39,511 |
Lakshadweep | 4 | 3 | 2 | 1 | 10 | 250 |
Madhya Pradesh | 1420 | 324 | 72 | 51 | 1867 | 38,140 |
Maharashtra | 2638 | 430 | 101 | 70 | 3239 | 68,998 |
Manipur | 87 | 17 | 1 | 9 | 114 | 2562 |
Meghalaya | 138 | 29 | 13 | 180 | 4585 | |
Mizoram | 65 | 10 | 3 | 9 | 87 | 2312 |
Nagaland | 134 | 21 | 11 | 166 | 1944 | |
Odisha | 1360 | 377 | 27 | 35 | 1799 | 16,497 |
Puducherry | 40 | 4 | 5 | 4 | 53 | 4462 |
Punjab | 521 | 146 | 47 | 28 | 742 | 13,527 |
Rajasthan | 2463 | 579 | 64 | 33 | 3139 | 51,844 |
Sikkim | 25 | 2 | 1 | 4 | 32 | 1145 |
Tamil Nadu | 1854 | 385 | 310 | 32 | 2581 | 72,616 |
Telangana | 788 | 82 | 47 | 15 | 932 | 17,358 |
Tripura | 114 | 22 | 12 | 9 | 157 | 4895 |
Uttar Pradesh | 3277 | 671 | 174 | 4122 | 58,310 | |
Uttarakhand | 275 | 69 | 19 | 20 | 383 | 6660 |
West Bengal | 1374 | 406 | 70 | 55 | 1905 | 51,163 |
Source: Data as uploaded by States-UTs on HMIS portal, status as of 20 July 2018.
States/UTs | Rural hospitals | Urban hospitals | As on | ||
---|---|---|---|---|---|
No. | Beds | No. | Beds | ||
Andhra Pradesh | 193 | 6480 | 65 | 16,658 | 01.01.2017 |
Arunachal Pradesh* | 208 | 2136 | 10 | 268 | 31.12.2017 |
Assam | 1176 | 10,944 | 50 | 6198 | 31.12.2017 |
Bihar | 930 | 6083 | 103 | 5936 | 31.12.2016 |
Chhattisgarh | 169 | 5070 | 45 | 4342 | 01.01.2016 |
Goa* | 17 | 1405 | 25 | 1608 | 31.12.2017 |
Gujarat | 364 | 11,715 | 122 | 20,565 | 31.12.2016 |
Haryana* | 609 | 6690 | 59 | 4550 | 31.12.2016 |
Himachal Pradesh* | 705 | 5665 | 96 | 6734 | 31.12.2017 |
Jammu & Kashmir | 56 | 7234 | 76 | 4417 | 30.12.2016 |
Jharkhand | 519 | 5842 | 36 | 4942 | 31.12.2015 |
Karnataka* | 2471 | 21,072 | 374 | 49,093 | 31.12.2017 |
Kerala | 981 | 16,865 | 299 | 21,139 | 01.01.2017 |
Madhya Pradesh | 334 | 10,020 | 117 | 18,819 | 01.01.2016 |
Maharashtra | 273 | 12,398 | 438 | 39,048 | 31.12.2015 |
Manipur | 23 | 730 | 7 | 697 | 01.01.2014 |
Meghalaya* | 143 | 1970 | 14 | 2487 | 31.12.2017 |
Mizoram* | 56 | 604 | 34 | 1393 | 31.12.2017 |
Nagaland | 21 | 630 | 15 | 1250 | 31.12.2015 |
Odisha* | 1655 | 6339 | 149 | 12,180 | 31.12.2017 |
Punjab* | 510 | 5805 | 172 | 12,128 | 31.12.2017 |
Rajasthan | 602 | 21,088 | 150 | 10,760 | 31.12.2016 |
Sikkim* | 24 | 260 | 9 | 1300 | 31.12.2017 |
Tamil Nadu* | 692 | 40,179 | 525 | 37,353 | 31.12.2017 |
Telangana* | 802 | 7668 | 61 | 13,315 | 31.12.2017 |
Tripura* | 99 | 1140 | 56 | 3277 | 31.12.2017 |
Uttar Pradesh* | 4442 | 39,104 | 193 | 37,156 | 31.12.2017 |
Uttarakhand | 410 | 3284 | 50 | 5228 | 31.12.2015 |
West Bengal | 1272 | 19,684 | 294 | 58,882 | 01.01.2015 |
Andaman & Nicobar Islands | 27 | 575 | 3 | 500 | 31.12.2016 |
Chandigarh | 0 | 0 | 4 | 778 | 31.12.2016 |
Dadra & Nagar Haveli* | 10 | 273 | 1 | 316 | 31.12.2017 |
Daman & Diu | 5 | 240 | 0 | 0 | 31.12.2015 |
Delhi | 0 | 0 | 109 | 24,383 | 01.01.2015 |
Lakshadweep | 9 | 300 | 0 | 0 | 01.01.2016 |
Puducherry | 3 | 96 | 11 | 3473 | 01.01.2016 |
INDIA | 19,810 | 279,588 | 3772 | 431,173 |
States/UTs provided information for the year 2017 and PHCs are also included in the number of hospitals.
Source: National Health Profile 2018/Directorate General of State Health Services.
Notes: Government hospitals include central government, state government, and local govt. bodies. Figures are provisional.
Srl no. | State/UT | Number of hospitals | Number of beds | ||||||
---|---|---|---|---|---|---|---|---|---|
Govt. | Local Body | Others | Total | Govt. | Local Body | Others | Total | ||
1 | Andhra Pradesh | 8 | 0 | 0 | 8 | 365 | 0 | 0 | 365 |
2 | Arunachal Pradesh | 11 | 0 | 1 | 12 | 100 | 0 | 25 | 125 |
3 | Assam | 4 | 0 | 0 | 4 | 205 | 0 | 0 | 205 |
4 | Bihar | 8 | 0 | 0 | 8 | 950 | 0 | 0 | 950 |
5 | Chhattisgarh | 7 | 0 | 8 | 15 | 370 | 0 | 470 | 840 |
6 | Delhi | 4 | 0 | 1 | 5 | 390 | 0 | 210 | 600 |
7 | Goa | 0 | 2 | 0 | 2 | 0 | 150 | 0 | 150 |
8 | Gujarat | 35 | 29 | 0 | 64 | 1495 | 1763 | 0 | 3258 |
9 | Haryana | 4 | 0 | 7 | 11 | 145 | 0 | 600 | 745 |
10 | Himachal Pradesh | 34 | 0 | 0 | 34 | 710 | 0 | 0 | 710 |
11 | Jammu & Kashmir | 2 | 0 | 0 | 2 | 75 | 0 | 0 | 75 |
12 | Jharkhand | 1 | 4 | 0 | 5 | 50 | 300 | 0 | 350 |
13 | Karnataka | 156 | 0 | 57 | 213 | 2455 | 0 | 7740 | 10,195 |
14 | Kerala | 162 | 0 | 0 | 162 | 4054 | 0 | 0 | 4054 |
15 | Madhya Pradesh | 23 | 0 | 0 | 23 | 690 | 0 | 0 | 690 |
16 | Maharashtra | 5 | 0 | 66 | 71 | 812 | 0 | 8024 | 8836 |
17 | Manipur | 10 | 0 | 0 | 10 | 0 | 0 | 0 | 0 |
18 | Meghalaya | 10 | 0 | 0 | 10 | 100 | 0 | 0 | 100 |
19 | Mizoram | 2 | 0 | 0 | 2 | 100 | 0 | 0 | 100 |
20 | Nagaland | 2 | 0 | 0 | 2 | 10 | 0 | 0 | 10 |
21 | Odisha | 9 | 0 | 5 | 14 | 593 | 0 | 310 | 903 |
22 | Punjab | 5 | 0 | 4 | 9 | 100 | 0 | 108 | 208 |
23 | Rajasthan | 137 | 0 | 0 | 137 | 1391 | 0 | 0 | 1391 |
24 | Sikkim | 1 | 0 | 0 | 1 | 10 | 0 | 0 | 10 |
25 | Tamil Nadu | 293 | 0 | 0 | 293 | 2381 | 0 | 0 | 2381 |
26 | Tripura | 4 | 0 | 0 | 4 | 60 | 0 | 0 | 60 |
27 | Uttar Pradesh | 2315 | 0 | 1 | 2316 | 11,361 | 0 | 100 | 11,461 |
28 | Uttarakhand | 404 | 0 | 1 | 405 | 2023 | 0 | 50 | 2073 |
29 | West Bengal | 11 | 0 | 11 | 22 | 530 | 0 | 620 | 1150 |
30 | Andaman & Nicobar Islands | 5 | 0 | 0 | 5 | 90 | 0 | 0 | 90 |
31 | Chandigarh | 0 | 0 | 2 | 2 | 0 | 0 | 80 | 80 |
32 | Dadra &Nagar Haveli | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
33 | Daman &Diu | 2 | 0 | 0 | 2 | 20 | 0 | 0 | 20 |
34 | Lakshdweep | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
35 | Puducherry | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
36 | Telangana | 20 | 0 | 0 | 20 | 841 | 0 | 0 | 841 |
Total (A) | 3694 | 35 | 164 | 3893 | 32,476 | 2213 | 18,337 | 53,026 | |
B. CGHS & central government organizations | 50 | 0 | 0 | 50 | 2216 | 0 | 0 | 2216 | |
Total (A+B) | 3744 | 35 | 164 | 3943 | 34,692 | 2213 | 18,337 | 55,242 |
Source: Ministry of AYUSH.
S. no. | Name of state | No. of hospitals | No. of beds |
---|---|---|---|
1 | Assam | 8 | 2357 |
2 | Andhra Pradesh | 1 | 306 |
3 | Andaman & Nicobar Islands | 1 | 107 |
4 | Arunachal Pradesh | 1 | 198 |
5 | Bihar | 2 | 348 |
6 | Delhi | 2 | 1993 |
7 | Goa | 2 | 175 |
8 | Gujarat | 5 | 666 |
9 | Haryana | 3 | 1458 |
10 | Himachal Pradesh | 6 | 699 |
11 | Jammu & Kashmir | 11 | 2643 |
12 | Jharkhand | 2 | 649 |
13 | Karnataka | 3 | 1090 |
14 | Kerala | 5 | 744 |
15 | Madhya Pradesh | 7 | 1402 |
16 | Maharastra | 11 | 4202 |
17 | Manipur | 1 | 74 |
18 | Meghalaya | 1 | 247 |
19 | Nagaland | 2 | 398 |
20 | Odisha | 2 | 147 |
21 | Punjab | 10 | 2990 |
22 | Rajasthan | 11 | 2115 |
23 | Sikkim | 2 | 247 |
24 | Tamil Nadu | 3 | 373 |
25 | Telangana | 3 | 764 |
26 | Tripura | 1 | 49 |
27 | Uttarakhand | 5 | 1402 |
28 | Uttar Pradesh | 15 | 4570 |
29 | West Bengal | 7 | 2107 |
Total | 133 | 34,520 |
Source: Ministry of Defense
S. no. | Zone/PU | Total no. of hospitals | Total no. of indoor beds |
---|---|---|---|
1 | Central Railway | 11 | 1164 |
2 | Eastern Railway | 8 | 1587 |
3 | East central Railway | 9 | 819 |
4 | East coast Railway | 4 | 339 |
5 | Northern Railway | 9 | 1101 |
6 | North Central Railway | 5 | 586 |
7 | North East Railway | 6 | 927 |
8 | North East Frontier Railway | 10 | 1107 |
9 | North Western Railway | 8 | 584 |
10 | Southern Railway | 10 | 1131 |
11 | South Central Railway | 7 | 714 |
12 | South Eastern Railway | 6 | 1086 |
13 | South East Central Railway | 5 | 250 |
14 | South Western Railway | 3 | 300 |
15 | Western Railway | 9 | 976 |
16 | West Central Railway | 7 | 456 |
17 | Intergral Coach Factory | 1 | 101 |
18 | Rail Coach Factory | 1 | 60 |
19 | Chittaranjan Locomotive Works | 1 | 197 |
20 | Diesal Locomotive Works | 1 | 105 |
21 | Diesel Loco Modernisation Works | 1 | 50 |
22 | Rail Wheel Factory | 1 | 46 |
23 | Research Design and Standards Organization | 1 | 30 |
24 | Metro/Kolkata | 1 | 30 |
25 | MCF/Raibareli | 1 | 2 |
26 |
Source: National Health Profile 2018 (as on 21/3/2018).
S. no. | States/UTs | Total no. of hospital | Total no. of beds |
---|---|---|---|
1 | Andhra Pradesh | 5 | 345 |
2 | Assam | 1 | 75 |
3 | Bihar | 3 | 50 |
4 | Chandigarh [Adm.] | 1 | 70 |
5 | Chhattisgarh | 0 | 0 |
6 | Delhi | 4 | 1416 |
7 | Goa | 1 | 15 |
8 | Gujarat | 12 | 910 |
9 | Himachal Pradesh | 2 | 150 |
10 | Haryana | 7 | 781 |
11 | Jammu & Kashmir | 1 | 50 |
12 | Jharkhand | 3 | 210 |
13 | Karnataka | 11 | 1675 |
14 | Kerala | 12 | 1178 |
15 | Madhya Pradesh | 7 | 725 |
16 | Meghalaya | 0 | 0 |
17 | Maharashtra | 13 | 2390 |
18 | Nagaland | 0 | 0 |
19 | Odisha | 6 | 325 |
20 | Puducherry | 1 | 75 |
21 | Punjab | 8 | 647 |
22 | Rajasthan | 6 | 495 |
23 | Sikkim | 0 | 0 |
24 | Tamil Nadu | 10 | 1856 |
25 | Telangana | 7 | 907 |
26 | Tripura | 0 | 0 |
27 | Uttar Pradesh | 16 | 1886 |
28 | Uttarakhand | 0 | 0 |
29 | West Bengal | 14 | 3534 |
Total |
Source: National Health Profile 2018.
The hospital pharmacy is one of the most important departments in the hospital, and it is responsible for drug procurement, storage, compounding, dispensing, manufacturing, testing, packaging, and distribution. This section is also in charge of pharmaceutical science and education research, which is carried out by skilled and knowledgeable pharmacists. The hospital pharmacy has a significant impact on healthcare cost economics. In today\'s hospital pharmacy, medication monitoring and drug information services are combined. Purchasing, storing, handling, pricing, and dispensing pharmaceuticals are all skills that a hospital pharmacist possesses. In addition, pharmacists give drug information to all healthcare professionals and the public, as well as serve as a link between the patient and the doctor. The criteria for acquiring pharmaceuticals, chemical and biological medications, and other items are provided by hospital pharmacists. They are also in charge of manufacturing and distributing pharmaceuticals like transfusion fluids, parenteral goods, pills, capsules, ointments, stock combinations, and safe drug storage. Hospital pharmacists can sterilize and dispense parenteral drugs made in hospitals. They fill, label, and distribute all medicine packages. Hospital pharmacists oversee purchasing pharmaceuticals, ensuring correct drug storage conditions, keeping records, and distributing pharmaceuticals to the outpatient department. In addition, hospital pharmacists provide drug monitoring services for inpatients and participate in hospital research programs [8]. Due to low wages, the hospital parts of a pharmacist\'s job have historically been overlooked in India; also, pharmacists have never been trained for a patient-centered role. Medical practitioners have never embraced pharmacists for clinical functions, while pharmacists have been hesitant to accept their profession\'s clinical obligations. Many Indian hospitals have begun to assign pharmacists a clinical role, with encouraging outcomes, but India still lags behind other countries in this regard. In India, the concept of a hospital pharmacy is confined to the dispensing of medications at hospital pharmacies [9].
Hospital pharmacies require certain personnel.
The dispensing, manufacturing, quality assurance, and clinical pharmacy services are all integrated within the hospital pharmacy. Personnel requirements for an inpatient pharmacy are determined by the nature and scope of services supplied by the department. The number of hospital pharmacists required is determined by the workload and the number of beds in the hospital. Small hospitals typically require a minimum of three pharmacists; however, this varies depending on the number of beds. Table 1 shows the number of pharmacists necessary based on the number of beds in a hospital [8].
Pharmacist requirement | |
---|---|
Bed strength | No. of pharmacists required |
Up to 50 beds | 3 |
Up to 100 beds | 5 |
Up to 200 beds | 8 |
Up to 300 beds | 10 |
Up to 500 beds | 15 |
Pharmacist requirement in hospitals.
According to 2011 data, the number of government hospital beds in rural and urban locations is shown in Table 2.
State | Rural hospital beds (government) | Urban hospital beds (government) | Total beds (government) | Proportion of rural and urban beds |
---|---|---|---|---|
Bihar | 1830 | 16,686 | 18,516 | 10:90 |
Chhattisgarh | 3270 | 6158 | 9428 | 35:65 |
Jharkhand | N.A. | N.A. | N.A. | N.A. |
Madhya Pradesh | 10,040 | 18,493 | 28,533 | 35:65 |
Odisha | 7099 | 8715 | 15,814 | 45:55 |
Rajasthan | 13,754 | 12,236 | 25,990 | 53:47 |
Uttar Pradesh | 15,450 | 40,934 | 56,384 | 27:73 |
Uttarakhand | 3746 | 4219 | 7965 | 47:53 |
EAG states | 55,189 | 107,477 | 162,630 | 34:66 |
Non-EAG states | 114,673 | 511,187 | 622,310 | 18:82 |
All India | 169,862 | 618,664 | 784,940 | 20.5:79.5 |
State and union territory wise number hospitals and beds in rural and urban areas in India.
N.A., not available.
Source: GOI, Table 6.2.2 State/UT wise number of govt. hospitals and beds in rural and urban areas (including CHCs) in India (provisional), in “Health infrastructure” in “National Health Profile, 2011,” Central Bureau of Health Intelligence, Ministry of Health and Family Welfare, 2011.
Personnel who work in hospital pharmacies must be knowledgeable and well-trained. The director of the pharmacy must have a postgraduate degree in hospital pharmacy, pharmacology, or pharmaceutics and serves as a liaison between pharmacy and non-pharmacy personnel. The hospital pharmacy\'s structure is depicted in the Flowchart below (Figure 1).
Organization structure of hospital pharmacy. Source: Nahata [
Even we have seen the present status, there were no significant improvements.
In India, the Pharmacy Act of 1948 was passed to ensure that every practicing pharmacist had a registration certificate [11, 12, 13]. On completion of the minimum diploma in pharmacy, educational institutes authorized by the PCI can grant this credential. A pharmacy diploma involves at least 2 years of education and 500 h of practical training, including three months in a community or hospital pharmacy [11]. These pharmacists with a diploma represent most of the workforce and run most community pharmacies in India today. A bachelor\'s degree in pharmacy is designed to meet the needs of the pharmaceutical business, with most graduates working in pharmaceutical companies or regulatory agencies. In comparison to community pharmacy, many B. Pharm graduates prefer to work in the pharmaceutical business because of the higher pay scale and other benefits.
In practice, these pharmacists with a diploma or bachelor\'s degree are still unheard of in half of the community pharmacies. Most patients come to community pharmacists for help on sexually transmitted diseases, minor ailments, contraceptive options, and menstruation issues [11]. The majority of community pharmacies are administered by people with minimal awareness of health issues or medical training, and pharmacists are hired on low pay rates. Most pharmacists in community pharmacies lack counseling abilities and are simply able to deliver medications. Despite the public\'s negative opinion of pharmacists and the idea that pharmacies are like grocery stores, community pharmacies remain the principal provider of low-cost medical treatment.
In India nowadays, the average cost of a prescription per patient who visited a private clinic is around 1000–1500 rupees, and the number of prescriptions per drug has increased. The marketing efforts of pharmaceutical companies have a significant impact on doctors\' prescribing patterns. Pharmaceutical companies spend less on R&D than they do on marketing. Medical representatives are trained by pharmaceutical companies to advertise and sell pharmaceuticals utilizing printed product materials, medicine samples, and gifts. Around 80,000 medical representatives are hired by pharmaceutical companies in India, and they are paid well.
In addition to their pay, they are offered significant incentives. General practitioners have been found to prescribe new products under the influence of sales reps. Furthermore, medical representatives promote medications by stating more indications than are officially registered.
One of the main tools used by pharmaceutical firms to advertise their medication is gifts (ranging from a table-top reminder to an air conditioner), gratification, foreign excursions, pleasure excursions, and so on. From clocks to air conditioners, calendars to cars, rubber bands to refrigerators, telephone indexes to television, and office items to overseas trips, the variety of gifts includes stationery, timepieces, bags, books, folders, office desks, medical supplies, and household items—from clocks to air conditioners, calendars to cars, rubber bands to refrigerators, telephone indexes to television, and office items to overseas trips. According to Chren and associates, there is an implicit relationship between doctors and the pharmaceutical industry, which leads to a responsibility to respond to gifts [14].
Advertising has a significant role in the marketing of medicine. Pharmaceutical companies spend a lot of money to advertise in medical and pharmaceutical magazines, which are read by a lot of general practitioners and clinical specialists. Medical journals in India would perish if pharmaceutical companies did not advertise in them. The advertising of pharmaceuticals is strictly monitored, and if there is any false information, harsh action is taken. Drug information should be accurate, current, and balanced, according to the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) and The Association of the British Pharmaceutical Industry (ABPI) guidelines. The IFPMA code must be followed by all members of the Organization of Pharmaceutical Producers of India (OPPI). Internal codes and promotional material for the pharmaceutical producers of India must be approved by medical advisers, according to the organization. A Promotional Quality Improvement and Assurance Committee also performs a thorough study of these promotional materials. Furthermore, this committee makes recommendations for marketing enhancements.
Irrational prescription and its consequences are heavily influenced by pharmaceutical marketing and promotional activities. The Medical Council of India has issued a new code of ethics for practitioners who receive any sort of compensation from pharmaceutical companies. New legislation in Rajasthan, India, states that a doctor must only put the generic name of a medicine on a prescription [14].
With the advent of clinical pharmacy, which provides high-quality treatment and assistance to patients, a pharmacist\'s job has been expanded. Pharmacists now provide drug and toxicity information, manage anticoagulation clinics, and administer smoking cessation programs, among other things.
The paramedic education system has been supply-driven, with no regard for industry demand. Allied healthcare providers are the most crucial because, if a patient has a hundred interactions at a hospital, allied healthcare workers account for 80 of those encounters. In India, healthcare is the third most important source of employment. It is broken down into three categories: Doctors make up 10–15% of the healthcare workforce, nurses make up 20–25% of the workforce, and paramedics, also known as allied healthcare professionals or healthcare technicians, make up the largest segment of the healthcare workforce. The doctor-to-allied healthcare-professional ratio in India is 1:4. The advanced countries, such as the United States and the United Kingdom, have a 1:20 ratio. India already employs over 10 million allied healthcare workers, but to meet the 1:20 ratio, we will need to increase this number to 40–50 million in the next few years. Diagnostic, curative, and rehabilitative allied healthcare professions are categorized into three groups. The diagnostic and therapeutic industries in India have been expanding. Allied healthcare professionals such as X-ray technicians and medical app technicians work in diagnostic. Technicians such as OT technicians and emergency medical technicians work in Curative. The difficulty is that in India, only about 7% of these allied healthcare professionals are certified because there was no centralized authority to certify them until the NSTC was established. Before NSTC, each state certified them at their own level, and the biggest problem today is for quality healthcare services, allied healthcare professionals are the most important because if a patient has a hundred interactions in a hospital, 80 of those interactions are with allied healthcare professionals, and the biggest challenge in India is that there are less than a hundred allied healthcare professionals. Until 2008, there was no centralized body. One of the most significant issues is that, in general, education in India has been supply-driven, with no connection to industry needs. As a result, when compared to worldwide norms, we are one of the least prepared for the workforce. What needs to be done is for education to be driven by demand. It must be presented from the standpoint of the company and how these individuals will work in the sector. To do so, we must recognize three factors—technical training, practical training, and soft skills and grooming training, all of which must be provided so that these individuals are prepared to fully contribute to the workforce in a productive manner when they enter the workforce. Mr. Narendra Modi, Prime Minister of India, believes that ongoing training of the workforce required to combat the COVID 19 crisis is critical. He recommended officials and doctors to hold training sessions and webinars, particularly for paramedics and doctors who work in rural areas. He also requested that the officials endeavor to reduce vaccination waste in the district. Interacting with Varanasi doctors and administrators via video chat Prime Minister Narendra Modi paid a heartfelt tribute to those who died because of COVID-19. He emphasized the necessity of ongoing training for those fighting COVID, advising officials and doctors to hold training sessions and webinars, particularly for paramedics and doctors functioning in remote areas. He also requested that the officials endeavor to reduce vaccination waste in the district. "Jahan Bimar Wahan Upchar," is the new slogan in COVID management in terms of delivering therapy to the patient\'s doorstep that will minimize the strain on the health system. The doctors from Varanasi updated the other doctors through video conference on the measures made in the last month to restrict the spread of COVID, vaccination status, and ongoing steps and strategies to prepare the district for future difficulties. They stated that they have been vigilant in their response to the threat of mucormycosis and have already taken action and established facilities to handle the condition. Our Prime Minister also praised the microcontainment zones project and praised the home distribution of medicines, and he urged health professionals to make the campaign as widespread as possible in rural areas. He praised the physicians, nurses, technicians, ward boys, ambulance drivers, and other Kashi frontline health professionals for their efforts. He praised the medical staff in Kashi for their efforts in controlling the pandemic to a large extent, but warned against complacency, urging them to fight a lengthy battle right now by focusing on the rural districts of Banaras and Purvanchal. PM emphasized the critical role of Accredited Social Health Activists (ASHAs) and Auxiliary Nursing Midwifery (ANMs) sisters in the ongoing village campaign against COVID-19 and urged health officials to use their potential and experience. The main reason is if the frontline employees had already been vaccinated, they were able to serve the people safely during the second wave. We need to encourage everyone to get the vaccine when it is their turn, that is what has currently been done.
Diverse countries and continents, including emerging, transitional, and industrialized countries, have different pharmaceutical practices. The World Health Organization (WHO)/International Pharmaceutical Federation (FIP) joint guideline of good pharmacy practice (GPP), which was updated in 2011, is meant to account for these changes in practice. The pharmacy profession is rapidly expanding, with new responsibilities being offered and announced not only by pharmacists but also by other medical professionals, national organizations, and institutions. The GPP\'s guideline is progressive and adaptable, and it must remain relevant when new positions develop. Standardizing many parts of pharmacies is one of the most important techniques of quality control for medications and pharmaceutical services for the public. The GPP Guide is a significant step toward bettering pharmacy services [12]. The GPP guideline is designed for use by national professional pharmaceutical associations, as well as national authorities and other relevant agencies responsible for drafting relevant documents and related laws and regulations in their countries, according to the WHO and FIP. It is not a clear national standard, but it does provide guidance on certain tasks, responsibilities, and actions that help pharmacists to fulfill their mission. Professional issues and attitudes are given specific attention throughout the guideline\'s content, and the patient\'s well-being is given priority. However, it should be noted that this is the first time that a legal, economic, and labor framework has been introduced in the context of the GPP structure, and it comes at an appropriate time given global debates on the economic aspects of medicines, access to quality medicines, access to skilled medical workers, the global workforce failure, the increased cost of medical care, and new models of healthcare [13]. The GPP is defined by the WHO and the FIP as a pharmacy practice that satisfies the needs of people who use pharmacists\' services to deliver optimal medical care based on evidence-based medicine principles. To support this approach, a national framework of quality standards and guidelines is required. The goal of this project is to investigate the historical stages of development of GPP requirements, as well as to examine modern normative texts proposed by FIP for use in global pharmaceutical practice, as well as to investigate the current state of this issue around the world. The study included the generalization of information material and system analysis methods. The WHO and the FIP have been working together since the late 1980s to define pharmacist duties and functions, as well as produce guidelines for the GPP as a framework for pharmacological care. The WHO amended the medicines strategy, which was accepted by the World Health Assembly in 1986, and two meetings on the function of pharmacists were held in accordance with it. The inaugural meeting was held in Delhi, India, in 1988 [15]. The FIP produced criteria for pharmaceutical services in 1992, and the WHO Information Centers disseminated the approach of good pharmaceutical practice in March 1993. The standards of pharmacy services entitled "GPP in Public and Hospital Pharmacies" were officially issued during the convention in Tokyo, Japan [15]. Under the framework of the Tokyo declaration on quality standards of pharmaceutical services, the FIP congress accepted the FIP/GPP text. The FIP has asked pharmaceutical companies and governments to work together to implement GPP standards or to amend current national standards in countries where they currently exist, according to this paper. Then, in May 1994, the World Health Assembly adopted a resolution on the role of the pharmacist in support of the WHO\'s new pharmaceuticals strategy. In 1994, a version of the GPP was also presented to the WHO Expert Committee on Pharmaceutical Medicine Specifications in Geneva. In 1999, a joint document of the WHO/FIP of the GPP was published in a series of technical reports of the WHO Expert Committee on concerns of pharmaceutical medicine specification, following the recommendations of the WHO Expert Committee and the approval of the Board of the FIP in 1997. This gave the GPP more formal standing and assured that it was widely distributed around the world [16]. A Soon after, the WHO convened two more meetings on the pharmacist\'s role, one in 1997 in Vancouver, Canada, and the other in 1998 in The Hague, Netherlands. These gatherings reinforced the necessity for reforming pharmacy education programs and highlighted the pharmacist\'s role in self-help and self-healing. The European Union\'s (EU) pharmaceutical group prepared a paper containing the GPP for Europe in 1998, with special emphasis dedicated to EU countries—"the GPP in Europe." [17]. The “GPP in the New Independent States” was established in 2001. The Copenhagen Center for Drug Policy and Development of Pharmaceutical Practice developed “Guidelines for the creation and implementation of standards” in Denmark. The document examined the state of pharmacy practice and focused on issues such as health education and morbidity prevention, the provision of prescription drugs and their use, self-treatment, the effects of prescription and use of drugs, as well as the method of implementing proper pharmacy practices in developing countries. The WHO experts recommended that European standards for pharmacies be implemented on a par with existing national standards to regulate various aspects of pharmaceutical activity, including the quality of prescription data received by the pharmacist, the development of medical forms, the building of contacts with doctors based on individual recipes, and the evaluation of data on the use of medical products [18]. There is a strategy for establishing national GPP standards, according to FIP recommendations. To begin, fundamental pharmaceutical services must be established, for which a regulatory framework and relevant standards must be created. The secondary and higher education systems in pharmacy should be revised after that because pharmacists will require a more in-depth understanding of pharmacotherapy, pharmacopeia, and communications skills. The provision of more complex professional pharmaceutical services is the ultimate stage. The FIP highlights GPP elements that demonstrate that the pharmacy provides high-quality service and adheres to strict guidelines: The presence of a zone in the pharmacy with information about healthy lifestyles; availability of a pharmacy for people with disabilities and elderly patients; availability of a comfortable waiting area; the possibility of a private conversation between a pharmacist and a patient, including those with disabilities; and the presence of a pharmacist on call. The pharmacist\'s responsibility in providing successful drug therapy, according to FIP\'s recommendations, is as follows: Management of therapy, monitoring of treatment success, and disseminating information on the safe and effective use of medications. The pharmacist should evaluate the client\'s health and needs, taking into consideration his unique qualities. Professional collaboration between the pharmacist and the doctor is an important part of GPP. Each patient\'s medical and pharmacological information (diagnosis and laboratory data) should be in the first one. It is also crucial to keep track of whether GPP standards are being followed. It can be internal and/or external; it can also be necessary or simply for accreditation/certification purposes. This will disclose the drawbacks of meeting GPP requirements as well as ideas for how to avoid them. One of the simplest ways to ensure that a pharmacy\'s work is of high quality is to assess customer satisfaction with the service. In 2006, FIP and WHO collaborated to publish the handbook "Developing Pharmacy Practice—A Patient-Centered Approach." This guide introduces the new pharmacy practice paradigm and the approach to pharmaceutical assistance. The FIP has taken the initiative to explore the possibilities of providing technical assistance to its member organizations in Cambodia, Moldova, Mongolia, Paraguay, Thailand, Uruguay, and Vietnam in developing national standards of the GPP in a pilot project to improve standards and practice of medicine distribution and use with the help of the WHO/FIP setting with the GPP as the framework. The “Bangkok declaration of the GPP in public pharmacies” was adopted across Southeast Asia in 2007, and member associations pledged to improve the quality of pharmacy services and professional practice [19]. Significant advances in practice applied science and technology, and pharmaceutical policy has happened since the GPP guideline was accepted in community and hospital settings. Despite changes that have occurred since the GPP\'s previous guidance in pharmaceutical policy, practice, and applied science was adopted in 2007, FIP was established to investigate the problem of updating the GPP\'s guiding principles to reflect current standards and professional thinking peculiarities [20]. During the 68th World Congress in Basel, Switzerland, in 2008, the FIP convened expert consultations for this aim. A total of 50 people attended the meeting, including members of the working group (WG), FIP of the GPP, WHO headquarters staff, representatives from the WHO regional office for the Eastern Mediterranean countries, medicines advisers from Ghana, Nigeria, and the United Republic of Tanzania, presidents, and secretaries of six Regional Pharmaceutical Forums, FIP member organizations, and several NGOs [21]. Following these consultations, the FIP GPP working group performed a detailed examination of current national standards for GPP in at least 37 countries and developed a time zone that could allow for adequate consultations with all 120 national associations, relevant experts, and the WHO. In October 2008, a proposal for this project was given to the WHO Expert Committee on concerns of pharmaceutical medicine specification at its 43rd meeting, and an updated report was provided to the Committee of Experts at its 44th meeting in October 2009. Simultaneously, in late 2008, the Pan-American Health Organization prepared “the guide for pharmaceutical services in primary health care” with the help of a group of experts from various pharmaceutical organizations, with the goal of highlighting the role of pharmaceutical experts in Latin America\'s health system. Following discussion with 120 national members of the FIP in 2011 and changes in the pharmaceutical industry, the GPP recommendations were adopted and updated by the approval of a joint guideline FIP/WHO titled "the GPP: Standards of the quality of pharmacy services." This general guideline was released as new standards of pharmacy service quality in the WHO Expert Committee\'s 45th report. In addition, this document encourages national pharmacy professional associations to embrace these standards and propose some GPP-specific norms [22]. The GPP establishes standards that are usually higher than the requirements of a country\'s pharmaceutical legislation. In the modified version of the GPP, pharmacists play many roles:
Medical product manufacturing, receiving, storage, security, distribution, usage, release, and disposal.
Ensuring that the pharmacological therapy is properly managed.
Continuation and enhancement of professional activity.
Encouraging the system of medical care and health to become more effective [20].
Depending on the duties that each pharmacist does, these positions may differ. Only through national pharmacy professional associations may specific GPP standards be defined. This recommendation is made in the form of a set of professional goals that must consider the needs of patients and other pharmaceutical stakeholders.
In comparison to the previously authorized concept of the GPP, the present updated version reinforces the requirements for the GPP\'s well-known primary aspects and identifies functions in each pharmacist\'s position for which minimum national standards should be established. Different countries have different versions of the GPP rules. There are holistic papers in some countries that cover both requirements for the material-technical base, infrastructure, personnel, and standards for the provision of pharmacological treatment. These rules and regulations are spelled out in numerous documents in other countries. The standards for pharmacists in France, for example, are established in several guidelines. In Austria, on the other hand, nearly all the requirements for pharmacists are encapsulated in a single piece of legislation. There is also a guideline for pharmacists\' work, which includes standards for a quality management system in addition to the typical criteria for premises, equipment, and staff. The GPP standards have a recommended status in industrialized countries. As a result, the Norwegian pharmaceutical association\'s standards of pharmacy practice, created in partnership with other professional groups, include requirements for pharmacy activities that are utilized by pharmacy owners to conduct internal quality control of pharmacy services. The government adopts legislation acts that provide the minimum standards for the functioning of pharmacies [23]. The Pharmaceutical Society of Ireland published a guideline on pharmacy practice to help pharmacists meet legal and regulatory requirements when providing pharmaceutical services [24]. In addition, the GPP is adopted in CIS countries. Belarus has implemented a pharmacy classification system. The GPP was adopted in Kazakhstan in 2006, and the provisions of the GPP of the customs union are currently approved in the Russian Federation. It should be noted that the GPP standard and guidance on the implementation of proper pharmacy practices serve as the foundation for implementing the total quality management (TQM) concept and the international standard of ISO quality management at pharmaceutical companies, both of which have been in use for more than 30 years. The understanding of the existence of an inextricable link between the quality management system and the organization\'s management system, as well as the understanding that this is an essential tool for continuous improvement and increasing the pharmacy organization\'s competitiveness in any market, is the foundation of TQM [25]. As a result, by enhancing the requirements to assure the quality of public services, the GPP standards are a significant step toward the expansion and enhancement of pharmacy operations. Despite improvements in pharmaceutical research and practice, the development and implementation of GPP criteria into pharmacy practice is a long-term and ongoing process. The standardization of pharmacists\' activity in providing people with medications and medical items receives a lot of attention in GPP guides of all years. Because national regulation of pharmacy practice differs widely among nations, the establishment of GPP standards should be handled at the level of public professional organizations. The results of the study will be used to design and apply GPP national standards around the world, according to future scientific research.
A recent countrywide survey done by final year postgraduate diploma in management students from Indian Institute of Health Management & Research, Bangalore finds that out of 107 hospitals 66 hospitals only follow the WHO/FIP GPP 2011 or Indian Pharmacy Practice Regulations 2015 which is merely 62% of the entire sample.
Students were asked to conduct a brief analysis and report on the top five hospitals or community pharmacy dept. in their area or where they did train/observer ship whether these guidelines are followed or not and where are the loopholes in following this guideline. There were two kinds of data generated, such as
The graphical representation of the quantitative survey data is illustrated as follows:
The qualitative observational/survey data is represented as follows:
Qualitative survey result | Observations |
---|---|
Narayana Health City | While working in a Pharmacy Department of the Hospital, many things are founded like:
There should be a proper space in the IP pharmacy. Pharmacists should be provided with more space with more no of counters. Expired medicine should be categorized separately. Medicine should be categorized on a monthly basis so that it may return on time. Calls should be attended properly by the staff. The pharmacy should categorize the drugs, injections, medical consumables in an order so that anyone can find it quickly. Drinking water facilities should be there. There should be proper lighting facilities. The pharmacy should be hygienic. |
Dr. Agarwal\'s Eye Hospital Chain, S V Hospital & C M N Hospital |
|
Sagar Hospital | Most common loopholes and challenges found in the hospital pharmacy. As hospitals have a pharmacy, they mostly followed the FIP guidelines but there are some challenges and loopholes faced by the hospital pharmacy. The challenges related to the pharmacist include the inadequacy of service promotion, absence of service continuity, poor DIC service, and lack of commitment, communication, and confidence among clinical pharmacists. Most respondents declared that poor attitude toward the services, conflict of interest due to the unclear scope of practice, and absence of cooperation are the challenges that radiate from health practitioners such as nurses and physicians. Some respondents also described challenges that arise from the hospital management and its set-up. The challenges they mentioned include lack of training, shortage of skilled manpower, lack of incentives, absence of facilities in the ward for clinical pharmacists, and collaboration between academics and hospital clinical pharmacists. The other challenges stated by the respondents were due to the academic policy and the curriculum itself. This encompasses some gaps of the curriculum; absence of clear job description and working guidelines; and documentation system. The major challenges for clinical pharmacy services described were a lack of support from hospital management, absence of clearly defined roles and responsibilities for the clinical pharmacists, a shortage of pharmacy workforce and staff turnover, a lack of follow-up from responsible bodies, and a lack of enough salaries and incentives for the healthcare providers. |
Aditya Netralaya |
|
Mithra Hospital |
|
General | Many of the hospitals do not have an assigned clinical pharmacist, which makes the difficulty in practicing Rule number 2 of the standards of GPP. Workforce shortage during peak OPD hours there should be a training of pharmacists and associated personnel on regular basis. Updating newer guidelines. Sometimes when too much workload is there, pharmacists are unable to properly counsel the patients/attendants regarding doses, their uses, drug interactions, etc. Shortage of time for EWS pharmacy. Because medications are not always available, it is extremely inconvenient for patients to return after time. The room does not have adequate light and ventilation. There is a lack of adequate space for the storage area of the pharmacy. No trained personnel in pharmacy, that is, the staff is from nonpharmaceutical or nonmedical backgrounds. No proper support is seen in abiding by policies of government related to health outcomes as per the guidelines of Role 4. Drug availability is not meet the needs of patients. No proper record is maintained in any aspects related to dispensing or storing of drugs. |
No proper follow-up of patient turnaround time at the pharmacy | |
Narayana Health City | Missing of personnel in the pharmacy increases the patient waiting time |
Omni R K Hospital | No trained personnel in pharmacy, that is, staff from nonpharmaceutical or nonmedical background |
Gayathri Hospital | No trained personnel in pharmacy, that is, staff from non-pharmaceutical or non-medical background |
Pharmacy practice, which includes clinical, community, and hospital pharmacy, is referred to as healthcare in the true sense. PPs establish a vital link between doctors, nurses, and patients in a social community group, with the goal of improving patient welfare and safety [26]. Pharmacists must provide more than only distribution; they must also provide services to society, such as patient counseling, guidance, and the organization of drug data for human services, suppliers, and patients [27]. For example, before the product patent was implemented in India in the early 2000s, the pharma industry thrived successfully after the amendment of new monetary reforms in India in the mid-1990s until the early 2000s [28]. In terms of educational outcomes, the degree of student achievement in pharmacy has improved from 2012 to 2020 and is predicted to continue to climb due to its scope. Many pharmacy graduates have expressed an interest in medication discovery and innovation through research [29]. It has been suggested that pharmacies play an important role in strengthening social security because they work around the clock to maintain a chain of elegant integrity on drugs, particularly during the COVID-19 pandemic. From the standpoint of regulatory authorities, PPs play a variety of roles and duties in the execution of new recommendations based on situational faults [30].
It entails the implementation, evaluation, and interpretation of pharmacy orders as well as the dispensing of prescriptions. Pharmacists are responsible for providing patient counseling, legislation, and social services to promote pharmaceutical treatment as primary care in all areas of patient health [31]. They are also in charge of segregating and labeling pharmaceuticals and medical devices, as well as guaranteeing the safety of medication and device storage and maintaining adequate records [32].
The Pharmacy Act is a nonconstitutional statute.
There cannot be two regulators at the same time.
The AICTE Act is a broad statute.
The Pharmacy Act is a unique piece of legislation.
The Pharmacy Act is a comprehensive code that includes pharmacy specialists.
Only the Pharmacy Council of India (PCI) has the authority to set pharmacist qualifications.
Only PCI has the authority to set standards for pharmacies.
PCI will be solely responsible for approval and admission to institutes.
The Pharmacy Act has the power to govern not just pharmacy education but also the profession [33].
In India, there are two types of pharmacists—those who work in hospitals and those who work in
Pharmaceutical industry
Pharmacies in the community
Pharmacovigilance is a term that refers to the monitoring of pharmaceuticals.
Pharmacy schooling
Pharmacovigilance procedures
Bengal Chemical and Pharmaceuticals Ltd. was founded in 1892 as an individual initiative by the "Father of Indian Chemistry," Acharya Prafulla Chandra Ray, and is considered the country\'s first pharmaceutical enterprise. For the first time in more than six decades, Bengal chemicals and medicines Ltd. made a profit in 2016–17 [34].
For the manufacture, distribution, and sale of medications, India has the harshest rules and regulations in the world. The ability of law enforcement is not just determined by good legislation; it also requires stringent regulations and the acceptance of successful challenges. According to the Mashelkar committee\'s recommendations, one drug inspector should be assigned to every 50 manufacturing units and one to every 200 distribution outlets. In most states, 30–50% of positions are vacant, and the number of positions available is insufficient to expand the pharmaceutical sector. According to the Mashelkar committee report, one drug inspector is assigned to every 200 retailers, and the data from the All-India Organization of Chemists and Druggists (AIOCD) indicates that there are approximately 8.5 lakh pharmacies to be considered, implying that more than 4250 drug inspectors are required to manage the retail pharmacy segment [35].
CDSCO and SDRA have different roles.
Pre-manufacturing is the process of preparing a product for manufacture.
Expert panels help the Central Drugs Standard Control Organization (CDSCO) to regulate premanufacturing. The following is their primary role in dealing with the two major criteria:
Clinical studies (clinical trial registry, GCP, inspections, ethics committee, and significant adverse events)
Import and marketing license approvals for new drugs [36].
The State Drug Regulatory Authority (SDRA) oversees regulating drug product manufacturing in the states, while CDSCO oversees union territories. In some circumstances, the CDSCO and SDRAs undertake joint inspections [37]. The terms listed below are required for the manufacture of pharmaceutical products.
Permit (generic and marketing license)
GMP (good manufacturing practices) inspection
Drug testing and noncompliance penalties [31].
The SDRAs oversee regulating the distribution and sale of drugs in the states, while the CDSCO oversees the union territories. The terms listed below are required for the distribution and sale of pharmaceutical items.
Permit (sale and distribution practices)
Good Distribution Practices Inspection (GDP)
Drug testing and noncompliance penalties [38].
The current state of pharmacy education, authority functions, and future difficulties of pharmacists in all aspects was discussed, particularly considering the COVID-19 epidemic. During the development phase, it must overcome numerous obstacles, including regulations, duration, process controls, legal stumbling blocks, and situational flaws [39]. Table 3 summarized the educational updates.
Pharmacy program | Number of institutions | Annual intake |
---|---|---|
D Pharm | 3022 | 180,770 |
B Pharm | 1961 | 125,524 |
Pharm D | 267 | 8010 |
M Pharm | 792 | 24,465 |
Ph. D. in Pharmacy | 31 | 1240 |
Statistics of pharmacy education program in India.
From June 2, 2020, the PLI Scheme will be open for 4 months, allowing investors to propose the construction of Greenfield facilities for any of the 53 important drug intermediates and bulk pharmaceuticals that are now barely made in India [40]. The list contains important chemicals found in regularly given medications such as paracetamol, aspirin, metformin, atorvastatin, and others. The whole planned incentive package is worth Rs. 13,760 Crore, which is divided between bulk medicines and medical devices as shown in Figure 1.
COVID-19 PPs
Millions of people around the world are affected
Insight into no cure
Online (digital) education
Evaluate Indian strategy and tactics.
India\'s pharmaceutical industry\'s expectations in terms of global visibility
Opportunities with challenges
Across the several layers of regulatory and enforcement procedures, this industry suffers from knowledge asymmetry. Because each state has its own regulations, there is a lot of variation in the quality of drug regulation across the country [41]. India\'s drug inspectors, who are crucial players in drug regulation, should be highly qualified and adequately compensated to reflect the dignity that comes with such a large duty. The agency has a budget limit when it comes to implementing innovative methods of regulatory monitoring [39].
There is a great deal of anticipation, price pressure, and caution in the development of vaccines, particularly (Covaxin, Covishield, or Sputnik) for the treatment of COVID-19, which is still in Phase I and II clinical trials in India. There is a potential that poor data will emerge in a Phase III study, as several countries have done in the past, leading to vaccine development and outcome failure [42]. Nowadays, one of the most pressing issues in the management of process controls during the formulation of pharmaceuticals is the formation of impurities in the form of genotoxic and carcinogenic impurities, which are extremely toxic and harmful to patients taking medication for diabetes, gastric ulcers, and psychosis [43]. There is also a compensation challenge in India due to the loss of fixed-dose combination (FDC) drugs, as many of the 344 drugs in this category were banned and withdrawn because they were therapeutically irrational and caused toxicity in patients when used to treat chronic diseases like tuberculosis and HIV. As a result, there are still hopes of bringing FDCs to market for patient benefit with assurances of safety and efficacy [44]. If the financial expenditure is not increased, the quality of research, drug discovery, and development will suffer.
According to Holon IQ global education intelligence, the current $6 trillion education market will grow to $10 trillion by 2030. Digital platforms account for only 3% of worldwide education spending, and by 2025, they will account for $325 billion, or less than 5% of total spending [45, 46]. Although this will go a long way toward solving the country\'s educational challenges, the government\'s present worries include guaranteeing smooth delivery of education on the post-Covid road of digital education [47]. The UGC is now working on a game-changing regulation that will allow universities with a high “NAAC” score in the top 100 NIRF rankings to offer online programs. This will be a game-changer since educational jurisdiction will become worldwide, and only equipped universities will survive [48].
The following recommendations were implemented for the PPs based on the unique circumstance faced by each country because of COVID-19:
The pharmaceutical business must shift its focus away from COVID-19 and onto the needs of the country, as well as ideas for overcoming governmental and regulatory obstacles.
The government should provide adequate funds to PPs researchers for the development of novel drugs and the conduct of clinical trials.
To achieve the required results, the pharmaceutical business should learn to invest in quality staff and move its attention from the product to the patient [49].
Application of state and federal norms to protect public health and disease prevention.
Strengthening the regulations governing healthcare administration and professionals, requiring them to adhere to severe state-based rules.
There should not be a large reliance on API procurement from China; instead, actions should be done to ensure API supply from within the country.
Enabling workflow changes in principles while dealing with emergencies
To raise awareness and develop educational training programs to protect people\'s physical and mental health during the pandemic.
To combat COVID-19 as a naturopathy-based treatment, the pharmacognosy and phytopharmacy department should focus on herbal and ayurvedic formulation development.
Positive, credible, and evidence-based marketing to be made by PPs on the conventional way of using AYUSH-based drugs to combat COVID-19.
The general public should consume “Kapasura kudineer,” which is widely available in retail pharmacies, particularly in south India, and contains many combinations of herbs that can combat the coronavirus and other microorganisms. This has shown promising results, as many people have been benefited and relieved from COVID-19 in asymptomatic reported positive cases.
Steps to be done for e-learning/webinar programs in order to receive additional updates from the WHO and the health advisory council for pharmaceutical development and public health protection.
In the event of an emergency, the use of PPs as second-line healers or physicians to diagnose the patient\'s ailment [50].
During the COVID-19 epidemic, enabling e-prescriptions and home delivery of medicines to self-isolated individuals and older people by guaranteeing preventive steps and safety.
Advocacy with policymakers and stakeholders must be strengthened in order to create the optimal regulatory framework for the pharmaceutical industry to thrive.
The devastating second wave of the COVID-19 outbreak has brought strangers together offline and online to assist one another in any way they can. Even terrible stories of death and loss have not deterred some people from engaging in unethical and immoral actions including black-marketing medical life-saving medicines, hoarding, and defrauding in the name of COVID-19 medical supplies, and charging exorbitant prices for ambulance service. The Delhi Police recently raided a fine-dining restaurant in Lodhi Colony and seized 419 oxygen concentrators. These were being sold at an astronomical price of 69,999, complete with bogus MRP labels. About 96 oxygen concentrators were seized from Khan Chacha, owner of a famous food joint in Khan Market. When Delhi-NCR is in the midst of the biggest crisis in its history, notable figures in the city urge tough punishments for anyone who engages in such unlawful and inhumane activities. In connection with a Rs 450 crore medical equipment maintenance scam, Andhra Pradesh\'s Crime Investigation Department (CID) has filed a complaint against Bengaluru-based TBS India Telematic & Biomedical Services Private Limited, private individuals, and health department employees. The case was filed under the sections of the Indian Penal Code dealing with cheating, criminal conspiracy, and criminal breach of trust. Price increases, inflated bills for nonexisting equipment, and increased invoices for equipment in government hospitals in AP are among the irregularities. Over 300 doses of anti-COVID vaccination were taken from a hospital in Jaipur during a spike in coronavirus illness, forcing authorities to file a criminal complaint. According to agency reports citing a Centre RTI response, Tamil Nadu recorded 12.10% vaccine wastage, followed by Haryana (9.74%), Punjab (8.12%), Manipur (7.80%), and Telangana (7.80%) (7.55%). Vaccine wastage in Tamil Nadu is up to 13% for Covaxin and 9% for Covishield, according to data from the state directorate of public health, which distributes vaccines and regulates its use. Between January 16 and April 17, 7.14 lakh doses of Covaxin and 44.80 lakh doses of Covishield were sent to drug retailers, according to state authorities. A vial must be used within 4 h of being opened and stored at a temperature between 2 and 8°C. The state has used 47.05 lakh dosages by April 17, including 40.5 lakh Covishield. Health staff was under pressure to vaccinate as many individuals as possible. Even though there were not enough individuals, they opened bottles of 20 and 10 dosages. We will now be able to expand immunizations due to an increase in cases and stock. On Friday, as a new day dawned over Delhi, a somber narrative surfaced from Sir Ganga Ram Hospital, one of the capital\'s most prestigious institutions. In the last 24 h, at least 25 COVID-19 patients had perished there. Physical ventilation—occasional6manual compression of a gas-filled reservoir bag to drive the gas into a patient\'s lungs—has been used on occasion to ensure that patients on ventilator assistance survive. The burning question is how to treat patients when key supplies are not available. As per specialist doctors without oxygen, a patient who requires ventilator assistance can die in minutes. Many other hospitals were in a similar situation. The hospitals then devised a plan to have two patients share a cylinder by using connectors. But also, according to doctors, those on a ventilator can die in minutes if their oxygen supply is cut off. Doctors face a significant hurdle because of this. Despite government pledges and rules, the black market for Remdesivir, a crucial COVID-19 medicine, is thriving in Chennai, with many pharma dealers asking up to Rs 14,000 per 100-mg vial. Even though the Tamil Nadu government has promised to assist them in obtaining the drug, many private hospitals have thrown in the towel, leaving numerous COVID-19 patients in their care without treatment. A private COVID panel hospital has been charged with overbilling by the Kanpur district administration. On Monday, the complainant filed a complaint alleging that he was overcharged by Rs 3.50 lakh in the previous 7 days, and on Tuesday, the district administration issued a notice to the hospital\'s management after completing a preliminary investigation. The charges were confirmed to be accurate after a preliminary investigation by the extra city magistrate and a government doctor. When the hospital\'s management failed to respond satisfactorily, district magistrate Alok Tiwari issued an order to register an FIR against it on Tuesday. The administration has appointed static magistrates and sector magistrates to investigate overbilling issues in private panel hospitals, according to the district magistrate. Furthermore, the government has already circulated cell phone numbers for the public to use to report any overbilling complaints. Despite threats of severe consequences for overbilling, private panel hospitals are seizing every opportunity to overcharge patients. Prices of oxygen concentrators, oximeters, and nebulizers have risen by 50–100% in the last 10 days, owing to a massive demand-supply mismatch as the coronavirus epidemic enters its second wave. Even as the organized medical device sector, legal entities, and consumers pressed for enforcing pricing control over these products, e-commerce giant Amazon stated it has begun removing listings of accounts selling these products beyond MRP. Over the last 7 days, the price of oxygen concentrators, which generate oxygen from the air, has nearly doubled, while the price of oximeters has increased by Rs 1000–2000. Prices have risen in both physical businesses and online marketplaces such as Amazon and Flipkart. The government set a price cap on certain products last year, but some vendors, companies, and importers are not following it. A spokesman for Amazon India stated the business is taking urgent action to stop the surge pricing. Hundreds of tweets from customers have gone viral, claiming that they had to pay more than Rs 1 lakh for oxygen concentrators that would normally cost Rs 45,000. The device\'s monthly rentals have also increased from Rs 5000 to Rs 10,000–20,000. Many sellers and importers have boosted costs of COVID-essential medical supplies by two to four times in just a week, even on online markets like Amazon and Flipkart. The problem is large with imported products by opportunistic dealers who import these products at low costs and then continuously raise prices to profit from the scenario while blaming it on their suppliers.
Since the pharmaceutical industry\'s exponential rise, there has been a need to regulate the interaction between pharmaceutical firms and medical practitioners. The Indian Medical Council (Professional Conduct, Etiquette, and Ethics) Regulations, 2002, as revised until February 1, 2016, ("MCI Regulations") were enacted with this in mind. The MCI Regulations, Regulation 6 (Unethical Acts), establishes a code of conduct for medical practitioners in their interactions with the pharmaceutical and allied healthcare industries. The MCI Regulations, on the other hand, apply only to medical practitioners. As a result, on December 12, 2014, the Department of Pharmaceuticals ("DoP") declared the Uniform Code of Pharmaceuticals Marketing Practices ("UCPMP") effective on January 1, 2015, for a 6-month period of voluntary adoption. When the DoP announced UCPMP, it stated that it was a voluntary code for the Indian pharmaceutical industry, but warned that if it is discovered that the pharma associations/companies have not implemented it successfully, the government may consider making it a statutory code. The DoP then extended UCPMP until further orders on August 30, 2016. Despite the fact that the UCPMP was the first of its kind and contained substantial regulations, the DoP attempted to replace the voluntary code with mandatory recommendations since it was optional. As a result, the DoP transmitted the draught Essential Commodities (Control of Unethical Practices in Drug Marketing) Order, 2017 ("Order") to the Law Ministry in July 2017 for final approval. The Law Ministry, on the other hand, is concerned about the Order, which is now being sought to be issued under the Essential Commodities Act, 1955. It is worth noting that the Order is beyond the scope of the Vital Commodities Act of 1955 ("Act"), whose goals are to control the manufacture, supply, and distribution of essential commodities rather than to oversee medication marketing. In 2015, the UCPMP was expanded to include the medical devices business, which is worth more than Rs 25,000 crore annually. The Order indicates that it will not apply to medical devices because the DoP is in the process of creating and releasing a separate code of marketing practices for the medical device industry (which would be voluntary for 6 months). The Order, like the UCPMP, prohibits pharmaceutical corporations from presenting cash, gifts, or sponsorship to doctors, chemists, or pharmacists, as well as giving travel facilities or paid vacations. Any pharmaceutical firm or its representatives are prohibited from giving presents, cash cards, hampers, or any other item that may produce monetary benefit or allow profits in kind to a medical practitioner, a retail chemist, or pharmacists, or their "family members" under paragraph 3 of the Order. It does, however, allow for the financing of academic conferences organized by medical groups, as well as the organization of screening camps or awareness campaigns in government-owned healthcare institutions, with the caveat that these cannot be used as surrogate advertising. A pharmaceutical business or its agent is also prohibited from providing free samples to any medical practitioner under the terms of the Order. Allowing pharmaceutical companies to distribute free samples up to a full course of medicines for a maximum of three patients has created an exemption to this norm. Three, on the other hand, is a modest amount for any medical professional to comprehend and analyze the effects of a new drug on patients. It is important to note that the term "Agent" is defined very broadly in paragraph 2(b) of the Order, and includes any person, company, society, nongovernmental organization, or other institution who has been hired or authorized by a third party to call on any healthcare facility to promote a pharmaceutical company\'s drugs. The Order further states that a company\'s MD or CEO is accountable for ensuring that the Order is followed. All complaints involving violations of the Order shall be investigated by an Ethics Compliance Officer (ECO) designated by the Government of India, who shall not be below the rank of a Joint Secretary to the Government of India, according to paragraph 5 of the Order. It should be noted that a firm or its agent who fails to comply with the terms of subparagraphs (a) (b) (c) or (d) of paragraph 3 of the Order will face a penalty under paragraph 4 of the Order. Furthermore, paragraph 5(4) of the Order lays out the mechanism for imposing a penalty by prohibiting the breaching corporation from marketing its best-selling product for the previous 12 months for a period of three to one year. The Order also states that corporations can pay a penalty ranging from Rs 5 lakh to Rs 10 lakh to have the marketing prohibition lifted. According to the Order, the DoP Secretary will be the appellate authority, and appeals from the Appellate authority\'s orders will be handled by the court.
There is an utmost necessity to relook and re-establish the standards of pharmacy practice in healthcare setups available in each and every corner of the country in line with guidelines provided by the World Health Organization (WHO) and International Pharmaceutical Federation (FIP). For that, the dependency and responsibilities are very high on healthcare professionals, particularly in this pandemic situation. The pharmacy zone is adaptable, evolving, and increasingly diverse, offering a wide range of work and management opportunities to execute [27]. PPs are human service professionals whose responsibilities include safeguarding individuals by dispensing medications based on prescriptions [28]. Representing the world\'s third-largest medicinal services with active gathering, and in India, there are over 1,000,000 (1 million) enrolled PPs employed in various capacities and readily contributing to the country\'s well-being [51]. Pharmacy practice, which includes clinical, community, and hospital pharmacy, is referred to as total healthcare in its true sense. Through adaptation and implementation of GPP in healthcare setup, PPs form an essential link between physicians, nurses, and patients in the social community group, with an ultimate emphasis on patient well-being and protection [30].
There should be country-wise GPP training programs are specifically aimed to gain rapid insights from World Health Organization (WHO) and International Pharmaceutical Federation (FIP) joint guidelines for advancing pharmacy practice worldwide and especially in India. In the view of current COVID-19 crisis, this initiative should be the first of its kind training program being offered in India. This training program mainly focuses on experiential training while promoting the GPP concept among healthcare professionals in India. This course will help the participants to get easy access to the guidelines, provides opportunities for peer discussions, and eventually be influential in improving pharmacy practices.
There should be a very focused approach for the same as follows
To understand the roles of pharmacists, national pharmaceutical organizations, and healthcare systems in developing GPP standards.
To understand the role of the pharmacist as a part of healthcare and the requirements of this role.
To understand the methodology and principles of quality management.
Be able to set standards, measure the quality and use the principle of continual improvement in one’s own working environment.
This course mainly explores and discusses the WHO/FIP GPP guidelines, the model of GPP in the hospital setting, and aseptic preparations.
Additionally, focus on WHO, MoH & FW, ICMR & NCDC guidelines for handling, treatment, and disposal of biomedical waste at healthcare facilities.
Across the globe, pharmacy is one of the most important, dynamic, and versatile segments of the healthcare industry. The pharmacy zone has become adaptable, evolving, increasingly diverse, adhering to the quality standards. However, the importance of ensuring appropriate quality to every patient has taken a center stage in this pandemic, especially in India. In such time, it is important to understand and execute the methodology and principles of quality management and set standards, for continual improvement in one’s own working environment, while realizing the emerging roles of pharmacists, national pharmaceutical organizations, and healthcare systems in developing good pharmacy practice (GPP) standards in this pandemic era.
The International Pharmaceutical Federation and World Health Organization define good pharmacy practice (GPP) as practices that meet the personal needs of patients or those using pharmacy services by offering appropriate evidence-based care. In developed countries, pharmaceutical assistance is defined as a pharmaceutical practice model that involves attitudes, ethical values, behaviors, skills, appointments, and co-responsibility to prevent diseases, promote and recovery health in an integrated manner as part of the healthcare process, highlighting, among other, the requirement that the institution fully adopts the GPP. The program should be designed to take care of the Indian healthcare system and its context of adoption of “new normal” due to the unprecedented event of COVID 19 and the importance of GPP for the healthcare professionals in same.
This kind of training program should be opened to
Health, Health IT, Hospital & Pharma Management Students & Professionals.
Medical, Dental, Physiotherapy, Nursing, Pharma, Paramedical Students.
Any Graduate student/Professional who wants to pursue a career in healthcare.
Today, the forms of care are shifting from secondary care providers to primary care providers to patients (Figure 2). This trend has already started in developed countries, such as the behind-the-counter drug option in European countries that was already endorsed by the FDA. The FDA showed positive signs toward boosting the numbers of nonprescription drug statuses to over-the-counter statuses. The healthcare delivery system is coming closer to the patient due to knowledge and understanding, as well as better diagnostic tools and monitoring devices [52] (Figure 2).
The healthcare delivery status of 2007 and 2020. Source: PricewaterhouseCoopers.
The use of simulation and related technology in healthcare education will continue to grow in the next years, and this methodology has a collective role within the pharmacy curriculum. It is expected that increasing the quantity of simulation in pharmacy curricula will have a good impact on pharmacy student education and training, resulting in favorable outcomes for patients and the healthcare team. The obvious goal of incorporating simulation techniques into the pharmacy student training curriculum is to increase pharmacist education and training with the ultimate goal of enhancing patient care and safety. Simulation experiences will never be able to replace real-world clinical experiences, but they do have the ability to supplement clinical education and serve as a tool for developing the skills necessary for a successful pharmacist. Simulation approaches have been utilized in pharmacy education to address broad cognitive and social skills, particularly communication, decision-making, ethical dilemmas, prioritization, and teamwork, in addition to the development of technical skills such as procedural and clinical abilities. Simulated learning environments could provide a more systematic approach to both clinical skill training and pharmacy programs that aim to provide an opportunity for theoretical knowledge to be applied to a real clinical situation. Basic sciences, dispensing, and drug supply all benefit from simulation\'s constant, predictable experience. In an ideal world, simulation training would be integrated into all levels of pharmacy education and training.
Types of simulation technology used in healthcare education [53, 54].
1. | High-fidelity patient simulator or mannequin—able to mimic human actions and physiology and respond to physiologic and pharmacologic interventions |
2. | Task trainer —designed to help learners practice, specific skills and do not have the extensive programming capabilities of high-fidelity models. It can be considered as |
3. | Standardized patients—live people who are coached to portray patients, usually referred to as simulated patients |
4. | Virtual reality simulator—in which a computer display simulates the physical world and user interactions are with the computer within that simulated (virtual) world |
5. | Full environment simulation—it involves the incorporation of high-fidelity mannequins, standardized patients, healthcare professionals, and ancillary equipment to recreate a real-life clinical environment |
Serves to increase efficiency and accuracy of dispensing
Re-direct staff time away from routine technical tasks and toward more direct patient care activities
Featured Systems: ADC, place medications much closer to the user, but still allow electronic verification
Pharmacy Robot: Reduced preparation and check time for medications, minimizations of potential contamination in sterile product preparation
Bar coded medication administration
Computerized prescriber order entry systems (CPOE)
Smart pumps
Clinical decision support system (CDSS)
Predictive population risk stratification
Patient self-management tools
list of contributors in who gpp 2011/ippr 2015 regulation adherence survey | |
---|---|
As this section deals with legal issues pertaining to the rights of individual Authors and IntechOpen, for the avoidance of doubt, each category of publication is dealt with separately. Consequently, much of the information, for example definition of terms used, is repeated to ensure that there can be no misunderstanding of the policies that apply to each category.
",metaTitle:"Copyright Policy",metaDescription:"Copyright is the term used to describe the rights related to the publication and distribution of original works. Most importantly from a publisher's perspective, copyright governs how authors, publishers and the general public can use, publish and distribute publications.",metaKeywords:null,canonicalURL:"/page/copyright-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"Copyright is the term used to describe the rights related to the publication and distribution of original Works. Most importantly from a publisher's perspective, copyright governs how Authors, publishers and the general public can use, publish, and distribute publications.
\\n\\nIntechOpen only publishes manuscripts for which it has publishing rights. This is governed by a publication agreement between the Author and IntechOpen. This agreement is accepted by the Author when the manuscript is submitted and deals with both the rights of the publisher and Author, as well as any obligations concerning a particular manuscript. However, in accepting this agreement, Authors continue to retain significant rights to use and share their publications.
\\n\\nHOW COPYRIGHT WORKS WITH OPEN ACCESS LICENSES?
\\n\\nAgreement samples are listed here for the convenience of prospective Authors:
\\n\\nDEFINITIONS
\\n\\nThe following definitions apply in this Copyright Policy:
\\n\\nAuthor - in order to be identified as an Author, three criteria must be met: (i) Substantial contribution to the conception or design of the Work, or the acquisition, analysis, or interpretation of data for the Work; (ii) Participation in drafting or revising the Work; (iii) Approval of the final version of the Work to be published.
\\n\\nWork - a Chapter, including Conference Papers, a Scientific Article and any and all text, graphics, images and/or other materials forming part of or accompanying the Chapter/Conference Paper.
\\n\\nMonograph/Compacts - a full manuscript usually written by a single Author, including any and all text, graphics, images and/or other materials.
\\n\\nCompilation - a collection of Works distributed in a Book that IntechOpen has selected, and for which the coordination of the preparation, arrangement and publication has been the responsibility of IntechOpen. Any Work included is accepted in its entirety in unmodified form and is published with one or more other contributions, each constituting a separate and independent Work, but which together are assembled into a collective whole.
\\n\\nScientific Journal – Periodical publication intended to further the progress of science.
\\n\\nJournal Article/Scientific Article – Publication based on empirical evidence. It can support a hypothesis with original research, describe existing research or comment on current trends in a specific field.
\\n\\nIntechOpen - Registered publisher with office at 5 Princes Gate Court, London, SW7 2QJ - UNITED KINGDOM
\\n\\nIntechOpen platform - IntechOpen website www.intechopen.com whose main purpose is to host Monographs in the format of Book Chapters, Long Form Monographs, Compacts, Conference Proceedings, Scientific Journals and Videos.
\\n\\nVideo Lecture – an audiovisual recording of a lecture or a speech given by a Lecturer, recorded, edited, owned and published by IntechOpen.
\\n\\nTERMS
\\n\\nAll Works published on the IntechOpen platform and in print are licensed under a Creative Commons Attribution 3.0 Unported and Creative Commons 4.0 International License, a license which allows for the broadest possible reuse of published material.
\\n\\nCopyright on the individual Works belongs to the specific Author, subject to an agreement with IntechOpen. The Creative Common license is granted to all others to:
\\n\\nAnd for any purpose, provided the following conditions are met:
\\n\\nAll Works are published under the CC BY 3.0 and CC BY 4.0 license. However, please note that book Chapters may fall under a different CC license, depending on their publication date as indicated in the table below:
\\n\\n\\n\\n
LICENSE | \\n\\t\\t\\tUSED FROM - | \\n\\t\\t\\tUP TO - | \\n\\t\\t
\\n\\t\\t\\t Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) \\n\\t\\t\\t | \\n\\t\\t\\t1 July 2005 (2005-07-01) | \\n\\t\\t\\t3 October 2011 (2011-10-03) | \\n\\t\\t
\\n\\t\\t\\t Creative Commons Attribution 3.0 Unported (CC BY 3.0) \\n\\t\\t\\t | \\n\\t\\t\\t5 October 2011 (2011-10-05) | \\n\\t\\t\\tCurrently | \\n\\t\\t
\\n\\t\\t\\t Creative Commons 4.0 International (CC BY 4.0) – for Journal Articles \\n\\t\\t\\t | \\n\\t\\t\\t15 March 2022 | \\n\\t\\t\\tCurrently | \\n\\t\\t
The CC BY 3.0 and CC BY 4.0 license permits Works to be freely shared in any medium or format, as well as the reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as the source Work is cited and its Authors are acknowledged in the following manner:
\\n\\nContent reuse:
\\n\\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\\n\\nContent adaptation & reuse:
\\n\\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\\n\\nReposting & sharing:
\\n\\nOriginally published in {full citation}. Available from: {DOI}
\\n\\nRepublishing – More about Attribution Policy can be found here.
\\n\\nThe same principles apply to Works published under the CC BY-NC-SA 3.0 license, with the caveats that (1) the content may not be used for commercial purposes, and (2) derivative works building on this content must be distributed under the same license. The restrictions contained in these license terms may, however, be waived by the copyright holder(s). Users wishing to circumvent any of the license terms are required to obtain explicit permission to do so from the copyright holder(s).
\\n\\nDISCLAIMER: Neither the CC BY 3.0 license, CC BY 4.0, nor any other license IntechOpen currently uses or has used before, applies to figures and tables reproduced from other works, as they may be subject to different terms of reuse. In such cases, if the copyright holder is not noted in the source of a figure or table, it is the responsibility of the User to investigate and determine the exact copyright status of any information utilised. Users requiring assistance in that regard are welcome to send an inquiry to permissions@intechopen.com.
\\n\\nAll rights to Books and Journals and all other compilations published on the IntechOpen platform and in print are reserved by IntechOpen.
\\n\\nThe copyright to Books, Journals and other compilations is subject to separate copyright from those that exist in the included Works.
\\n\\nAll Long Form Monographs/Compacts are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others.
\\n\\nCopyright to the individual Works (Chapters) belongs to their specific Authors, subject to an agreement with IntechOpen and the Creative Common license granted to all others to:
\\n\\nUnder the following terms:
\\n\\nThere must be an Attribution, giving appropriate credit, provision of a link to the license, and indication if any changes were made.
\\n\\nNonCommercial - The use of the material for commercial purposes is prohibited. Commercial rights are reserved to IntechOpen or its licensees.
\\n\\nNo additional restrictions that apply legal terms or technological measures that restrict others from doing anything the license permits are allowed.
\\n\\nThe CC BY-NC 4.0 license permits Works to be freely shared in any medium or format, as well as reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as it is not used for commercial purposes. The source Work must be cited and its Authors acknowledged in the following manner:
\\n\\nContent reuse:
\\n\\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\\n\\nContent adaptation & reuse:
\\n\\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\\n\\nReposting & sharing:
\\n\\nOriginally published in {full citation}. Available from: {DOI}
\\n\\nAll Book cover design elements, as well as Video image graphics are subject to copyright by IntechOpen.
\\n\\nEvery reproduction of a front cover image must be accompanied by an appropriate Copyright Notice displayed adjacent to the image. The exact Copyright Notice depends on who the Author of a particular cover image is. Users wishing to reproduce cover images should contact permissions@intechopen.com.
\\n\\nAll Video Lectures under IntechOpen's production are subject to copyright and are property of IntechOpen, unless defined otherwise, and are licensed under the Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This grants all others the right to:
\\n\\nShare — copy and redistribute the material in any medium or format
\\n\\nUnder the following terms:
\\n\\nUsers wishing to repost and share the Video Lectures are welcome to do so as long as they acknowledge the source in the following manner:
\\n\\n© {year} IntechOpen. Published under CC BY-NC-ND 4.0 license. Available from: {DOI}
\\n\\nUsers wishing to reuse, modify, or adapt the Video Lectures in a way not permitted by the license are welcome to contact us at permissions@intechopen.com to discuss waiving particular license terms.
\\n\\nAll software used on the IntechOpen platform, any used during the publishing process, and the copyright in the code constituting such software, is the property of IntechOpen or its software suppliers. As such, it may not be downloaded or copied without permission.
\\n\\nUnless otherwise indicated, all IntechOpen websites are the property of IntechOpen.
\\n\\nAll content included on IntechOpen Websites not forming part of contributed materials (such as text, images, logos, graphics, design elements, videos, sounds, pictures, trademarks, etc.), are subject to copyright and are property of, or licensed to, IntechOpen. Any other use, including the reproduction, modification, distribution, transmission, republication, display, or performance of the content on this site is strictly prohibited.
\\n\\nPolicy last updated: 2016-06-08
\\n"}]'},components:[{type:"htmlEditorComponent",content:'Copyright is the term used to describe the rights related to the publication and distribution of original Works. Most importantly from a publisher's perspective, copyright governs how Authors, publishers and the general public can use, publish, and distribute publications.
\n\nIntechOpen only publishes manuscripts for which it has publishing rights. This is governed by a publication agreement between the Author and IntechOpen. This agreement is accepted by the Author when the manuscript is submitted and deals with both the rights of the publisher and Author, as well as any obligations concerning a particular manuscript. However, in accepting this agreement, Authors continue to retain significant rights to use and share their publications.
\n\nHOW COPYRIGHT WORKS WITH OPEN ACCESS LICENSES?
\n\nAgreement samples are listed here for the convenience of prospective Authors:
\n\nDEFINITIONS
\n\nThe following definitions apply in this Copyright Policy:
\n\nAuthor - in order to be identified as an Author, three criteria must be met: (i) Substantial contribution to the conception or design of the Work, or the acquisition, analysis, or interpretation of data for the Work; (ii) Participation in drafting or revising the Work; (iii) Approval of the final version of the Work to be published.
\n\nWork - a Chapter, including Conference Papers, a Scientific Article and any and all text, graphics, images and/or other materials forming part of or accompanying the Chapter/Conference Paper.
\n\nMonograph/Compacts - a full manuscript usually written by a single Author, including any and all text, graphics, images and/or other materials.
\n\nCompilation - a collection of Works distributed in a Book that IntechOpen has selected, and for which the coordination of the preparation, arrangement and publication has been the responsibility of IntechOpen. Any Work included is accepted in its entirety in unmodified form and is published with one or more other contributions, each constituting a separate and independent Work, but which together are assembled into a collective whole.
\n\nScientific Journal – Periodical publication intended to further the progress of science.
\n\nJournal Article/Scientific Article – Publication based on empirical evidence. It can support a hypothesis with original research, describe existing research or comment on current trends in a specific field.
\n\nIntechOpen - Registered publisher with office at 5 Princes Gate Court, London, SW7 2QJ - UNITED KINGDOM
\n\nIntechOpen platform - IntechOpen website www.intechopen.com whose main purpose is to host Monographs in the format of Book Chapters, Long Form Monographs, Compacts, Conference Proceedings, Scientific Journals and Videos.
\n\nVideo Lecture – an audiovisual recording of a lecture or a speech given by a Lecturer, recorded, edited, owned and published by IntechOpen.
\n\nTERMS
\n\nAll Works published on the IntechOpen platform and in print are licensed under a Creative Commons Attribution 3.0 Unported and Creative Commons 4.0 International License, a license which allows for the broadest possible reuse of published material.
\n\nCopyright on the individual Works belongs to the specific Author, subject to an agreement with IntechOpen. The Creative Common license is granted to all others to:
\n\nAnd for any purpose, provided the following conditions are met:
\n\nAll Works are published under the CC BY 3.0 and CC BY 4.0 license. However, please note that book Chapters may fall under a different CC license, depending on their publication date as indicated in the table below:
\n\n\n\n
LICENSE | \n\t\t\tUSED FROM - | \n\t\t\tUP TO - | \n\t\t
\n\t\t\t Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) \n\t\t\t | \n\t\t\t1 July 2005 (2005-07-01) | \n\t\t\t3 October 2011 (2011-10-03) | \n\t\t
\n\t\t\t Creative Commons Attribution 3.0 Unported (CC BY 3.0) \n\t\t\t | \n\t\t\t5 October 2011 (2011-10-05) | \n\t\t\tCurrently | \n\t\t
\n\t\t\t Creative Commons 4.0 International (CC BY 4.0) – for Journal Articles \n\t\t\t | \n\t\t\t15 March 2022 | \n\t\t\tCurrently | \n\t\t
The CC BY 3.0 and CC BY 4.0 license permits Works to be freely shared in any medium or format, as well as the reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as the source Work is cited and its Authors are acknowledged in the following manner:
\n\nContent reuse:
\n\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\n\nContent adaptation & reuse:
\n\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\n\nReposting & sharing:
\n\nOriginally published in {full citation}. Available from: {DOI}
\n\nRepublishing – More about Attribution Policy can be found here.
\n\nThe same principles apply to Works published under the CC BY-NC-SA 3.0 license, with the caveats that (1) the content may not be used for commercial purposes, and (2) derivative works building on this content must be distributed under the same license. The restrictions contained in these license terms may, however, be waived by the copyright holder(s). Users wishing to circumvent any of the license terms are required to obtain explicit permission to do so from the copyright holder(s).
\n\nDISCLAIMER: Neither the CC BY 3.0 license, CC BY 4.0, nor any other license IntechOpen currently uses or has used before, applies to figures and tables reproduced from other works, as they may be subject to different terms of reuse. In such cases, if the copyright holder is not noted in the source of a figure or table, it is the responsibility of the User to investigate and determine the exact copyright status of any information utilised. Users requiring assistance in that regard are welcome to send an inquiry to permissions@intechopen.com.
\n\nAll rights to Books and Journals and all other compilations published on the IntechOpen platform and in print are reserved by IntechOpen.
\n\nThe copyright to Books, Journals and other compilations is subject to separate copyright from those that exist in the included Works.
\n\nAll Long Form Monographs/Compacts are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all others.
\n\nCopyright to the individual Works (Chapters) belongs to their specific Authors, subject to an agreement with IntechOpen and the Creative Common license granted to all others to:
\n\nUnder the following terms:
\n\nThere must be an Attribution, giving appropriate credit, provision of a link to the license, and indication if any changes were made.
\n\nNonCommercial - The use of the material for commercial purposes is prohibited. Commercial rights are reserved to IntechOpen or its licensees.
\n\nNo additional restrictions that apply legal terms or technological measures that restrict others from doing anything the license permits are allowed.
\n\nThe CC BY-NC 4.0 license permits Works to be freely shared in any medium or format, as well as reuse and adaptation of the original contents of Works (e.g. figures and tables created by the Authors), as long as it is not used for commercial purposes. The source Work must be cited and its Authors acknowledged in the following manner:
\n\nContent reuse:
\n\n© {year} {authors' full names}. Originally published in {short citation} under {license version} license. Available from: {DOI}
\n\nContent adaptation & reuse:
\n\n© {year} {authors' full names}. Adapted from {short citation}; originally published under {license version} license. Available from: {DOI}
\n\nReposting & sharing:
\n\nOriginally published in {full citation}. Available from: {DOI}
\n\nAll Book cover design elements, as well as Video image graphics are subject to copyright by IntechOpen.
\n\nEvery reproduction of a front cover image must be accompanied by an appropriate Copyright Notice displayed adjacent to the image. The exact Copyright Notice depends on who the Author of a particular cover image is. Users wishing to reproduce cover images should contact permissions@intechopen.com.
\n\nAll Video Lectures under IntechOpen's production are subject to copyright and are property of IntechOpen, unless defined otherwise, and are licensed under the Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This grants all others the right to:
\n\nShare — copy and redistribute the material in any medium or format
\n\nUnder the following terms:
\n\nUsers wishing to repost and share the Video Lectures are welcome to do so as long as they acknowledge the source in the following manner:
\n\n© {year} IntechOpen. Published under CC BY-NC-ND 4.0 license. Available from: {DOI}
\n\nUsers wishing to reuse, modify, or adapt the Video Lectures in a way not permitted by the license are welcome to contact us at permissions@intechopen.com to discuss waiving particular license terms.
\n\nAll software used on the IntechOpen platform, any used during the publishing process, and the copyright in the code constituting such software, is the property of IntechOpen or its software suppliers. As such, it may not be downloaded or copied without permission.
\n\nUnless otherwise indicated, all IntechOpen websites are the property of IntechOpen.
\n\nAll content included on IntechOpen Websites not forming part of contributed materials (such as text, images, logos, graphics, design elements, videos, sounds, pictures, trademarks, etc.), are subject to copyright and are property of, or licensed to, IntechOpen. Any other use, including the reproduction, modification, distribution, transmission, republication, display, or performance of the content on this site is strictly prohibited.
\n\nPolicy last updated: 2016-06-08
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr.",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Rheinmetall (Germany)",country:{name:"Germany"}}},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:13388},{group:"region",caption:"Middle and South America",value:2,count:11658},{group:"region",caption:"Africa",value:3,count:4168},{group:"region",caption:"Asia",value:4,count:22334},{group:"region",caption:"Australia and Oceania",value:5,count:2019},{group:"region",caption:"Europe",value:6,count:33638}],offset:12,limit:12,total:135272},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish"},books:[{type:"book",id:"11616",title:"Foraging",subtitle:null,isOpenForSubmission:!0,hash:"955b60bb658c8d1a09dd4efc9bf6674b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11616.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11632",title:"Updated Research on Bacteriophages",subtitle:null,isOpenForSubmission:!0,hash:"d34dfa0d5d10511184f97ddaeef9936b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11632.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11730",title:"Midwifery",subtitle:null,isOpenForSubmission:!0,hash:"95389fcd878d0e929234c441744ba398",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11730.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11697",title:"Scoliosis",subtitle:null,isOpenForSubmission:!0,hash:"fa052443744b8f6ba5a87091e373bafe",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11697.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11699",title:"Neonatal Surgery",subtitle:null,isOpenForSubmission:!0,hash:"e52adaee8e54f51c2ba4972daeb410f7",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11699.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11369",title:"RNA Viruses Infection",subtitle:null,isOpenForSubmission:!0,hash:"52f8a3a1486912beae40b34ac557fed3",slug:null,bookSignature:"Ph.D. Yogendra Shah",coverURL:"https://cdn.intechopen.com/books/images_new/11369.jpg",editedByType:null,editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11776",title:"Fashion Industry",subtitle:null,isOpenForSubmission:!0,hash:"e8d53d1029a7bccf825aa55d43fecc68",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11776.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11858",title:"Terahertz Radiation",subtitle:null,isOpenForSubmission:!0,hash:"f08ee0bf20cd8b5fa772b4752081f2fe",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11858.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11809",title:"Lagomorpha",subtitle:null,isOpenForSubmission:!0,hash:"1e8fd5779205c16e5797b05455dc5be0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11809.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11837",title:"Ecology and Geography of the Mediterranean",subtitle:null,isOpenForSubmission:!0,hash:"bbb25987a982d61da4f47fb13614ba3c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11837.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11843",title:"Abortion Access",subtitle:null,isOpenForSubmission:!0,hash:"e07ed1706ed2bf6ad56aa7399d9edf1a",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11843.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11818",title:"Uveitis",subtitle:null,isOpenForSubmission:!0,hash:"f8c178e6f45ba7b500281005b5d5b67a",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11818.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:28},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:8},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:17},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:8},{group:"topic",caption:"Engineering",value:11,count:45},{group:"topic",caption:"Environmental Sciences",value:12,count:6},{group:"topic",caption:"Immunology and Microbiology",value:13,count:10},{group:"topic",caption:"Materials Science",value:14,count:17},{group:"topic",caption:"Mathematics",value:15,count:9},{group:"topic",caption:"Medicine",value:16,count:74},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:3},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:6},{group:"topic",caption:"Psychology",value:21,count:6},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:8},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:512},popularBooks:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11263",title:"Supply Chain",subtitle:"Recent Advances and New Perspectives in the Industry 4.0 Era",isOpenForSubmission:!1,hash:"aab634c9c1f9a692c1e9881d18e9c9b7",slug:"supply-chain-recent-advances-and-new-perspectives-in-the-industry-4-0-era",bookSignature:"Tamás Bányai, Ágota Bányai and Ireneusz Kaczmar",coverURL:"https://cdn.intechopen.com/books/images_new/11263.jpg",editors:[{id:"201248",title:"Dr.",name:"Tamás",middleName:null,surname:"Bányai",slug:"tamas-banyai",fullName:"Tamás Bányai"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10669",title:"Corrosion",subtitle:"Fundamentals and Protection Mechanisms",isOpenForSubmission:!1,hash:"4a76d54f8a40fc2e7002a8d13fd617c1",slug:"corrosion-fundamentals-and-protection-mechanisms",bookSignature:"Fahmina Zafar, Anujit Ghosal and Eram Sharmin",coverURL:"https://cdn.intechopen.com/books/images_new/10669.jpg",editors:[{id:"89672",title:"Dr.",name:"Fahmina",middleName:null,surname:"Zafar",slug:"fahmina-zafar",fullName:"Fahmina Zafar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3560",title:"Advances in Landscape Architecture",subtitle:null,isOpenForSubmission:!1,hash:"a20614517ec5f7e91188fe8e42832138",slug:"advances-in-landscape-architecture",bookSignature:"Murat Özyavuz",coverURL:"https://cdn.intechopen.com/books/images_new/3560.jpg",editors:[{id:"93073",title:"Dr.",name:"Murat",middleName:null,surname:"Ozyavuz",slug:"murat-ozyavuz",fullName:"Murat Ozyavuz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"3568",title:"Recent Advances in Plant in vitro Culture",subtitle:null,isOpenForSubmission:!1,hash:"830bbb601742c85a3fb0eeafe1454c43",slug:"recent-advances-in-plant-in-vitro-culture",bookSignature:"Annarita Leva and Laura M. R. Rinaldi",coverURL:"https://cdn.intechopen.com/books/images_new/3568.jpg",editors:[{id:"142145",title:"Dr.",name:"Annarita",middleName:null,surname:"Leva",slug:"annarita-leva",fullName:"Annarita Leva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4805},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",publishedDate:"July 27th 2022",numberOfDownloads:7107,editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1955,editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",publishedDate:"July 27th 2022",numberOfDownloads:1452,editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10796",title:"Extracellular Vesicles",subtitle:"Role in Diseases, Pathogenesis and Therapy",isOpenForSubmission:!1,hash:"eb5407fcf93baff7bca3fae5640153a2",slug:"extracellular-vesicles-role-in-diseases-pathogenesis-and-therapy",bookSignature:"Manash K. Paul",coverURL:"https://cdn.intechopen.com/books/images_new/10796.jpg",publishedDate:"July 20th 2022",numberOfDownloads:2289,editors:[{id:"319365",title:"Assistant Prof.",name:"Manash K.",middleName:null,surname:"Paul",slug:"manash-k.-paul",fullName:"Manash K. Paul"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11263",title:"Supply Chain",subtitle:"Recent Advances and New Perspectives in the Industry 4.0 Era",isOpenForSubmission:!1,hash:"aab634c9c1f9a692c1e9881d18e9c9b7",slug:"supply-chain-recent-advances-and-new-perspectives-in-the-industry-4-0-era",bookSignature:"Tamás Bányai, Ágota Bányai and Ireneusz Kaczmar",coverURL:"https://cdn.intechopen.com/books/images_new/11263.jpg",publishedDate:"July 27th 2022",numberOfDownloads:888,editors:[{id:"201248",title:"Dr.",name:"Tamás",middleName:null,surname:"Bányai",slug:"tamas-banyai",fullName:"Tamás Bányai"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10739",title:"Global Decline of Insects",subtitle:null,isOpenForSubmission:!1,hash:"543783652b9092962a8fa4bed38eeb17",slug:"global-decline-of-insects",bookSignature:"Hamadttu Abdel Farag El-Shafie",coverURL:"https://cdn.intechopen.com/books/images_new/10739.jpg",publishedDate:"July 20th 2022",numberOfDownloads:1566,editors:[{id:"192142",title:"Dr.",name:"Hamadttu",middleName:null,surname:"Abdel Farag El-Shafie",slug:"hamadttu-abdel-farag-el-shafie",fullName:"Hamadttu Abdel Farag El-Shafie"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10911",title:"Higher Education",subtitle:"New Approaches to Accreditation, Digitalization, and Globalization in the Age of Covid",isOpenForSubmission:!1,hash:"223a02337498e535e967174c1f648fbc",slug:"higher-education-new-approaches-to-accreditation-digitalization-and-globalization-in-the-age-of-covid",bookSignature:"Lee Waller and Sharon Waller",coverURL:"https://cdn.intechopen.com/books/images_new/10911.jpg",publishedDate:"July 13th 2022",numberOfDownloads:2054,editors:[{id:"263301",title:"Dr.",name:"Lee",middleName:null,surname:"Waller",slug:"lee-waller",fullName:"Lee Waller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10669",title:"Corrosion",subtitle:"Fundamentals and Protection Mechanisms",isOpenForSubmission:!1,hash:"4a76d54f8a40fc2e7002a8d13fd617c1",slug:"corrosion-fundamentals-and-protection-mechanisms",bookSignature:"Fahmina Zafar, Anujit Ghosal and Eram Sharmin",coverURL:"https://cdn.intechopen.com/books/images_new/10669.jpg",publishedDate:"July 27th 2022",numberOfDownloads:780,editors:[{id:"89672",title:"Dr.",name:"Fahmina",middleName:null,surname:"Zafar",slug:"fahmina-zafar",fullName:"Fahmina Zafar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"95",title:"Applications and Experiences of Quality Control",subtitle:null,isOpenForSubmission:!1,hash:"4bcb22b1eee68210a977a97d5a0f363a",slug:"applications-and-experiences-of-quality-control",bookSignature:"Ognyan Ivanov",coverURL:"https://cdn.intechopen.com/books/images_new/95.jpg",publishedDate:"April 26th 2011",numberOfDownloads:318480,editors:[{id:"22230",title:"Prof.",name:"Ognyan",middleName:null,surname:"Ivanov",slug:"ognyan-ivanov",fullName:"Ognyan Ivanov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"2160",title:"MATLAB",subtitle:"A Fundamental Tool for Scientific Computing and Engineering Applications - Volume 1",isOpenForSubmission:!1,hash:"dd9c658341fbd264ed4f8d9e6aa8ca29",slug:"matlab-a-fundamental-tool-for-scientific-computing-and-engineering-applications-volume-1",bookSignature:"Vasilios N. Katsikis",coverURL:"https://cdn.intechopen.com/books/images_new/2160.jpg",publishedDate:"September 26th 2012",numberOfDownloads:271760,editors:[{id:"12289",title:"Prof.",name:"Vasilios",middleName:"N.",surname:"Katsikis",slug:"vasilios-katsikis",fullName:"Vasilios Katsikis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"10808",title:"Current Concepts in Dental Implantology",subtitle:"From Science to Clinical Research",isOpenForSubmission:!1,hash:"4af8830e463f89c57515c2da2b9777b0",slug:"current-concepts-in-dental-implantology-from-science-to-clinical-research",bookSignature:"Dragana Gabrić and Marko Vuletić",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"26946",title:"Prof.",name:"Dragana",middleName:null,surname:"Gabrić",slug:"dragana-gabric",fullName:"Dragana Gabrić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11328",title:"Botulinum Toxin",subtitle:"Recent Topics and Applications",isOpenForSubmission:!1,hash:"7dd05a316001cef143e209eda51387a7",slug:"botulinum-toxin-recent-topics-and-applications",bookSignature:"Suna Sabuncuoglu",coverURL:"https://cdn.intechopen.com/books/images_new/11328.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"270856",title:"Associate Prof.",name:"Suna",middleName:null,surname:"Sabuncuoglu",slug:"suna-sabuncuoglu",fullName:"Suna Sabuncuoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11085",title:"Polycystic Ovary Syndrome",subtitle:"Functional Investigation and Clinical Application",isOpenForSubmission:!1,hash:"3066dd3ff29e1fac072fd60b08d4d3e7",slug:"polycystic-ovary-syndrome-functional-investigation-and-clinical-application",bookSignature:"Zhengchao Wang",coverURL:"https://cdn.intechopen.com/books/images_new/11085.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"204883",title:"Dr.",name:"Zhengchao",middleName:null,surname:"Wang",slug:"zhengchao-wang",fullName:"Zhengchao Wang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10833",title:"Tumor Angiogenesis and Modulators",subtitle:null,isOpenForSubmission:!1,hash:"f29b575c46128b2da061ef7f9bd1070b",slug:"tumor-angiogenesis-and-modulators",bookSignature:"Ke Xu",coverURL:"https://cdn.intechopen.com/books/images_new/10833.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"59529",title:"Dr.",name:"Ke",middleName:null,surname:"Xu",slug:"ke-xu",fullName:"Ke Xu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11356",title:"Molecular Cloning",subtitle:null,isOpenForSubmission:!1,hash:"671c629dd86e97f0fb467b9e70e92296",slug:"molecular-cloning",bookSignature:"Sadık Dincer, Hatice Aysun Mercimek Takcı and Melis Sumengen Ozdenef",coverURL:"https://cdn.intechopen.com/books/images_new/11356.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"188141",title:"Prof.",name:"Sadik",middleName:null,surname:"Dincer",slug:"sadik-dincer",fullName:"Sadik Dincer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7827",title:"Interpersonal Relationships",subtitle:null,isOpenForSubmission:!1,hash:"ebf41f4d17c75010eb3294cc8cac3d47",slug:"interpersonal-relationships",bookSignature:"Martha Peaslee Levine",coverURL:"https://cdn.intechopen.com/books/images_new/7827.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"186919",title:"Dr.",name:"Martha",middleName:null,surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10908",title:"Advances in Decision Making",subtitle:null,isOpenForSubmission:!1,hash:"126486f7f91e18e2e3539a32c38be7b1",slug:"advances-in-decision-making",bookSignature:"Fausto Pedro García Márquez",coverURL:"https://cdn.intechopen.com/books/images_new/10908.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"22844",title:"Prof.",name:"Fausto Pedro",middleName:null,surname:"García Márquez",slug:"fausto-pedro-garcia-marquez",fullName:"Fausto Pedro García Márquez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10669",title:"Corrosion",subtitle:"Fundamentals and Protection Mechanisms",isOpenForSubmission:!1,hash:"4a76d54f8a40fc2e7002a8d13fd617c1",slug:"corrosion-fundamentals-and-protection-mechanisms",bookSignature:"Fahmina Zafar, Anujit Ghosal and Eram Sharmin",coverURL:"https://cdn.intechopen.com/books/images_new/10669.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"89672",title:"Dr.",name:"Fahmina",middleName:null,surname:"Zafar",slug:"fahmina-zafar",fullName:"Fahmina Zafar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10677",title:"Advanced Topics of Topology",subtitle:null,isOpenForSubmission:!1,hash:"bf964c52f9e653fac20a7fcab58070e5",slug:"advanced-topics-of-topology",bookSignature:"Francisco Bulnes",coverURL:"https://cdn.intechopen.com/books/images_new/10677.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"92918",title:"Dr.",name:"Francisco",middleName:null,surname:"Bulnes",slug:"francisco-bulnes",fullName:"Francisco Bulnes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11195",title:"Recent Advances in Biometrics",subtitle:null,isOpenForSubmission:!1,hash:"2d32e33e0f499cb5241734bb75dd2a83",slug:"recent-advances-in-biometrics",bookSignature:"Muhammad Sarfraz",coverURL:"https://cdn.intechopen.com/books/images_new/11195.jpg",editedByType:"Edited by",publishedDate:"July 27th 2022",editors:[{id:"215610",title:"Prof.",name:"Muhammad",middleName:null,surname:"Sarfraz",slug:"muhammad-sarfraz",fullName:"Muhammad Sarfraz"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1071",title:"Urogynecology",slug:"urogynecology",parent:{id:"189",title:"Obstetrics and Gynecology",slug:"obstetrics-and-gynecology"},numberOfBooks:8,numberOfSeries:0,numberOfAuthorsAndEditors:233,numberOfWosCitations:52,numberOfCrossrefCitations:56,numberOfDimensionsCitations:102,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"1071",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"10722",title:"Pelvic Floor Dysfunction",subtitle:"Symptoms, Causes, and Treatment",isOpenForSubmission:!1,hash:"fa669d0f9c768ec43040a30b98ca239f",slug:"pelvic-floor-dysfunction-symptoms-causes-and-treatment",bookSignature:"Ran Pang",coverURL:"https://cdn.intechopen.com/books/images_new/10722.jpg",editedByType:"Edited by",editors:[{id:"186524",title:"Prof.",name:"Ran",middleName:null,surname:"Pang",slug:"ran-pang",fullName:"Ran Pang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6278",title:"Pelvic Floor Disorders",subtitle:null,isOpenForSubmission:!1,hash:"e53630ad8f02658c6ca31163f9d68193",slug:"pelvic-floor-disorders",bookSignature:"Raheela M. Rizvi",coverURL:"https://cdn.intechopen.com/books/images_new/6278.jpg",editedByType:"Edited by",editors:[{id:"185970",title:"Dr.",name:"Raheela",middleName:"Mohsin",surname:"Rizvi",slug:"raheela-rizvi",fullName:"Raheela Rizvi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6152",title:"Debatable Topics in PCOS Patients",subtitle:null,isOpenForSubmission:!1,hash:"c47a69bf2dac1f402c7f1b5751f1ea7e",slug:"debatable-topics-in-pcos-patients",bookSignature:"Neeraj Kumar Agrawal and Kiran Singh",coverURL:"https://cdn.intechopen.com/books/images_new/6152.jpg",editedByType:"Edited by",editors:[{id:"136647",title:"Dr.",name:"N.K.",middleName:null,surname:"Agrawal",slug:"n.k.-agrawal",fullName:"N.K. Agrawal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5728",title:"Colposcopy and Cervical Pathology",subtitle:null,isOpenForSubmission:!1,hash:"f4232ee2dc701c710f42172d09afdc8f",slug:"colposcopy-and-cervical-pathology",bookSignature:"Rajamanickam Rajkumar",coverURL:"https://cdn.intechopen.com/books/images_new/5728.jpg",editedByType:"Edited by",editors:[{id:"120109",title:"Dr.",name:"Rajamanickam",middleName:null,surname:"Rajkumar",slug:"rajamanickam-rajkumar",fullName:"Rajamanickam Rajkumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4641",title:"Approaches to Hysterectomy",subtitle:null,isOpenForSubmission:!1,hash:"a2a63bba8f7b17c10aff3d6d59ea0d08",slug:"approaches-to-hysterectomy",bookSignature:"Zouhair O. Amarin",coverURL:"https://cdn.intechopen.com/books/images_new/4641.jpg",editedByType:"Edited by",editors:[{id:"101551",title:"Prof.",name:"Zouhair Odeh",middleName:null,surname:"Amarin",slug:"zouhair-odeh-amarin",fullName:"Zouhair Odeh Amarin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"684",title:"Endometriosis",subtitle:"Basic Concepts and Current Research Trends",isOpenForSubmission:!1,hash:"1f5625375189846e4fa04200c135afcc",slug:"endometriosis-basic-concepts-and-current-research-trends",bookSignature:"Koel Chaudhury and Baidyanath Chakravarty",coverURL:"https://cdn.intechopen.com/books/images_new/684.jpg",editedByType:"Edited by",editors:[{id:"83747",title:"Prof.",name:"Koel",middleName:null,surname:"Chaudhury",slug:"koel-chaudhury",fullName:"Koel Chaudhury"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"707",title:"Hysterectomy",subtitle:null,isOpenForSubmission:!1,hash:"219d88512350b2e1d01cfd8faf81aa9c",slug:"hysterectomy",bookSignature:"Ayman Al-Hendy and Mohamed Sabry",coverURL:"https://cdn.intechopen.com/books/images_new/707.jpg",editedByType:"Edited by",editors:[{id:"54087",title:"Dr.",name:"Ayman",middleName:null,surname:"Al-Hendy",slug:"ayman-al-hendy",fullName:"Ayman Al-Hendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1900",title:"In Vitro Fertilization",subtitle:"Innovative Clinical and Laboratory Aspects",isOpenForSubmission:!1,hash:"212b5ed00828501488c8d7025d84a188",slug:"in-vitro-fertilization-innovative-clinical-and-laboratory-aspects",bookSignature:"Shevach Friedler",coverURL:"https://cdn.intechopen.com/books/images_new/1900.jpg",editedByType:"Edited by",editors:[{id:"111647",title:"Prof.",name:"Shevach",middleName:null,surname:"Friedler",slug:"shevach-friedler",fullName:"Shevach Friedler"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:8,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"35165",doi:"10.5772/38592",title:"The Role of Ultrasound in the Evaluation of Endometrial Receptivity Following Assisted Reproductive Treatments",slug:"the-role-of-ultrasound-in-the-evaluation-of-endometrial-receptivity-following-assisted-reproductive-",totalDownloads:8248,totalCrossrefCites:2,totalDimensionsCites:7,abstract:null,book:{id:"1900",slug:"in-vitro-fertilization-innovative-clinical-and-laboratory-aspects",title:"In Vitro Fertilization",fullTitle:"In Vitro Fertilization - Innovative Clinical and Laboratory Aspects"},signatures:"Mitko Ivanovski",authors:[{id:"118205",title:"Ph.D.",name:"Mitko",middleName:null,surname:"Ivanovski",slug:"mitko-ivanovski",fullName:"Mitko Ivanovski"}]},{id:"36774",doi:"10.5772/29063",title:"Imaging Tools for Endometriosis: Role of Ultrasound, MRI and Other Imaging Modalities in Diagnosis and Planning Intervention",slug:"role-of-imaging-in-the-diagnosis-of-endometriosis",totalDownloads:7020,totalCrossrefCites:1,totalDimensionsCites:5,abstract:null,book:{id:"684",slug:"endometriosis-basic-concepts-and-current-research-trends",title:"Endometriosis",fullTitle:"Endometriosis - Basic Concepts and Current Research Trends"},signatures:"Shalini Jain Bagaria,\r\nDarshana D. Rasalkar and Bhawan K. Paunipagar",authors:[{id:"70915",title:"Prof.",name:"Shalini",middleName:null,surname:"Jain",slug:"shalini-jain",fullName:"Shalini Jain"},{id:"76390",title:"Dr.",name:"Darshana",middleName:null,surname:"Rasalkar",slug:"darshana-rasalkar",fullName:"Darshana Rasalkar"},{id:"126379",title:"Dr.",name:"Bhawan",middleName:null,surname:"Paunipagar",slug:"bhawan-paunipagar",fullName:"Bhawan Paunipagar"}]},{id:"54747",doi:"10.5772/68011",title:"The Role of miRNAs in Diagnosis, Prognosis and Treatment Prediction in Cervical Cancer",slug:"the-role-of-mirnas-in-diagnosis-prognosis-and-treatment-prediction-in-cervical-cancer",totalDownloads:1592,totalCrossrefCites:3,totalDimensionsCites:5,abstract:"Cervical cancer represents one of the major problems of health women worldwide, especially in the developing countries. If discovered in its earliest stages, cervical cancer is successfully treatable; however, due to lack of proper implementation of screening programs, the majority of cervical cancer patients are diagnosed in advanced stages, which dramatically influence their outcome. Almost a half of these patients will suffer recurrence or metastasis in the following 2 years after therapy. If there are no immediate prospects in terms of developing new or more effective therapies, identifying new tools for early diagnosis, prognosis and treatment prediction remains a big challenge for cervical cancer. miRNAs have been validated to be key players in cell physiology, alterations in miRNA expression being associated with cancer progression and response to therapy. Cervical cancer studies have showed that alterations of miRNA expression can be identified in tumor tissues, exfoliated cervical cells and patients serum and that their transcription pattern is regulated by the present HPV genotype. Furthermore, miRNAs have been associated with patients response to therapy, therefore suggesting their potential to be used as biomarkers for cervical cancer diagnosis, prognosis and treatment response.",book:{id:"5728",slug:"colposcopy-and-cervical-pathology",title:"Colposcopy and Cervical Pathology",fullTitle:"Colposcopy and Cervical Pathology"},signatures:"Ovidiu Balacescu, Loredana Balacescu, Oana Baldasici, Oana\nTudoran and Patriciu Achimas‐Cadariu",authors:[{id:"195763",title:"Ph.D.",name:"Ovidiu",middleName:null,surname:"Balacescu",slug:"ovidiu-balacescu",fullName:"Ovidiu Balacescu"},{id:"196758",title:"Dr.",name:"Loreadana",middleName:null,surname:"Balacescu",slug:"loreadana-balacescu",fullName:"Loreadana Balacescu"},{id:"196761",title:"Dr.",name:"Oana",middleName:null,surname:"Tudoran",slug:"oana-tudoran",fullName:"Oana Tudoran"},{id:"196770",title:"Prof.",name:"Patriciu",middleName:null,surname:"Achimas",slug:"patriciu-achimas",fullName:"Patriciu Achimas"},{id:"203875",title:"Dr.",name:"Oana",middleName:null,surname:"Baldasici",slug:"oana-baldasici",fullName:"Oana Baldasici"}]},{id:"36768",doi:"10.5772/29357",title:"Pathomechanism of Infertility in Endometriosis",slug:"pathomechanism-of-infertility-in-endometriosis",totalDownloads:2861,totalCrossrefCites:5,totalDimensionsCites:5,abstract:null,book:{id:"684",slug:"endometriosis-basic-concepts-and-current-research-trends",title:"Endometriosis",fullTitle:"Endometriosis - Basic Concepts and Current Research Trends"},signatures:"Hendi Hendarto",authors:[{id:"77444",title:"Dr.",name:"Hendi",middleName:null,surname:"Hendarto",slug:"hendi-hendarto",fullName:"Hendi Hendarto"}]},{id:"60744",doi:"10.5772/intechopen.76671",title:"Synthetic Materials Used in the Surgical Treatment of Pelvic Organ Prolapse: Problems of Currently Used Material and Designing the Ideal Material",slug:"synthetic-materials-used-in-the-surgical-treatment-of-pelvic-organ-prolapse-problems-of-currently-us",totalDownloads:1371,totalCrossrefCites:3,totalDimensionsCites:4,abstract:"Synthetic materials have long been used to provide structural support when surgically repairing pelvic organ prolapse (POP). The most widely used synthetic material is a mesh made of polypropylene (PPL). The use of mesh is intended to improve cure rates and prevent recurrences after POP surgery – however as more mesh materials have been implanted, it has become apparent that serious complications can occur in up to 30% of women, particularly when the mesh is implanted transvaginally. Over the years many different mesh kits have been marketed and used in the treatment of POP however polypropylene mesh was never designed or tested for use in pelvic floor. Instead it was approved for clinical use based on its biocompatibility and success in abdominal hernia repairs. It is now known that PPL meshes are neither compliant with the mechanical forces in the pelvic floor nor do they integrate well into paravaginal tissues. Better materials developed specifically for use in pelvic floor are urgently needed. The aim of this chapter is to define the requirements of an ideal mesh in terms of its material properties and to summarize the ongoing research on developing the next generation pelvic floor repair materials.",book:{id:"6278",slug:"pelvic-floor-disorders",title:"Pelvic Floor Disorders",fullTitle:"Pelvic Floor Disorders"},signatures:"Naşide Mangir, Christopher R. Chapple and Sheila MacNeil",authors:[{id:"192804",title:"M.D.",name:"Naşide",middleName:null,surname:"Mangır",slug:"naside-mangir",fullName:"Naşide Mangır"},{id:"212217",title:"Prof.",name:"Christopher",middleName:null,surname:"Chapple",slug:"christopher-chapple",fullName:"Christopher Chapple"},{id:"212218",title:"Prof.",name:"Sheila",middleName:null,surname:"MacNeil",slug:"sheila-macneil",fullName:"Sheila MacNeil"}]}],mostDownloadedChaptersLast30Days:[{id:"48951",title:"Peripartum Hysterectomy",slug:"peripartum-hysterectomy-",totalDownloads:2004,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"Peripartum hysterectomy is uncommon in modern obstetrics. It is mostly performed as an emergency procedure to control life-threatening haemorrhage. Despite recent technical advances in medicine, it is associated with high rates of morbidity and mortality. Peripartum hysterectomy constitutes a life-saving procedure.",book:{id:"4641",slug:"approaches-to-hysterectomy",title:"Approaches to Hysterectomy",fullTitle:"Approaches to Hysterectomy"},signatures:"Zouhair O. Amarin",authors:[{id:"101551",title:"Prof.",name:"Zouhair Odeh",middleName:null,surname:"Amarin",slug:"zouhair-odeh-amarin",fullName:"Zouhair Odeh Amarin"}]},{id:"60935",title:"Pathophysiology of Pelvic Organ Prolapse",slug:"pathophysiology-of-pelvic-organ-prolapse",totalDownloads:1851,totalCrossrefCites:5,totalDimensionsCites:3,abstract:"Pelvic organ support is provided by interaction between the pelvic floor muscle, ligaments and its connective tissues. Failure of anatomical support may result in pelvic organ prolapse. Therefore in managing anterior, posterior, or apical compartments prolapse, conceptual understanding of pelvic floor anatomy is essential for the surgeons. To appropriately treat these entities, comprehension of the various theories of the pathophysiology of pelvic organ prolapse is of paramount importance. DeLancey has described vaginal connective tissue support of the pelvis at three levels that has helped us to understand various clinical manifestations of pelvic organ support dysfunction. Pelvic floor disorder is frequently associated with etiological risk factors which include aging, parity, obesity, connective tissue disorder, increased intra-abdominal pressure and hysterectomy. A better understanding of pathophysiology of muscular, collagen, and neuronal components of the pelvic organs and their support would provide an insight of site specific defects and its prevention.",book:{id:"6278",slug:"pelvic-floor-disorders",title:"Pelvic Floor Disorders",fullTitle:"Pelvic Floor Disorders"},signatures:"Lubna Razzak",authors:[{id:"212077",title:"Dr.",name:"Lubna",middleName:null,surname:"Razzak",slug:"lubna-razzak",fullName:"Lubna Razzak"}]},{id:"49153",title:"B-Lynch Compression Suture as an Alternative to Paripartum Hysterectomy",slug:"b-lynch-compression-suture-as-an-alternative-to-paripartum-hysterectomy",totalDownloads:2744,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Obstetrics haemorrhage is a major killer of women of all categories of class, religion, social and economic status. Women of third world countries suffer the most adversity because of poor resources and infrastructure. In major substandard care, haemorrhage emerges as the major cause of severe maternal morbidity in almost all ‘near miss’ audits in both developed and developing countries [1, 2, 24].",book:{id:"4641",slug:"approaches-to-hysterectomy",title:"Approaches to Hysterectomy",fullTitle:"Approaches to Hysterectomy"},signatures:"Christopher Balogun-Lynch and Tahira Aziz Javaid",authors:[{id:"176667",title:"Dr.",name:"Christopher",middleName:null,surname:"Balogun-Lynch",slug:"christopher-balogun-lynch",fullName:"Christopher Balogun-Lynch"},{id:"176773",title:"Dr.",name:"Tahira Aziz",middleName:null,surname:"Javaid",slug:"tahira-aziz-javaid",fullName:"Tahira Aziz Javaid"}]},{id:"61034",title:"Recurrent Pelvic Organ Prolapse",slug:"recurrent-pelvic-organ-prolapse",totalDownloads:1806,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"The treatment of recurrent pelvic organ prolapse is challenging. The pelvic floor symptom needs to be treated, a high quality of life has to be ensured and complications have to be minimized. There is a wide range of surgical options that may be used. The surgeon should be able to discuss and offer native tissue procedures for prolapse. In addition, for the clinically challenging situations of recurrent prolapse, mesh augmented procedures may need to be discussed with the patient. A thorough knowledge of mesh and graft options, as well as knowledge of prolapse recurrence and adverse events rate, can help guide clinicians in counseling their patients effectively. Ultimately, this will allow surgeons to choose a personalized treatment option that best align with a woman’s lifestyle and treatment goals. In this chapter the anatomical concepts of supports of vagina are elaborated. The pelvic diaphragm, lateral attachment of vagina to arcus tendineus fascia pelvis, intrinsic and extrinsic sphincter control mechanisms are elaborated. The surgical techniques of suspending the vaginal vault with autologous tissue and synthetic mesh are discussed. Finally, the role of minimally invasive surgery of pelvic floor is discussed as an integral part of management of recurrent vaginal prolapse.",book:{id:"6278",slug:"pelvic-floor-disorders",title:"Pelvic Floor Disorders",fullTitle:"Pelvic Floor Disorders"},signatures:"Nidhi Sharma and Sudakshina Chakrabarti",authors:[{id:"220214",title:"Prof.",name:"Nidhi",middleName:null,surname:"Sharma",slug:"nidhi-sharma",fullName:"Nidhi Sharma"},{id:"224544",title:"Dr.",name:"Sudakshina",middleName:null,surname:"Chakrabarti",slug:"sudakshina-chakrabarti",fullName:"Sudakshina Chakrabarti"}]},{id:"61308",title:"Effects of Posture and Gravity on Pelvic Organ Prolapse",slug:"effects-of-posture-and-gravity-on-pelvic-organ-prolapse",totalDownloads:1302,totalCrossrefCites:2,totalDimensionsCites:2,abstract:"Female pelvic floor dysfunction occurs when the integrity of the pelvic floor muscles is compromised and impacts the position and function of the pelvic organs. Physicians use international guidelines to evaluate and treat women for POP taking into account that posture and gravity impact pelvic organ position, and degree of prolapse. Our clinical focuses on the description of surface anatomy. This examination alone is insufficient. Although imaging is recommended, the modalities currently available are recognized to have flaws. MRI is performed in the supine position regardless the effect of posture and gravity on POP. A literature search was performed using databases, searching MEDLINE and PubMed using the key terms ultrasound, MRI, and CT. We describe use of a new protocol and advanced technique to evaluate the changes of POP in different positions using open MRI (MRO). POP patients underwent MRO imaging of the pelvic floor using a 0.5 T MRO scanner. The extent of displacement of prolapsed organs was determined using validated reference lines drawn on the mid-sagittal images. Manual segmentation and surface modeling were used to construct the 3D models. MRO offers new levels of anatomic detail; 3D sequences based on 2D images are an additional refinement.",book:{id:"6278",slug:"pelvic-floor-disorders",title:"Pelvic Floor Disorders",fullTitle:"Pelvic Floor Disorders"},signatures:"Marwa Abdulaziz, Lynn Stothers and Andrew Macnab",authors:[{id:"117248",title:"Dr.",name:"Andrew",middleName:null,surname:"Macnab",slug:"andrew-macnab",fullName:"Andrew Macnab"},{id:"183155",title:"Dr.",name:"Lynn",middleName:null,surname:"Stothers",slug:"lynn-stothers",fullName:"Lynn Stothers"},{id:"209987",title:"M.Sc.",name:"Marwa",middleName:"Mohammed",surname:"Abdulaziz",slug:"marwa-abdulaziz",fullName:"Marwa Abdulaziz"}]}],onlineFirstChaptersFilter:{topicId:"1071",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:330,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:9,numberOfPublishedChapters:139,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:122,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:21,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:10,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"August 2nd, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:33,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:4,paginationItems:[{id:"14",title:"Cell and Molecular Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",isOpenForSubmission:!0,editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",biography:"Dr. Rosa María Martínez-Espinosa has been a Spanish Full Professor since 2020 (Biochemistry and Molecular Biology) and is currently Vice-President of International Relations and Cooperation development and leader of the research group 'Applied Biochemistry” (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of Master Programs, Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise and Engagement at the Faculty of Science (University of Alicante). She received her Bachelor in Biology in 1998 (University of Alicante) and her PhD in 2003 (Biochemistry, University of Alicante). She undertook post-doctoral research at the University of East Anglia (Norwich, U.K. 2004-2005; 2007-2008).\nHer multidisciplinary research focuses on investigating archaea and their potential applications in biotechnology. She has an H-index of 21. She has authored one patent and has published more than 70 indexed papers and around 60 book chapters.\nShe has contributed to more than 150 national and international meetings during the last 15 years. Her research interests include archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids and bioplastics production, antioxidant\ncompounds, waste water treatments, and brines bioremediation.\nRosa María’s other roles include editorial board member for several journals related\nto biochemistry, reviewer for more than 60 journals (biochemistry, molecular biology, biotechnology, chemistry and microbiology) and president of several organizing committees in international meetings related to the N-cycle or respiratory processes.",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"15",title:"Chemical Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",isOpenForSubmission:!0,editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",slug:"sukru-beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",biography:"Dr. Şükrü Beydemir obtained a BSc in Chemistry in 1995 from Yüzüncü Yıl University, MSc in Biochemistry in 1998, and PhD in Biochemistry in 2002 from Atatürk University, Turkey. He performed post-doctoral studies at Max-Planck Institute, Germany, and University of Florence, Italy in addition to making several scientific visits abroad. He currently works as a Full Professor of Biochemistry in the Faculty of Pharmacy, Anadolu University, Turkey. Dr. Beydemir has published over a hundred scientific papers spanning protein biochemistry, enzymology and medicinal chemistry, reviews, book chapters and presented several conferences to scientists worldwide. He has received numerous publication awards from various international scientific councils. He serves in the Editorial Board of several international journals. Dr. Beydemir is also Rector of Bilecik Şeyh Edebali University, Turkey.",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",slug:"deniz-ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",biography:"Dr. Deniz Ekinci obtained a BSc in Chemistry in 2004, MSc in Biochemistry in 2006, and PhD in Biochemistry in 2009 from Atatürk University, Turkey. He studied at Stetson University, USA, in 2007-2008 and at the Max Planck Institute of Molecular Cell Biology and Genetics, Germany, in 2009-2010. Dr. Ekinci currently works as a Full Professor of Biochemistry in the Faculty of Agriculture and is the Head of the Enzyme and Microbial Biotechnology Division, Ondokuz Mayıs University, Turkey. He is a member of the Turkish Biochemical Society, American Chemical Society, and German Genetics society. Dr. Ekinci published around ninety scientific papers, reviews and book chapters, and presented several conferences to scientists. He has received numerous publication awards from several scientific councils. Dr. Ekinci serves as the Editor in Chief of four international books and is involved in the Editorial Board of several international journals.",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null},{id:"17",title:"Metabolism",coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",isOpenForSubmission:!0,editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",slug:"yannis-karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",biography:"Yannis Karamanos, born in Greece in 1953, completed his pre-graduate studies at the Université Pierre et Marie Curie, Paris, then his Masters and Doctoral degree at the Université de Lille (1983). He was associate professor at the University of Limoges (1987) before becoming full professor of biochemistry at the Université d’Artois (1996). He worked on the structure-function relationships of glycoconjugates and his main project was the investigations on the biological roles of the de-N-glycosylation enzymes (Endo-N-acetyl-β-D-glucosaminidase and peptide-N4-(N-acetyl-β-glucosaminyl) asparagine amidase). From 2002 he contributes to the understanding of the Blood-brain barrier functioning using proteomics approaches. He has published more than 70 papers. His teaching areas are energy metabolism and regulation, integration and organ specialization and metabolic adaptation.",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null},{id:"18",title:"Proteomics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",isOpenForSubmission:!0,editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",slug:"paolo-iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",biography:"Paolo Iadarola graduated with a degree in Chemistry from the University of Pavia (Italy) in July 1972. He then worked as an Assistant Professor at the Faculty of Science of the same University until 1984. In 1985, Prof. Iadarola became Associate Professor at the Department of Biology and Biotechnologies of the University of Pavia and retired in October 2017. Since then, he has been working as an Adjunct Professor in the same Department at the University of Pavia. His research activity during the first years was primarily focused on the purification and structural characterization of enzymes from animal and plant sources. During this period, Prof. Iadarola familiarized himself with the conventional techniques used in column chromatography, spectrophotometry, manual Edman degradation, and electrophoresis). Since 1995, he has been working on: i) the determination in biological fluids (serum, urine, bronchoalveolar lavage, sputum) of proteolytic activities involved in the degradation processes of connective tissue matrix, and ii) on the identification of biological markers of lung diseases. In this context, he has developed and validated new methodologies (e.g., Capillary Electrophoresis coupled to Laser-Induced Fluorescence, CE-LIF) whose application enabled him to determine both the amounts of biochemical markers (Desmosines) in urine/serum of patients affected by Chronic Obstructive Pulmonary Disease (COPD) and the activity of proteolytic enzymes (Human Neutrophil Elastase, Cathepsin G, Pseudomonas aeruginosa elastase) in sputa of these patients. More recently, Prof. Iadarola was involved in developing techniques such as two-dimensional electrophoresis coupled to liquid chromatography/mass spectrometry (2DE-LC/MS) for the proteomic analysis of biological fluids aimed at the identification of potential biomarkers of different lung diseases. He is the author of about 150 publications (According to Scopus: H-Index: 23; Total citations: 1568- According to WOS: H-Index: 20; Total Citations: 1296) of peer-reviewed international journals. He is a Consultant Reviewer for several journals, including the Journal of Chromatography A, Journal of Chromatography B, Plos ONE, Proteomes, International Journal of Molecular Science, Biotech, Electrophoresis, and others. He is also Associate Editor of Biotech.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",slug:"simona-viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",biography:"Simona Viglio is an Associate Professor of Biochemistry at the Department of Molecular Medicine at the University of Pavia. She has been working since 1995 on the determination of proteolytic enzymes involved in the degradation process of connective tissue matrix and on the identification of biological markers of lung diseases. She gained considerable experience in developing and validating new methodologies whose applications allowed her to determine both the amount of biomarkers (Desmosine and Isodesmosine) in the urine of patients affected by COPD, and the activity of proteolytic enzymes (HNE, Cathepsin G, Pseudomonas aeruginosa elastase) in the sputa of these patients. Simona Viglio was also involved in research dealing with the supplementation of amino acids in patients with brain injury and chronic heart failure. She is presently engaged in the development of 2-DE and LC-MS techniques for the study of proteomics in biological fluids. The aim of this research is the identification of potential biomarkers of lung diseases. She is an author of about 90 publications (According to Scopus: H-Index: 23; According to WOS: H-Index: 20) on peer-reviewed journals, a member of the “Società Italiana di Biochimica e Biologia Molecolare,“ and a Consultant Reviewer for International Journal of Molecular Science, Journal of Chromatography A, COPD, Plos ONE and Nutritional Neuroscience.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:42,paginationItems:[{id:"82914",title:"Glance on the Critical Role of IL-23 Receptor Gene Variations in Inflammation-Induced Carcinogenesis",doi:"10.5772/intechopen.105049",signatures:"Mohammed El-Gedamy",slug:"glance-on-the-critical-role-of-il-23-receptor-gene-variations-in-inflammation-induced-carcinogenesis",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Chemokines Updates",coverURL:"https://cdn.intechopen.com/books/images_new/11672.jpg",subseries:{id:"18",title:"Proteomics"}}},{id:"82875",title:"Lipidomics as a Tool in the Diagnosis and Clinical Therapy",doi:"10.5772/intechopen.105857",signatures:"María Elizbeth Alvarez Sánchez, Erick Nolasco Ontiveros, Rodrigo Arreola, Adriana Montserrat Espinosa González, Ana María García Bores, Roberto Eduardo López Urrutia, Ignacio Peñalosa Castro, María del Socorro Sánchez Correa and Edgar Antonio Estrella Parra",slug:"lipidomics-as-a-tool-in-the-diagnosis-and-clinical-therapy",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Fatty Acids - Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/11669.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82440",title:"Lipid Metabolism and Associated Molecular Signaling Events in Autoimmune Disease",doi:"10.5772/intechopen.105746",signatures:"Mohan Vanditha, Sonu Das and Mathew John",slug:"lipid-metabolism-and-associated-molecular-signaling-events-in-autoimmune-disease",totalDownloads:17,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Fatty Acids - Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/11669.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82483",title:"Oxidative Stress in Cardiovascular Diseases",doi:"10.5772/intechopen.105891",signatures:"Laura Mourino-Alvarez, Tamara Sastre-Oliva, Nerea Corbacho-Alonso and Maria G. Barderas",slug:"oxidative-stress-in-cardiovascular-diseases",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Importance of Oxidative Stress and Antioxidant System in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/11671.jpg",subseries:{id:"15",title:"Chemical Biology"}}}]},overviewPagePublishedBooks:{paginationCount:33,paginationItems:[{type:"book",id:"7006",title:"Biochemistry and Health Benefits of Fatty Acids",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7006.jpg",slug:"biochemistry-and-health-benefits-of-fatty-acids",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Viduranga Waisundara",hash:"c93a00abd68b5eba67e5e719f67fd20b",volumeInSeries:1,fullTitle:"Biochemistry and Health Benefits of Fatty Acids",editors:[{id:"194281",title:"Dr.",name:"Viduranga Y.",middleName:null,surname:"Waisundara",slug:"viduranga-y.-waisundara",fullName:"Viduranga Y. Waisundara",profilePictureURL:"https://mts.intechopen.com/storage/users/194281/images/system/194281.jpg",biography:"Dr. Viduranga Waisundara obtained her Ph.D. in Food Science\nand Technology from the Department of Chemistry, National\nUniversity of Singapore, in 2010. She was a lecturer at Temasek Polytechnic, Singapore from July 2009 to March 2013.\nShe relocated to her motherland of Sri Lanka and spearheaded the Functional Food Product Development Project at the\nNational Institute of Fundamental Studies from April 2013 to\nOctober 2016. She was a senior lecturer on a temporary basis at the Department of\nFood Technology, Faculty of Technology, Rajarata University of Sri Lanka. She is\ncurrently Deputy Principal of the Australian College of Business and Technology –\nKandy Campus, Sri Lanka. She is also the Global Harmonization Initiative (GHI)",institutionString:"Australian College of Business & Technology",institution:{name:"Kobe College",institutionURL:null,country:{name:"Japan"}}}]},{type:"book",id:"6820",title:"Keratin",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6820.jpg",slug:"keratin",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Miroslav Blumenberg",hash:"6def75cd4b6b5324a02b6dc0359896d0",volumeInSeries:2,fullTitle:"Keratin",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}}]},{type:"book",id:"7978",title:"Vitamin A",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7978.jpg",slug:"vitamin-a",publishedDate:"May 15th 2019",editedByType:"Edited by",bookSignature:"Leila Queiroz Zepka, Veridiana Vera de Rosso and Eduardo Jacob-Lopes",hash:"dad04a658ab9e3d851d23705980a688b",volumeInSeries:3,fullTitle:"Vitamin A",editors:[{id:"261969",title:"Dr.",name:"Leila",middleName:null,surname:"Queiroz Zepka",slug:"leila-queiroz-zepka",fullName:"Leila Queiroz Zepka",profilePictureURL:"https://mts.intechopen.com/storage/users/261969/images/system/261969.png",biography:"Prof. Dr. Leila Queiroz Zepka is currently an associate professor in the Department of Food Technology and Science, Federal University of Santa Maria, Brazil. She has more than fifteen years of teaching and research experience. She has published more than 550 scientific publications/communications, including 15 books, 50 book chapters, 100 original research papers, 380 research communications in national and international conferences, and 12 patents. She is a member of the editorial board of five journals and acts as a reviewer for several national and international journals. Her research interests include microalgal biotechnology with an emphasis on microalgae-based products.",institutionString:"Universidade Federal de Santa Maria",institution:{name:"Universidade Federal de Santa Maria",institutionURL:null,country:{name:"Brazil"}}}]},{type:"book",id:"7953",title:"Bioluminescence",subtitle:"Analytical Applications and Basic Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7953.jpg",slug:"bioluminescence-analytical-applications-and-basic-biology",publishedDate:"September 25th 2019",editedByType:"Edited by",bookSignature:"Hirobumi Suzuki",hash:"3a8efa00b71abea11bf01973dc589979",volumeInSeries:4,fullTitle:"Bioluminescence - Analytical Applications and Basic Biology",editors:[{id:"185746",title:"Dr.",name:"Hirobumi",middleName:null,surname:"Suzuki",slug:"hirobumi-suzuki",fullName:"Hirobumi Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/185746/images/system/185746.png",biography:"Dr. Hirobumi Suzuki received his Ph.D. in 1997 from Tokyo Metropolitan University, Japan, where he studied firefly phylogeny and the evolution of mating systems. He is especially interested in the genetic differentiation pattern and speciation process that correlate to the flashing pattern and mating behavior of some fireflies in Japan. He then worked for Olympus Corporation, a Japanese manufacturer of optics and imaging products, where he was involved in the development of luminescence technology and produced a bioluminescence microscope that is currently being used for gene expression analysis in chronobiology, neurobiology, and developmental biology. Dr. Suzuki currently serves as a visiting researcher at Kogakuin University, Japan, and also a vice president of the Japan Firefly Society.",institutionString:"Kogakuin University",institution:null}]}]},openForSubmissionBooks:{paginationCount:2,paginationItems:[{id:"11673",title:"Stem Cell Research",coverURL:"https://cdn.intechopen.com/books/images_new/11673.jpg",hash:"13092df328080c762dd9157be18ca38c",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 13th 2022",isOpenForSubmission:!0,editors:[{id:"203598",title:"Ph.D.",name:"Diana",surname:"Kitala",slug:"diana-kitala",fullName:"Diana Kitala"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"12215",title:"Cell Death and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/12215.jpg",hash:"dfd456a29478fccf4ebd3294137eb1e3",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 29th 2022",isOpenForSubmission:!0,editors:[{id:"59529",title:"Dr.",name:"Ke",surname:"Xu",slug:"ke-xu",fullName:"Ke Xu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:47,paginationItems:[{id:"82938",title:"Trauma from Occlusion: Practical Management Guidelines",doi:"10.5772/intechopen.105960",signatures:"Prashanth Shetty, Shweta Hegde, Shubham Chelkar, Rahul Chaturvedi, Shruti Pochhi, Aakanksha Shrivastava, Dudala Lakshmi, Shreya Mukherjee, Pankaj Bajaj and Shahzada Asif Raza",slug:"trauma-from-occlusion-practical-management-guidelines",totalDownloads:5,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82654",title:"Atraumatic Restorative Treatment: More than a Minimally Invasive Approach?",doi:"10.5772/intechopen.105623",signatures:"Manal A. Ablal",slug:"atraumatic-restorative-treatment-more-than-a-minimally-invasive-approach",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82608",title:"Early Management of Dental Trauma in the Era of COVID-19",doi:"10.5772/intechopen.105992",signatures:"Khairul Bariah Chi Adam, Haszelini Hassan, Pram Kumar Subramaniam, Izzati Nabilah Ismail, Nor Adilah Harun and Naziyah Shaban Mustafa",slug:"early-management-of-dental-trauma-in-the-era-of-covid-19",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82767",title:"Teeth Avulsion",doi:"10.5772/intechopen.105846",signatures:"Manal Abdalla Eltahir, Randa Fath Elrahman Ibrahim and Hanan Alharbi",slug:"teeth-avulsion",totalDownloads:20,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82735",title:"The Influence of Salivary pH on the Prevalence of Dental Caries",doi:"10.5772/intechopen.106154",signatures:"Laura-Cristina Rusu, Alexandra Roi, Ciprian-Ioan Roi, Codruta Victoria Tigmeanu and Lavinia Cosmina Ardelean",slug:"the-influence-of-salivary-ph-on-the-prevalence-of-dental-caries",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"82288",title:"Dental Emergency and Conditions",doi:"10.5772/intechopen.105495",signatures:"Navneet Kaur",slug:"dental-emergency-and-conditions",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"81961",title:"Antioxidants as an Adjuncts to Periodontal Therapy",doi:"10.5772/intechopen.105016",signatures:"Sura Dakhil Jassim and Ali Abbas Abdulkareem",slug:"antioxidants-as-an-adjuncts-to-periodontal-therapy",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Trauma",coverURL:"https://cdn.intechopen.com/books/images_new/11567.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"82357",title:"Caries Management Aided by Fluorescence-Based Devices",doi:"10.5772/intechopen.105567",signatures:"Atena Galuscan, Daniela Jumanca and Aurora Doris Fratila",slug:"caries-management-aided-by-fluorescence-based-devices",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"81894",title:"Diet and Nutrition and Their Relationship with Early Childhood Dental Caries",doi:"10.5772/intechopen.105123",signatures:"Luanna Gonçalves Ferreira, Giuliana de Campos Chaves Lamarque and Francisco Wanderley Garcia Paula-Silva",slug:"diet-and-nutrition-and-their-relationship-with-early-childhood-dental-caries",totalDownloads:20,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Dental Caries - The Selection of Restoration Methods and Restorative Materials",coverURL:"https://cdn.intechopen.com/books/images_new/11565.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"80963",title:"Pain Perception in Patients Treated with Ligating/Self-Ligating Brackets versus Patients Treated with Aligners",doi:"10.5772/intechopen.102796",signatures:"Farid Bourzgui, Rania Fastani, Salwa Khairat, Samir Diouny, Mohamed El Had, Zineb Serhier and Mohamed Bennani Othmani",slug:"pain-perception-in-patients-treated-with-ligating-self-ligating-brackets-versus-patients-treated-wit",totalDownloads:31,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Current Trends in Orthodontics",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}}]},subseriesFiltersForOFChapters:[{caption:"Prosthodontics and Implant Dentistry",value:2,count:22,group:"subseries"},{caption:"Oral Health",value:1,count:25,group:"subseries"}],publishedBooks:{paginationCount:12,paginationItems:[{type:"book",id:"9883",title:"Biosensors",subtitle:"Current and Novel Strategies for Biosensing",coverURL:"https://cdn.intechopen.com/books/images_new/9883.jpg",slug:"biosensors-current-and-novel-strategies-for-biosensing",publishedDate:"May 5th 2021",editedByType:"Edited by",bookSignature:"Luis Jesús Villarreal-Gómez and Ana Leticia Iglesias",hash:"028f3e5dbf9c32590183ac4b4f0a2825",volumeInSeries:11,fullTitle:"Biosensors - Current and Novel Strategies for Biosensing",editors:[{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",slug:"luis-villarreal-gomez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9959",title:"Biomedical Signal and Image Processing",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9959.jpg",slug:"biomedical-signal-and-image-processing",publishedDate:"April 14th 2021",editedByType:"Edited by",bookSignature:"Yongxia Zhou",hash:"22b87a09bd6df065d78c175235d367c8",volumeInSeries:10,fullTitle:"Biomedical Signal and Image Processing",editors:[{id:"259308",title:"Dr.",name:"Yongxia",middleName:null,surname:"Zhou",slug:"yongxia-zhou",fullName:"Yongxia Zhou",profilePictureURL:"https://mts.intechopen.com/storage/users/259308/images/system/259308.jpeg",institutionString:"University of Southern California",institution:{name:"University of Southern California",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9973",title:"Data Acquisition",subtitle:"Recent Advances and Applications in Biomedical Engineering",coverURL:"https://cdn.intechopen.com/books/images_new/9973.jpg",slug:"data-acquisition-recent-advances-and-applications-in-biomedical-engineering",publishedDate:"March 17th 2021",editedByType:"Edited by",bookSignature:"Bartłomiej Płaczek",hash:"75ea6cdd241216c9db28aa734ab34446",volumeInSeries:9,fullTitle:"Data Acquisition - Recent Advances and Applications in Biomedical Engineering",editors:[{id:"313277",title:"Dr.",name:"Bartłomiej",middleName:null,surname:"Płaczek",slug:"bartlomiej-placzek",fullName:"Bartłomiej Płaczek",profilePictureURL:"https://mts.intechopen.com/storage/users/313277/images/system/313277.jpg",institutionString:"University of Silesia",institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9905",title:"Biometric Systems",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9905.jpg",slug:"biometric-systems",publishedDate:"February 10th 2021",editedByType:"Edited by",bookSignature:"Muhammad Sarfraz",hash:"c730560dd2e3837a03407b3a86b0ef2a",volumeInSeries:8,fullTitle:"Biometric Systems",editors:[{id:"215610",title:"Prof.",name:"Muhammad",middleName:null,surname:"Sarfraz",slug:"muhammad-sarfraz",fullName:"Muhammad Sarfraz",profilePictureURL:"https://mts.intechopen.com/storage/users/215610/images/system/215610.jpeg",institutionString:"Kuwait University",institution:{name:"Kuwait University",institutionURL:null,country:{name:"Kuwait"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8622",title:"Peptide Synthesis",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8622.jpg",slug:"peptide-synthesis",publishedDate:"December 18th 2019",editedByType:"Edited by",bookSignature:"Jaya T. Varkey",hash:"de9fa48c5248dbfb581825b8c74f5623",volumeInSeries:0,fullTitle:"Peptide Synthesis",editors:[{id:"246502",title:"Dr.",name:"Jaya T.",middleName:"T",surname:"Varkey",slug:"jaya-t.-varkey",fullName:"Jaya T. Varkey",profilePictureURL:"https://mts.intechopen.com/storage/users/246502/images/11160_n.jpg",institutionString:"St. Teresa’s College",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7497",title:"Computer Vision in Dentistry",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7497.jpg",slug:"computer-vision-in-dentistry",publishedDate:"September 18th 2019",editedByType:"Edited by",bookSignature:"Monika Elzbieta Machoy",hash:"1e9812cebd46ef9e28257f3e96547f6a",volumeInSeries:7,fullTitle:"Computer Vision in Dentistry",editors:[{id:"248279",title:"Dr.",name:"Monika",middleName:"Elzbieta",surname:"Machoy",slug:"monika-machoy",fullName:"Monika Machoy",profilePictureURL:"https://mts.intechopen.com/storage/users/248279/images/system/248279.jpeg",institutionString:"Pomeranian Medical University",institution:{name:"Pomeranian Medical University",institutionURL:null,country:{name:"Poland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8633",title:"Novel Diagnostic Methods in Ophthalmology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8633.jpg",slug:"novel-diagnostic-methods-in-ophthalmology",publishedDate:"September 4th 2019",editedByType:"Edited by",bookSignature:"Anna Nowinska",hash:"da2c90e8db647ead30504defce3fb5d3",volumeInSeries:6,fullTitle:"Novel Diagnostic Methods in Ophthalmology",editors:[{id:"261466",title:"Dr.",name:"Anna",middleName:"Karolina",surname:"Nowińska",slug:"anna-nowinska",fullName:"Anna Nowińska",profilePictureURL:"https://mts.intechopen.com/storage/users/261466/images/system/261466.jpeg",institutionString:"Medical University of Silesia",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7437",title:"Nanomedicines",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7437.jpg",slug:"nanomedicines",publishedDate:"February 13th 2019",editedByType:"Edited by",bookSignature:"Muhammad Akhyar Farrukh",hash:"0e1f5f6258f074c533976c4f4d248568",volumeInSeries:5,fullTitle:"Nanomedicines",editors:[{id:"63182",title:"Dr.",name:"Muhammad Akhyar",middleName:null,surname:"Farrukh",slug:"muhammad-akhyar-farrukh",fullName:"Muhammad Akhyar Farrukh",profilePictureURL:"https://mts.intechopen.com/storage/users/63182/images/system/63182.png",institutionString:"Forman Christian College",institution:{name:"Forman Christian College",institutionURL:null,country:{name:"Pakistan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6843",title:"Biomechanics",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6843.jpg",slug:"biomechanics",publishedDate:"January 30th 2019",editedByType:"Edited by",bookSignature:"Hadi Mohammadi",hash:"85132976010be1d7f3dbd88662b785e5",volumeInSeries:4,fullTitle:"Biomechanics",editors:[{id:"212432",title:"Prof.",name:"Hadi",middleName:null,surname:"Mohammadi",slug:"hadi-mohammadi",fullName:"Hadi Mohammadi",profilePictureURL:"https://mts.intechopen.com/storage/users/212432/images/system/212432.jpeg",institutionString:"University of British Columbia",institution:{name:"University of British Columbia",institutionURL:null,country:{name:"Canada"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7560",title:"Non-Invasive Diagnostic Methods",subtitle:"Image Processing",coverURL:"https://cdn.intechopen.com/books/images_new/7560.jpg",slug:"non-invasive-diagnostic-methods-image-processing",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Mariusz Marzec and Robert Koprowski",hash:"d92fd8cf5a90a47f2b8a310837a5600e",volumeInSeries:3,fullTitle:"Non-Invasive Diagnostic Methods - Image Processing",editors:[{id:"253468",title:"Dr.",name:"Mariusz",middleName:null,surname:"Marzec",slug:"mariusz-marzec",fullName:"Mariusz Marzec",profilePictureURL:"https://mts.intechopen.com/storage/users/253468/images/system/253468.png",institutionString:"University of Silesia",institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7218",title:"OCT",subtitle:"Applications in Ophthalmology",coverURL:"https://cdn.intechopen.com/books/images_new/7218.jpg",slug:"oct-applications-in-ophthalmology",publishedDate:"September 19th 2018",editedByType:"Edited by",bookSignature:"Michele Lanza",hash:"e3a3430cdfd6999caccac933e4613885",volumeInSeries:2,fullTitle:"OCT - Applications in Ophthalmology",editors:[{id:"240088",title:"Prof.",name:"Michele",middleName:null,surname:"Lanza",slug:"michele-lanza",fullName:"Michele Lanza",profilePictureURL:"https://mts.intechopen.com/storage/users/240088/images/system/240088.png",institutionString:'University of Campania "Luigi Vanvitelli"',institution:{name:'University of Campania "Luigi Vanvitelli"',institutionURL:null,country:{name:"Italy"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6692",title:"Medical and Biological Image Analysis",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6692.jpg",slug:"medical-and-biological-image-analysis",publishedDate:"July 4th 2018",editedByType:"Edited by",bookSignature:"Robert Koprowski",hash:"e75f234a0fc1988d9816a94e4c724deb",volumeInSeries:1,fullTitle:"Medical and Biological Image Analysis",editors:[{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",slug:"robert-koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",value:9,count:1},{group:"subseries",caption:"Bioinspired Technology and Biomechanics",value:8,count:2},{group:"subseries",caption:"Bioinformatics and Medical Informatics",value:7,count:9}],publicationYearFilters:[{group:"publicationYear",caption:"2021",value:2021,count:4},{group:"publicationYear",caption:"2019",value:2019,count:5},{group:"publicationYear",caption:"2018",value:2018,count:3}],authors:{paginationCount:302,paginationItems:[{id:"280338",title:"Dr.",name:"Yutaka",middleName:null,surname:"Tsutsumi",slug:"yutaka-tsutsumi",fullName:"Yutaka Tsutsumi",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/280338/images/7961_n.jpg",biography:null,institutionString:null,institution:{name:"Fujita Health University",country:{name:"Japan"}}},{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/116250/images/system/116250.jpg",biography:"Professor Nima Rezaei obtained an MD from Tehran University of Medical Sciences, Iran. He also obtained an MSc in Molecular and Genetic Medicine, and a Ph.D. in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also completed a short-term fellowship in Pediatric Clinical Immunology and Bone Marrow Transplantation at Newcastle General Hospital, England. Dr. Rezaei is a Full Professor of Immunology and Vice Dean of International Affairs and Research, at the School of Medicine, Tehran University of Medical Sciences, and the co-founder and head of the Research Center for Immunodeficiencies. He is also the founding president of the Universal Scientific Education and Research Network (USERN). Dr. Rezaei has directed more than 100 research projects and has designed and participated in several international collaborative projects. He is an editor, editorial assistant, or editorial board member of more than forty international journals. He has edited more than 50 international books, presented more than 500 lectures/posters in congresses/meetings, and published more than 1,100 scientific papers in international journals.",institutionString:"Tehran University of Medical Sciences",institution:{name:"Tehran University of Medical Sciences",country:{name:"Iran"}}},{id:"180733",title:"Dr.",name:"Jean",middleName:null,surname:"Engohang-Ndong",slug:"jean-engohang-ndong",fullName:"Jean Engohang-Ndong",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/180733/images/system/180733.png",biography:"Dr. Jean Engohang-Ndong was born and raised in Gabon. After obtaining his Associate Degree of Science at the University of Science and Technology of Masuku, Gabon, he continued his education in France where he obtained his BS, MS, and Ph.D. in Medical Microbiology. He worked as a post-doctoral fellow at the Public Health Research Institute (PHRI), Newark, NJ for four years before accepting a three-year faculty position at Brigham Young University-Hawaii. Dr. Engohang-Ndong is a tenured faculty member with the academic rank of Full Professor at Kent State University, Ohio, where he teaches a wide range of biological science courses and pursues his research in medical and environmental microbiology. Recently, he expanded his research interest to epidemiology and biostatistics of chronic diseases in Gabon.",institutionString:"Kent State University",institution:{name:"Kent State University",country:{name:"United States of America"}}},{id:"188773",title:"Prof.",name:"Emmanuel",middleName:null,surname:"Drouet",slug:"emmanuel-drouet",fullName:"Emmanuel Drouet",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/188773/images/system/188773.png",biography:"Emmanuel Drouet, PharmD, is a Professor of Virology at the Faculty of Pharmacy, the University Grenoble-Alpes, France. As a head scientist at the Institute of Structural Biology in Grenoble, Dr. Drouet’s research investigates persisting viruses in humans (RNA and DNA viruses) and the balance with our host immune system. He focuses on these viruses’ effects on humans (both their impact on pathology and their symbiotic relationships in humans). He has an excellent track record in the herpesvirus field, and his group is engaged in clinical research in the field of Epstein-Barr virus diseases. He is the editor of the online Encyclopedia of Environment and he coordinates the Universal Health Coverage education program for the BioHealth Computing Schools of the European Institute of Science.",institutionString:null,institution:{name:"Grenoble Alpes University",country:{name:"France"}}},{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",biography:"Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly zoonotic and vector-borne diseases (especially arboviral diseases). He is the president of the Travel Medicine Committee of the Pan-American Infectious Diseases Association (API), as well as the president of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is a vice-president of the Latin American Society for Travel Medicine (SLAMVI) and a Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as a Senior Researcher, at the Ministry of Science of Colombia. He is a professor at the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Americas, in Pereira, Risaralda, Colombia. He is an External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also a professor at the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. In 2021 he has been awarded the “Raul Isturiz Award” Medal of the API. Also, in 2021, he was awarded with the “Jose Felix Patiño” Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions to COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 47 (Google Scholar H index, 68).",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null},{id:"332819",title:"Dr.",name:"Chukwudi Michael",middleName:"Michael",surname:"Egbuche",slug:"chukwudi-michael-egbuche",fullName:"Chukwudi Michael Egbuche",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/332819/images/14624_n.jpg",biography:"I an Dr. Chukwudi Michael Egbuche. I am a Senior Lecturer in the Department of Parasitology and Entomology, Nnamdi Azikiwe University, Awka.",institutionString:null,institution:{name:"Nnamdi Azikiwe University",country:{name:"Nigeria"}}},{id:"284232",title:"Mr.",name:"Nikunj",middleName:"U",surname:"Tandel",slug:"nikunj-tandel",fullName:"Nikunj Tandel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/284232/images/8275_n.jpg",biography:'Mr. Nikunj Tandel has completed his Master\'s degree in Biotechnology from VIT University, India in the year of 2012. He is having 8 years of research experience especially in the field of malaria epidemiology, immunology, and nanoparticle-based drug delivery system against the infectious diseases, autoimmune disorders and cancer. He has worked for the NIH funded-International Center of Excellence in Malaria Research project "Center for the study of complex malaria in India (CSCMi)" in collaboration with New York University. The preliminary objectives of the study are to understand and develop the evidence-based tools and interventions for the control and prevention of malaria in different sites of the INDIA. Alongside, with the help of next-generation genomics study, the team has studied the antimalarial drug resistance in India. Further, he has extended his research in the development of Humanized mice for the study of liver-stage malaria and identification of molecular marker(s) for the Artemisinin resistance. At present, his research focuses on understanding the role of B cells in the activation of CD8+ T cells in malaria. Received the CSIR-SRF (Senior Research Fellow) award-2018, FIMSA (Federation of Immunological Societies of Asia-Oceania) Travel Bursary award to attend the IUIS-IIS-FIMSA Immunology course-2019',institutionString:"Nirma University",institution:{name:"Nirma University",country:{name:"India"}}},{id:"334383",title:"Ph.D.",name:"Simone",middleName:"Ulrich",surname:"Ulrich Picoli",slug:"simone-ulrich-picoli",fullName:"Simone Ulrich Picoli",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/334383/images/15919_n.jpg",biography:"Graduated in Pharmacy from Universidade Luterana do Brasil (1999), Master in Agricultural and Environmental Microbiology from Federal University of Rio Grande do Sul (2002), Specialization in Clinical Microbiology from Universidade de São Paulo, USP (2007) and PhD in Sciences in Gastroenterology and Hepatology (2012). She is currently an Adjunct Professor at Feevale University in Medicine and Biomedicine courses and a permanent professor of the Academic Master\\'s Degree in Virology. She has experience in the field of Microbiology, with an emphasis on Bacteriology, working mainly on the following topics: bacteriophages, bacterial resistance, clinical microbiology and food microbiology.",institutionString:null,institution:{name:"Universidade Feevale",country:{name:"Brazil"}}},{id:"229220",title:"Dr.",name:"Amjad",middleName:"Islam",surname:"Aqib",slug:"amjad-aqib",fullName:"Amjad Aqib",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229220/images/system/229220.png",biography:"Dr. Amjad Islam Aqib obtained a DVM and MSc (Hons) from University of Agriculture Faisalabad (UAF), Pakistan, and a PhD from the University of Veterinary and Animal Sciences Lahore, Pakistan. Dr. Aqib joined the Department of Clinical Medicine and Surgery at UAF for one year as an assistant professor where he developed a research laboratory designated for pathogenic bacteria. Since 2018, he has been Assistant Professor/Officer in-charge, Department of Medicine, Manager Research Operations and Development-ORIC, and President One Health Club at Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan. He has nearly 100 publications to his credit. His research interests include epidemiological patterns and molecular analysis of antimicrobial resistance and modulation and vaccine development against animal pathogens of public health concern.",institutionString:"Cholistan University of Veterinary and Animal Sciences",institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"333753",title:"Dr.",name:"Rais",middleName:null,surname:"Ahmed",slug:"rais-ahmed",fullName:"Rais Ahmed",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/333753/images/20168_n.jpg",biography:null,institutionString:null,institution:{name:"University of Agriculture Faisalabad",country:{name:"Pakistan"}}},{id:"62900",title:"Prof.",name:"Fethi",middleName:null,surname:"Derbel",slug:"fethi-derbel",fullName:"Fethi Derbel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62900/images/system/62900.jpeg",biography:"Professor Fethi Derbel was born in 1960 in Tunisia. He received his medical degree from the Sousse Faculty of Medicine at Sousse, University of Sousse, Tunisia. He completed his surgical residency in General Surgery at the University Hospital Farhat Hached of Sousse and was a member of the Unit of Liver Transplantation in the University of Rennes, France. He then worked in the Department of Surgery at the Sahloul University Hospital in Sousse. Professor Derbel is presently working at the Clinique les Oliviers, Sousse, Tunisia. His hospital activities are mostly concerned with laparoscopic, colorectal, pancreatic, hepatobiliary, and gastric surgery. He is also very interested in hernia surgery and performs ventral hernia repairs and inguinal hernia repairs. He has been a member of the GREPA and Tunisian Hernia Society (THS). During his residency, he managed patients suffering from diabetic foot, and he was very interested in this pathology. For this reason, he decided to coordinate a book project dealing with the diabetic foot. Professor Derbel has published many articles in journals and collaborates intensively with IntechOpen Access Publisher as an editor.",institutionString:"Clinique les Oliviers",institution:null},{id:"300144",title:"Dr.",name:"Meriem",middleName:null,surname:"Braiki",slug:"meriem-braiki",fullName:"Meriem Braiki",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/300144/images/system/300144.jpg",biography:"Dr. Meriem Braiki is a specialist in pediatric surgeon from Tunisia. She was born in 1985. She received her medical degree from the University of Medicine at Sousse, Tunisia. She achieved her surgical residency training periods in Pediatric Surgery departments at University Hospitals in Monastir, Tunis and France.\r\nShe is currently working at the Pediatric surgery department, Sidi Bouzid Hospital, Tunisia. Her hospital activities are mostly concerned with laparoscopic, parietal, urological and digestive surgery. She has published several articles in diffrent journals.",institutionString:"Sidi Bouzid Regional Hospital",institution:null},{id:"229481",title:"Dr.",name:"Erika M.",middleName:"Martins",surname:"de Carvalho",slug:"erika-m.-de-carvalho",fullName:"Erika M. de Carvalho",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/229481/images/6397_n.jpg",biography:null,institutionString:null,institution:{name:"Oswaldo Cruz Foundation",country:{name:"Brazil"}}},{id:"186537",title:"Prof.",name:"Tonay",middleName:null,surname:"Inceboz",slug:"tonay-inceboz",fullName:"Tonay Inceboz",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/186537/images/system/186537.jfif",biography:"I was graduated from Ege University of Medical Faculty (Turkey) in 1988 and completed his Med. PhD degree in Medical Parasitology at the same university. I became an Associate Professor in 2008 and Professor in 2014. I am currently working as a Professor at the Department of Medical Parasitology at Dokuz Eylul University, Izmir, Turkey.\n\nI have given many lectures, presentations in different academic meetings. I have more than 60 articles in peer-reviewed journals, 18 book chapters, 1 book editorship.\n\nMy research interests are Echinococcus granulosus, Echinococcus multilocularis (diagnosis, life cycle, in vitro and in vivo cultivation), and Trichomonas vaginalis (diagnosis, PCR, and in vitro cultivation).",institutionString:"Dokuz Eylül University",institution:{name:"Dokuz Eylül University",country:{name:"Turkey"}}},{id:"71812",title:"Prof.",name:"Hanem Fathy",middleName:"Fathy",surname:"Khater",slug:"hanem-fathy-khater",fullName:"Hanem Fathy Khater",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/71812/images/1167_n.jpg",biography:"Prof. Khater is a Professor of Parasitology at Benha University, Egypt. She studied for her doctoral degree, at the Department of Entomology, College of Agriculture, Food and Natural Resources, University of Missouri, Columbia, USA. She has completed her Ph.D. degrees in Parasitology in Egypt, from where she got the award for “the best scientific Ph.D. dissertation”. She worked at the School of Biological Sciences, Bristol, England, the UK in controlling insects of medical and veterinary importance as a grant from Newton Mosharafa, the British Council. Her research is focused on searching of pesticides against mosquitoes, house flies, lice, green bottle fly, camel nasal botfly, soft and hard ticks, mites, and the diamondback moth as well as control of several parasites using safe and natural materials to avoid drug resistances and environmental contamination.",institutionString:null,institution:{name:"Banha University",country:{name:"Egypt"}}},{id:"99780",title:"Prof.",name:"Omolade",middleName:"Olayinka",surname:"Okwa",slug:"omolade-okwa",fullName:"Omolade Okwa",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/99780/images/system/99780.jpg",biography:"Omolade Olayinka Okwa is presently a Professor of Parasitology at Lagos State University, Nigeria. She has a PhD in Parasitology (1997), an MSc in Cellular Parasitology (1992), and a BSc (Hons) Zoology (1990) all from the University of Ibadan, Nigeria. She teaches parasitology at the undergraduate and postgraduate levels. She was a recipient of a Commonwealth fellowship supported by British Council tenable at the Centre for Entomology and Parasitology (CAEP), Keele University, United Kingdom between 2004 and 2005. She was awarded an Honorary Visiting Research Fellow at the same university from 2005 to 2007. \nShe has been an external examiner to the Department of Veterinary Microbiology and Parasitology, University of Ibadan, MSc programme between 2010 and 2012. She is a member of the Nigerian Society of Experimental Biology (NISEB), Parasitology and Public Health Society of Nigeria (PPSN), Science Association of Nigeria (SAN), Zoological Society of Nigeria (ZSN), and is Vice Chairperson of the Organisation of Women in Science (OWSG), LASU chapter. She served as Head of Department of Zoology and Environmental Biology, Lagos State University from 2007 to 2010 and 2014 to 2016. She is a reviewer for several local and international journals such as Unilag Journal of Science, Libyan Journal of Medicine, Journal of Medicine and Medical Sciences, and Annual Research and Review in Science. \nShe has authored 45 scientific research publications in local and international journals, 8 scientific reviews, 4 books, and 3 book chapters, which includes the books “Malaria Parasites” and “Malaria” which are IntechOpen access publications.",institutionString:"Lagos State University",institution:{name:"Lagos State University",country:{name:"Nigeria"}}},{id:"273100",title:"Dr.",name:"Vijay",middleName:null,surname:"Gayam",slug:"vijay-gayam",fullName:"Vijay Gayam",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/273100/images/system/273100.jpeg",biography:"Dr. Vijay Bhaskar Reddy Gayam is currently practicing as an internist at Interfaith Medical Center in Brooklyn, New York, USA. He is also a Clinical Assistant Professor at the SUNY Downstate University Hospital and Adjunct Professor of Medicine at the American University of Antigua. He is a holder of an M.B.B.S. degree bestowed to him by Osmania Medical College and received his M.D. at Interfaith Medical Center. His career goals thus far have heavily focused on direct patient care, medical education, and clinical research. He currently serves in two leadership capacities; Assistant Program Director of Medicine at Interfaith Medical Center and as a Councilor for the American\r\nFederation for Medical Research. As a true academician and researcher, he has more than 50 papers indexed in international peer-reviewed journals. He has also presented numerous papers in multiple national and international scientific conferences. His areas of research interest include general internal medicine, gastroenterology and hepatology. He serves as an editor, editorial board member and reviewer for multiple international journals. His research on Hepatitis C has been very successful and has led to multiple research awards, including the 'Equity in Prevention and Treatment Award” from the New York Department of Health Viral Hepatitis Symposium (2018) and the 'Presidential Poster Award” awarded to him by the American College of Gastroenterology (2018). He was also awarded 'Outstanding Clinician in General Medicine” by Venus International Foundation for his extensive research expertise and services, perform over and above the standard expected in the advancement of healthcare, patient safety and quality of care.",institutionString:"Interfaith Medical Center",institution:{name:"Interfaith Medical Center",country:{name:"United States of America"}}},{id:"93517",title:"Dr.",name:"Clement",middleName:"Adebajo",surname:"Meseko",slug:"clement-meseko",fullName:"Clement Meseko",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/93517/images/system/93517.jpg",biography:"Dr. Clement Meseko obtained DVM and PhD degree in Veterinary Medicine and Virology respectively. He has worked for over 20 years in both private and public sectors including the academia, contributing to knowledge and control of infectious disease. Through the application of epidemiological skill, classical and molecular virological skills, he investigates viruses of economic and public health importance for the mitigation of the negative impact on people, animal and the environment in the context of Onehealth. \r\nDr. Meseko’s field experience on animal and zoonotic diseases and pathogen dynamics at the human-animal interface over the years shaped his carrier in research and scientific inquiries. He has been part of the investigation of Highly Pathogenic Avian Influenza incursions in sub Saharan Africa and monitors swine Influenza (Pandemic influenza Virus) agro-ecology and potential for interspecies transmission. He has authored and reviewed a number of journal articles and book chapters.",institutionString:"National Veterinary Research Institute",institution:{name:"National Veterinary Research Institute",country:{name:"Nigeria"}}},{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:"King George's Medical University",institution:{name:"King George's Medical University",country:{name:"India"}}},{id:"94928",title:"Dr.",name:"Takuo",middleName:null,surname:"Mizukami",slug:"takuo-mizukami",fullName:"Takuo Mizukami",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/94928/images/6402_n.jpg",biography:null,institutionString:null,institution:{name:"National Institute of Infectious Diseases",country:{name:"Japan"}}},{id:"233433",title:"Dr.",name:"Yulia",middleName:null,surname:"Desheva",slug:"yulia-desheva",fullName:"Yulia Desheva",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/233433/images/system/233433.png",biography:"Dr. Yulia Desheva is a leading researcher at the Institute of Experimental Medicine, St. Petersburg, Russia. She is a professor in the Stomatology Faculty, St. Petersburg State University. She has expertise in the development and evaluation of a wide range of live mucosal vaccines against influenza and bacterial complications. Her research interests include immunity against influenza and COVID-19 and the development of immunization schemes for high-risk individuals.",institutionString:'Federal State Budgetary Scientific Institution "Institute of Experimental Medicine"',institution:null},{id:"238958",title:"Mr.",name:"Atamjit",middleName:null,surname:"Singh",slug:"atamjit-singh",fullName:"Atamjit Singh",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/238958/images/6575_n.jpg",biography:null,institutionString:null,institution:null},{id:"252058",title:"M.Sc.",name:"Juan",middleName:null,surname:"Sulca",slug:"juan-sulca",fullName:"Juan Sulca",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/252058/images/12834_n.jpg",biography:null,institutionString:null,institution:null},{id:"191392",title:"Dr.",name:"Marimuthu",middleName:null,surname:"Govindarajan",slug:"marimuthu-govindarajan",fullName:"Marimuthu Govindarajan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/191392/images/5828_n.jpg",biography:"Dr. M. Govindarajan completed his BSc degree in Zoology at Government Arts College (Autonomous), Kumbakonam, and MSc, MPhil, and PhD degrees at Annamalai University, Annamalai Nagar, Tamil Nadu, India. He is serving as an assistant professor at the Department of Zoology, Annamalai University. His research interests include isolation, identification, and characterization of biologically active molecules from plants and microbes. He has identified more than 20 pure compounds with high mosquitocidal activity and also conducted high-quality research on photochemistry and nanosynthesis. He has published more than 150 studies in journals with impact factor and 2 books in Lambert Academic Publishing, Germany. He serves as an editorial board member in various national and international scientific journals.",institutionString:null,institution:null},{id:"274660",title:"Dr.",name:"Damodar",middleName:null,surname:"Paudel",slug:"damodar-paudel",fullName:"Damodar Paudel",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/274660/images/8176_n.jpg",biography:"I am DrDamodar Paudel,currently working as consultant Physician in Nepal police Hospital.",institutionString:null,institution:null},{id:"241562",title:"Dr.",name:"Melvin",middleName:null,surname:"Sanicas",slug:"melvin-sanicas",fullName:"Melvin Sanicas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/241562/images/6699_n.jpg",biography:null,institutionString:null,institution:null},{id:"322007",title:"Dr.",name:"Maria Elizbeth",middleName:null,surname:"Alvarez-Sánchez",slug:"maria-elizbeth-alvarez-sanchez",fullName:"Maria Elizbeth Alvarez-Sánchez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",country:{name:"Mexico"}}},{id:"337443",title:"Dr.",name:"Juan",middleName:null,surname:"A. Gonzalez-Sanchez",slug:"juan-a.-gonzalez-sanchez",fullName:"Juan A. Gonzalez-Sanchez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Puerto Rico System",country:{name:"United States of America"}}},{id:"337446",title:"Dr.",name:"Maria",middleName:null,surname:"Zavala-Colon",slug:"maria-zavala-colon",fullName:"Maria Zavala-Colon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Puerto Rico, Medical Sciences Campus",country:{name:"United States of America"}}},{id:"338856",title:"Mrs.",name:"Nur Alvira",middleName:null,surname:"Pascawati",slug:"nur-alvira-pascawati",fullName:"Nur Alvira Pascawati",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universitas Respati Yogyakarta",country:{name:"Indonesia"}}}]}},subseries:{item:{id:"94",type:"subseries",title:"Climate Change and Environmental Sustainability",keywords:"Environmental Protection, Socio-economic Development, Resource Exploitation, Environmental Degradation, Climate Change, Degraded Ecosystems, Biodiversity Loss",scope:"\r\n\tSustainable development focuses on linking economic development with environmental protection and social development to ensure future prosperity for people and the planet. To tackle global challenges of development and environment, the United Nations General Assembly in 2015 adopted the 17 Sustainable Development Goals. SDGs emphasize that environmental sustainability should be strongly linked to socio-economic development, which should be decoupled from escalating resource use and environmental degradation for the purpose of reducing environmental stress, enhancing human welfare, and improving regional equity. Moreover, sustainable development seeks a balance between human development and decrease in ecological/environmental marginal benefits. Under the increasing stress of climate change, many environmental problems have emerged causing severe impacts at both global and local scales, driving ecosystem service reduction and biodiversity loss. Humanity’s relationship with resource exploitation and environment protection is a major global concern, as new threats to human and environmental security emerge in the Anthropocene. Currently, the world is facing significant challenges in environmental sustainability to protect global environments and to restore degraded ecosystems, while maintaining human development with regional equality. Thus, environmental sustainability with healthy natural ecosystems is critical to maintaining human prosperity in our warming planet.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/94.jpg",hasOnlineFirst:!0,hasPublishedBooks:!1,annualVolume:11978,editor:{id:"61855",title:"Dr.",name:"Yixin",middleName:null,surname:"Zhang",slug:"yixin-zhang",fullName:"Yixin Zhang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYWJgQAO/Profile_Picture_2022-06-09T11:36:35.jpg",biography:"Professor Yixin Zhang is an aquatic ecologist with over 30 years of research and teaching experience in three continents (Asia, Europe, and North America) in Stream Ecology, Riparian Ecology, Urban Ecology, and Ecosystem Restoration and Aquatic Conservation, Human-Nature Interactions and Sustainability, Urbanization Impact on Aquatic Ecosystems. He got his Ph.D. in Animal Ecology at Umeå University in Sweden in 1998. He conducted postdoc research in stream ecology at the University of California at Santa Barbara in the USA. After that, he was a postdoc research fellow at the University of British Columbia in Canada to do research on large-scale stream experimental manipulation and watershed ecological survey in temperate rainforests of BC. He was a faculty member at the University of Hong Kong to run ecological research projects on aquatic insects, fishes, and newts in Tropical Asian streams. He also conducted research in streams, rivers, and caves in Texas, USA, to study the ecology of macroinvertebrates, big-claw river shrimp, fish, turtles, and bats. Current research interests include trophic flows across ecosystems; watershed impacts of land-use change on biodiversity and ecosystem functioning; ecological civilization and water resource management; urban ecology and urban/rural sustainable development.",institutionString:null,institution:{name:"Soochow University",institutionURL:null,country:{name:"China"}}},editorTwo:null,editorThree:null,series:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:"2753-6580"},editorialBoard:[{id:"267257",title:"Dr.",name:"Wame",middleName:null,surname:"Hambira",slug:"wame-hambira",fullName:"Wame Hambira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRZhvQAG/Profile_Picture_2022-06-09T08:16:15.jpg",institutionString:"Botswana University of Agriculture and Natural Resources, Botswana",institution:null},{id:"256906",title:"Dr.",name:"Zenebe",middleName:null,surname:"Mekonnen",slug:"zenebe-mekonnen",fullName:"Zenebe Mekonnen",profilePictureURL:"https://mts.intechopen.com/storage/users/256906/images/20300_n.jpg",institutionString:null,institution:{name:"Ethiopian Environment and Forest Research Institute",institutionURL:null,country:{name:"Ethiopia"}}}]},onlineFirstChapters:{paginationCount:8,paginationItems:[{id:"82858",title:"Corporate Social Responsibility a Case of the Provision of Recreational Facilities",doi:"10.5772/intechopen.105608",signatures:"Peter Musa Wash, Shida Irwana Omar, Badaruddin Mohamed and Mohd Ismail Isa",slug:"corporate-social-responsibility-a-case-of-the-provision-of-recreational-facilities",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82405",title:"Does Board Structure Matter in CSR Spending of Commercial Banks? Empirical Evidence from an Emerging Economy",doi:"10.5772/intechopen.105589",signatures:"Bishnu Kumar Adhikary and Ranjan Kumar Mitra",slug:"does-board-structure-matter-in-csr-spending-of-commercial-banks-empirical-evidence-from-an-emerging-",totalDownloads:17,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82395",title:"Toward a Better Understanding of Green Human Resource Management’s Impact on Green Competitive Advantage: A Conceptual Model",doi:"10.5772/intechopen.105528",signatures:"Hosna Hossari and Kaoutar Elfahli",slug:"toward-a-better-understanding-of-green-human-resource-management-s-impact-on-green-competitive-advan",totalDownloads:26,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82269",title:"CSR Reporting and Blockchain Technology",doi:"10.5772/intechopen.105512",signatures:"Pattarake Sarajoti, Pattanaporn Chatjuthamard, Suwongrat Papangkorn and Piyachart Phiromswad",slug:"csr-reporting-and-blockchain-technology",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82270",title:"From Corporate Social Opportunity to Corporate Social Responsibility",doi:"10.5772/intechopen.105445",signatures:"Brian Bolton",slug:"from-corporate-social-opportunity-to-corporate-social-responsibility",totalDownloads:14,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82339",title:"Green Human Resource Management: An Exploratory Study from Moroccan ISO 14001 Certified Companies",doi:"10.5772/intechopen.105565",signatures:"Hosna Hossari and Kaoutar Elfahli",slug:"green-human-resource-management-an-exploratory-study-from-moroccan-iso-14001-certified-companies",totalDownloads:15,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82194",title:"CSR and Female Directors: A Review and Future Research Agenda",doi:"10.5772/intechopen.105112",signatures:"Pattarake Sarajoti, Pattanaporn Chatjuthamard, Suwongrat Papangkorn and Sirimon Treepongkaruna",slug:"csr-and-female-directors-a-review-and-future-research-agenda",totalDownloads:17,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"81831",title:"Deep Network Model and Regression Analysis using OLS Method for Predicting Lung Vital Capacity",doi:"10.5772/intechopen.104737",signatures:"Harun Sümbül",slug:"deep-network-model-and-regression-analysis-using-ols-method-for-predicting-lung-vital-capacity",totalDownloads:18,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Decision Science - Recent Advances and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11604.jpg",subseries:{id:"86",title:"Business and Management"}}}]},publishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"11392",title:"Leadership in a Changing World",subtitle:"A Multidimensional Perspective",coverURL:"https://cdn.intechopen.com/books/images_new/11392.jpg",slug:"leadership-in-a-changing-world-a-multidimensional-perspective",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Muhammad Mohiuddin, Bilal Khalid, Md. Samim Al Azad and Slimane Ed-dafali",hash:"86a6d33cf601587e591064ce92effc02",volumeInSeries:1,fullTitle:"Leadership in a Changing World - A Multidimensional Perspective",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",institutionString:"Université Laval",institution:{name:"Université Laval",institutionURL:null,country:{name:"Canada"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:33,numberOfPublishedChapters:330,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:18,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:14,numberOfPublishedChapters:145,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:9,numberOfPublishedChapters:139,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:122,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:112,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:21,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:10,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:"2753-6580",doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"7",title:"Biomedical Engineering",doi:"10.5772/intechopen.71985",issn:"2631-5343",scope:"Biomedical Engineering is one of the fastest-growing interdisciplinary branches of science and industry. The combination of electronics and computer science with biology and medicine has improved patient diagnosis, reduced rehabilitation time, and helped to facilitate a better quality of life. Nowadays, all medical imaging devices, medical instruments, or new laboratory techniques result from the cooperation of specialists in various fields. The series of Biomedical Engineering books covers such areas of knowledge as chemistry, physics, electronics, medicine, and biology. This series is intended for doctors, engineers, and scientists involved in biomedical engineering or those wanting to start working in this field.",coverUrl:"https://cdn.intechopen.com/series/covers/7.jpg",latestPublicationDate:"August 3rd, 2022",hasOnlineFirst:!0,numberOfOpenTopics:3,numberOfPublishedChapters:107,numberOfPublishedBooks:12,editor:{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",biography:"Robert Koprowski, MD (1997), PhD (2003), Habilitation (2015), is an employee of the University of Silesia, Poland, Institute of Computer Science, Department of Biomedical Computer Systems. For 20 years, he has studied the analysis and processing of biomedical images, emphasizing the full automation of measurement for a large inter-individual variability of patients. Dr. Koprowski has authored more than a hundred research papers with dozens in impact factor (IF) journals and has authored or co-authored six books. Additionally, he is the author of several national and international patents in the field of biomedical devices and imaging. Since 2011, he has been a reviewer of grants and projects (including EU projects) in biomedical engineering.",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}},subseries:[{id:"7",title:"Bioinformatics and Medical Informatics",keywords:"Biomedical Data, Drug Discovery, Clinical Diagnostics, Decoding Human Genome, AI in Personalized Medicine, Disease-prevention Strategies, Big Data Analysis in Medicine",scope:"Bioinformatics aims to help understand the functioning of the mechanisms of living organisms through the construction and use of quantitative tools. The applications of this research cover many related fields, such as biotechnology and medicine, where, for example, Bioinformatics contributes to faster drug design, DNA analysis in forensics, and DNA sequence analysis in the field of personalized medicine. Personalized medicine is a type of medical care in which treatment is customized individually for each patient. Personalized medicine enables more effective therapy, reduces the costs of therapy and clinical trials, and also minimizes the risk of side effects. Nevertheless, advances in personalized medicine would not have been possible without bioinformatics, which can analyze the human genome and other vast amounts of biomedical data, especially in genetics. The rapid growth of information technology enabled the development of new tools to decode human genomes, large-scale studies of genetic variations and medical informatics. The considerable development of technology, including the computing power of computers, is also conducive to the development of bioinformatics, including personalized medicine. In an era of rapidly growing data volumes and ever lower costs of generating, storing and computing data, personalized medicine holds great promises. Modern computational methods used as bioinformatics tools can integrate multi-scale, multi-modal and longitudinal patient data to create even more effective and safer therapy and disease prevention methods. Main aspects of the topic are: Applying bioinformatics in drug discovery and development; Bioinformatics in clinical diagnostics (genetic variants that act as markers for a condition or a disease); Blockchain and Artificial Intelligence/Machine Learning in personalized medicine; Customize disease-prevention strategies in personalized medicine; Big data analysis in personalized medicine; Translating stratification algorithms into clinical practice of personalized medicine.",annualVolume:11403,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/7.jpg",editor:{id:"351533",title:"Dr.",name:"Slawomir",middleName:null,surname:"Wilczynski",fullName:"Slawomir Wilczynski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035U1loQAC/Profile_Picture_1630074514792",institutionString:null,institution:{name:"Medical University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"5886",title:"Dr.",name:"Alexandros",middleName:"T.",surname:"Tzallas",fullName:"Alexandros Tzallas",profilePictureURL:"https://mts.intechopen.com/storage/users/5886/images/system/5886.png",institutionString:"University of Ioannina, Greece & Imperial College London",institution:{name:"University of Ioannina",institutionURL:null,country:{name:"Greece"}}},{id:"257388",title:"Distinguished Prof.",name:"Lulu",middleName:null,surname:"Wang",fullName:"Lulu Wang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRX6kQAG/Profile_Picture_1630329584194",institutionString:"Shenzhen Technology University",institution:{name:"Shenzhen Technology University",institutionURL:null,country:{name:"China"}}},{id:"225387",title:"Prof.",name:"Reda R.",middleName:"R.",surname:"Gharieb",fullName:"Reda R. Gharieb",profilePictureURL:"https://mts.intechopen.com/storage/users/225387/images/system/225387.jpg",institutionString:"Assiut University",institution:{name:"Assiut University",institutionURL:null,country:{name:"Egypt"}}}]},{id:"8",title:"Bioinspired Technology and Biomechanics",keywords:"Bioinspired Systems, Biomechanics, Assistive Technology, Rehabilitation",scope:'Bioinspired technologies take advantage of understanding the actual biological system to provide solutions to problems in several areas. Recently, bioinspired systems have been successfully employing biomechanics to develop and improve assistive technology and rehabilitation devices. The research topic "Bioinspired Technology and Biomechanics" welcomes studies reporting recent advances in bioinspired technologies that contribute to individuals\' health, inclusion, and rehabilitation. Possible contributions can address (but are not limited to) the following research topics: Bioinspired design and control of exoskeletons, orthoses, and prostheses; Experimental evaluation of the effect of assistive devices (e.g., influence on gait, balance, and neuromuscular system); Bioinspired technologies for rehabilitation, including clinical studies reporting evaluations; Application of neuromuscular and biomechanical models to the development of bioinspired technology.',annualVolume:11404,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/8.jpg",editor:{id:"144937",title:"Prof.",name:"Adriano",middleName:"De Oliveira",surname:"Andrade",fullName:"Adriano Andrade",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRC8QQAW/Profile_Picture_1625219101815",institutionString:null,institution:{name:"Federal University of Uberlândia",institutionURL:null,country:{name:"Brazil"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"49517",title:"Prof.",name:"Hitoshi",middleName:null,surname:"Tsunashima",fullName:"Hitoshi Tsunashima",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTP4QAO/Profile_Picture_1625819726528",institutionString:null,institution:{name:"Nihon University",institutionURL:null,country:{name:"Japan"}}},{id:"425354",title:"Dr.",name:"Marcus",middleName:"Fraga",surname:"Vieira",fullName:"Marcus Vieira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003BJSgIQAX/Profile_Picture_1627904687309",institutionString:null,institution:{name:"Universidade Federal de Goiás",institutionURL:null,country:{name:"Brazil"}}},{id:"196746",title:"Dr.",name:"Ramana",middleName:null,surname:"Vinjamuri",fullName:"Ramana Vinjamuri",profilePictureURL:"https://mts.intechopen.com/storage/users/196746/images/system/196746.jpeg",institutionString:"University of Maryland, Baltimore County",institution:{name:"University of Maryland, Baltimore County",institutionURL:null,country:{name:"United States of America"}}}]},{id:"9",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",keywords:"Biotechnology, Biosensors, Biomaterials, Tissue Engineering",scope:"The Biotechnology - Biosensors, Biomaterials and Tissue Engineering topic within the Biomedical Engineering Series aims to rapidly publish contributions on all aspects of biotechnology, biosensors, biomaterial and tissue engineering. We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics can include but are not limited to: Biotechnology such as biotechnological products and process engineering; Biotechnologically relevant enzymes and proteins; Bioenergy and biofuels; Applied genetics and molecular biotechnology; Genomics, transcriptomics, proteomics; Applied microbial and cell physiology; Environmental biotechnology; Methods and protocols. Moreover, topics in biosensor technology, like sensors that incorporate enzymes, antibodies, nucleic acids, whole cells, tissues and organelles, and other biological or biologically inspired components will be considered, and topics exploring transducers, including those based on electrochemical and optical piezoelectric, thermal, magnetic, and micromechanical elements. Chapters exploring biomaterial approaches such as polymer synthesis and characterization, drug and gene vector design, biocompatibility, immunology and toxicology, and self-assembly at the nanoscale, are welcome. Finally, the tissue engineering subcategory will support topics such as the fundamentals of stem cells and progenitor cells and their proliferation, differentiation, bioreactors for three-dimensional culture and studies of phenotypic changes, stem and progenitor cells, both short and long term, ex vivo and in vivo implantation both in preclinical models and also in clinical trials.",annualVolume:11405,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",editor:{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"35539",title:"Dr.",name:"Cecilia",middleName:null,surname:"Cristea",fullName:"Cecilia Cristea",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYQ65QAG/Profile_Picture_1621007741527",institutionString:null,institution:{name:"Iuliu Hațieganu University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"40735",title:"Dr.",name:"Gil",middleName:"Alberto Batista",surname:"Gonçalves",fullName:"Gil Gonçalves",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYRLGQA4/Profile_Picture_1628492612759",institutionString:null,institution:{name:"University of Aveiro",institutionURL:null,country:{name:"Portugal"}}},{id:"211725",title:"Associate Prof.",name:"Johann F.",middleName:null,surname:"Osma",fullName:"Johann F. Osma",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDv7QAG/Profile_Picture_1626602531691",institutionString:null,institution:{name:"Universidad de Los Andes",institutionURL:null,country:{name:"Colombia"}}},{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",fullName:"Mani T. Valarmathi",profilePictureURL:"https://mts.intechopen.com/storage/users/69697/images/system/69697.jpg",institutionString:"Religen Inc. | A Life Science Company, United States of America",institution:null},{id:"205081",title:"Dr.",name:"Marco",middleName:"Vinícius",surname:"Chaud",fullName:"Marco Chaud",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDGeQAO/Profile_Picture_1622624307737",institutionString:null,institution:{name:"Universidade de Sorocaba",institutionURL:null,country:{name:"Brazil"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/39040",hash:"",query:{},params:{id:"39040"},fullPath:"/chapters/39040",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()